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The objective of studies described in this thesis was to elucidate molecular and cellular 
mechanisms by which caloric restriction (CR) and lithocholic acid (LCA) extend longevity of the 
budding yeast Saccharomyces cerevisiae. Recent studies of how CR influences a pattern of 
metabolism and organelle dynamics in the chronologically aging yeast S. cerevisiae have revealed 
that this low-calorie diet alters age-related dynamics of ethanol metabolism, lipid synthesis and 
degradation, trehalose metabolism, ROS homeostasis maintenance, mitochondrial morphology 
control, mitochondrial functionality preservation, stress response control, cell cycle regulation, 
quiescence maintenance, and apoptotic and liponecrotic death subroutines. Our hypothesis was 
that CR may delay yeast chronological aging by altering the age-related dynamics of some or all 
these cellular processes. Findings presented here support this hypothesis. Indeed, we found that 
CR slows yeast chronological aging by mechanisms that coordinate the spatiotemporal dynamics 
of various cellular processes before entry into a non-proliferative state and after such entry. CR 
causes a stepwise establishment of an aging-delaying cellular pattern by tuning a network that 
assimilates the following: 1) pathways of carbohydrate and lipid metabolism; 2) communications 
between the endoplasmic reticulum, lipid droplets, peroxisomes, mitochondria and the cytosol; 
and 3) a balance between the processes of mitochondrial fusion and fission. Through different 
phases of the aging process, the CR-dependent remodeling of this intricate network 1) postpones 
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the age-related onsets of apoptotic and liponecrotic modes of regulated cell death; and 2) actively 
increases the chance of cell survival by supporting the maintenance of cellular proteostasis. 
Because CR decreases the risk of cell death and actively increases the chance of cell survival 
throughout chronological lifespan, this dietary intervention extends longevity of chronologically 
aging yeast. 
We also used a mass spectrometry-based quantitative analysis of the water-soluble cellular 
metabolome for the investigation of how CR and the longevity-extending tor1Δ mutation (which 
eliminates the Tor1 protein kinase known to orchestrate the nutrient- and energy-sensing TOR 
[target of rapamycin] pro-aging signaling pathway) influence the concentrations of various water- 
soluble metabolites at consecutive stages of the chronological aging process in S. cerevisiae. Our 
investigation provided the first evidence that both the longevity-extending diet CR and the- 
longevity extending mutation tor1Δ establish a similar pattern of relative concentrations of 
methionine metabolism intermediates through the entire process of chronological aging in S. 
cerevisiae. We proposed a hypothesis that the observed redirection of metabolite flow from the 
biosynthesis of methionine and spermidine to the biosynthesis of cysteine and glutathione may 
represent an anti-aging pattern characteristic of the ʺmetabolic signatureʺ of longevity extension 
in chronologically aging yeast cells placed on the CR diet or having the TOR pro-aging signaling 
pathway being inactivated. 
Based on recent findings from the Titorenko laboratory, we hypothesized that the LCA- 
driven changes in mitochondrial lipidome may have a causal role in the age-related remodeling of 
proteome, thus eliciting changes in mitochondrial functionality and delaying yeast chronological 
aging. To test this hypothesis, we used a mass spectrometry-based quantitative analysis to 
investigate how certain mutations that eliminate enzymes involved in mitochondrial phospholipid 
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metabolism influence the mitochondrial proteome and how they affect the geroprotective 
efficiency of LCA in chronologically aging yeast. Our investigation provided the first evidence 
that LCA-driven specific changes in the composition of mitochondrial membrane lipids cause a 
distinct remodeling of mitochondrial proteome by decreasing and increasing concentration of 
many mitochondrial proteins. These proteins have been implicated in such vital mitochondrial 
functions as the ETC and respiration, the TCA cycle, ribosome assembly, amino acid metabolism, 
carbohydrate metabolism, protein import, proteostasis, metabolite synthesis, protein synthesis, 
ATP synthesis, metabolite transport, lipid metabolism, contact sites and cristae maintenance, redox 
homeostasis, mtDNA maintenance, stress response, mRNA synthesis and processing, the 
maintenance of contact sites between mitochondria and vacuoles, and mitochondrial fusion. We 
provided evidence that the LCA-dependent remodeling of mitochondrial lipidome and the 
resulting changes in mitochondrial proteome are essential for the ability of LCA to delay aging. 
Our recent studies have indicated that under CR conditions LCA influences not only the 
composition and functionality of mitochondria but also some cellular processes confined to other 
cellular compartments. We therefore hypothesized that LCA may delay chronological aging of 
yeast limited in calorie supply also because it affects these other cellular processes taking place in 
various cellular locations. To test this hypothesis, we investigated mechanisms through which 
LCA controls the spatiotemporal dynamics of these other cellular processes in different cellular 
locations under CR conditions. Our investigation provided important new insights into the 
mechanisms by which LCA delays yeast chronological aging under CR conditions by altering the 
spatiotemporal dynamics of a cellular network that integrates certain pathways of lipid and 
carbohydrate metabolism, some intercompartmental communications, specific aspects of 
mitochondrial morphology and functionality, and liponecrotic and apoptotic modes of regulated 
cell death. 
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Because LCA triggers major changes in the age-related chronology of several vital 
processes taking place in mitochondria, we hypothesized that LCA may cause these changes by 
eliciting a reversible phosphorylation of some mitochondrial proteins. To test this hypothesis, we 
investigated if an exposure of chronologically aging yeast to exogenous LCA can trigger such 
phosphorylation. We found that LCA elicits the establishment of a distinct phosphoprotein profile 
of mitochondria, which significantly differs from the phosphoprotein profile of mitochondria in 
yeast cells cultured without LCA. 
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The budding yeast Saccharomyces cerevisiae is an advantageous model organism for 
unveiling fundamental mechanisms and biological principles underlying the inherent complexity 
of cellular aging in multicellular eukaryotes [1-6]. Because this unicellular eukaryote is amenable 
to comprehensive biochemical, genetic, cell biological, chemical biological, system biological and 
microfluidic dissection analyses [7-12], its use as a model in aging research provided deep 
mechanistic insights into cellular processes essential for longevity regulation in evolutionarily 
distant eukaryotic organisms. Due to the relatively short and easily monitored chronological and 
replicative lifespans of the yeast S. cerevisiae, it played a pivotal role in discovering: 1) numerous 
genes that impact cellular aging and define organismal longevity not only in yeast but also in 
eukaryotic organisms across phyla; 2) some key nutrient- and energy-sensing signaling pathways 
that orchestrate an evolutionarily conserved set of longevity-defining cellular processes across 
species; and 3) several aging-decelerating and longevity-extending small molecules, many of 
which slow down aging, improve health, attenuate age-related pathologies and delay the onset of 
age-related diseases in evolutionarily distant multicellular eukaryotic organisms [1-6, 13-22]. 
These studies convincingly demonstrated that the signaling pathways governing cellular aging and 
mechanisms of their modulation by longevity-extending genetic, dietary and pharmacological 
interventions are conserved across species. 
 
1.1.1 Two ways of studying S. cerevisiae aging and two groups of mechanisms underlying 
aging of this yeast 
There are two different paradigms of yeast aging. Each of them is traditionally investigated 
separately from each other with the help of robust assays; these assays are conducted under 
controllable laboratory conditions [23-26] and have been recently automated to enable a systems- 
level analysis of the aging process in a high-throughput format [9-12, 27-29]. 
In the chronological aging paradigm, yeast aging is defined by the length of time during 
which a cell remains viable after an arrest of its growth and division [23, 30, 31]. Yeast 
chronological aging under laboratory conditions is assessed using a simple clonogenic assay. This 
assay measures the percentage of yeast cells that in liquid cultures remain viable at different time 
points following entry of a cell population into the non-proliferative stationary phase; cell viability 




surface of a solid nutrient-rich medium [3, 25, 30]. Chronological aging in yeast is believed: 1) to 
mimic aging of non-dividing, post-mitotic cells (such as neurons) in a multicellular eukaryotic 
organism; and 2) to serve as a simple model for organismal aging [32, 33]. 
In the replicative aging paradigm, yeast aging is defined by the maximum number of 
daughter cells that a mother cell can produce before becoming senescent [24, 34, 35]. S. cerevisiae 
reproduces by asymmetric cell division; therefore, its replicative aging under laboratory conditions 
is typically assessed by using a micromanipulator to remove the budding progeny of a mother cell 
and counting the cumulative number of asymmetric mitotic divisions this mother cell could 
undergo [24, 35]. Replicative aging in yeast is thought to mimic aging of dividing, mitotically 
active cells (such as lymphocytes) in a multicellular eukaryotic organism [2, 32]. 
The use of robust assays for elucidating longevity regulation in chronologically or 
replicatively aging yeast under controllable laboratory conditions has significantly advanced our 
understanding of cell-autonomous mechanisms that orchestrate longevity-defining cellular 
processes within an individual cell in eukaryotic organisms across phyla [1-3, 5, 6, 10]. Recent 
studies in yeast also advanced fundamental knowledge about cell-non-autonomous intraspecies 
mechanisms of longevity regulation. Such mechanisms operate within organized populations of 
yeast cells that are attached to solid surfaces to form a colony or a biofilm; these cells: 1) 
communicate with each other and cells in surrounding colonies or biofilms; 2) age chronologically 
and replicatively; and 3) undergo spatially organized growth, differentiation, aging or death, 
depending on their position within the colony [4, 36-43]. 
It seems that cell-autonomous and cell-non-autonomous intraspecies mechanisms 
regulating yeast longevity have evolved in the process of natural selection within an ecosystem 
[44-46]. It has been recently proposed that this process: 1) is governed by ecosystemic interspecies 
mechanisms of lifespan regulation operating within the ecosystem; and 2) is driven by the ability 
of yeast cells to undergo specific pro-survival changes to their metabolism and physiology in 
response to some chemical compounds that, after being released to the ecosystem by other groups 
of organisms, may trigger a hormetic and/or cytostatic response in yeast [44-48]. 
 
1.1.2 Cell-autonomous mechanisms orchestrate longevity-defining cellular processes in 




A body of recent evidence supports the view that certain cellular processes taking place 
early in life of a chronologically aging yeast cell, prior to entry into a non-proliferative state, define 
the length of time during which this cell remains viable after such entry - i.e., define longevity of 
chronologically aging yeast grown under controllable laboratory conditions in liquid media [3, 20, 
23, 49-73]. These longevity-defining cellular processes: 1) are essential for metabolism, growth, 
proliferation, stress resistance, macromolecular homeostasis, survival and death of individual yeast 
cells that age chronologically; and 2) are orchestrated via cell-autonomous mechanisms of lifespan 
regulation operating within these cells. The longevity-defining cellular processes and mechanisms 
orchestrating their progression in chronologically aging yeast prior to entry into a non-proliferative 
state (and, for some of them, after such entry) are outlined below in sections 1.1.3-1.1.6. 
 
1.1.3 Intracellular trehalose modulates cellular protein homeostasis (proteostasis) 
Recent studies revealed that the intracellular concentrations of trehalose prior to cell entry 
into a non-proliferative state and following such entry play essential and differing roles in defining 
longevity of chronologically aging yeast; this is because trehalose is involved in modulating 
protein folding, misfolding, unfolding, refolding, oxidative damage, solubility and aggregation 
throughout lifespan [23, 61] (Figure 1.1A). In chronologically ʺyoungʺ yeast cells, which undergo 
growth and division, trehalose plays an essential longevity-extending role because this non- 
reducing disaccharide: 1) binds to newly synthesized cellular proteins, thereby stabilizing their 
native folding states and attenuating their conversion into aberrantly folded and/or unfolded 
protein species; 2) shields the contiguous exposed hydrophobic side chains of amino acids that are 
abundant in misfolded, partially folded and unfolded protein species and that are known to promote 
their aggregation, thereby eliciting a direct inhibitory effect on the formation of insoluble protein 
aggregates; and 3) protects cellular proteins from oxidative carbonylation by interacting with their 
carbonylation-prone aberrantly folded species, thus having an indirect inhibitory effect on the 
aggregation of oxidatively damaged proteins [23, 61] (Figure 1.1A). In contrast, in chronologically 
ʺoldʺ yeast cells, which do not grow or divide, trehalose plays a key role in shortening longevity. 
This is because in such cells trehalose shields the patches of hydrophobic amino acid residues that 
are abundant in aberrantly folded protein species [61]. Thus, in chronologically ʺoldʺ yeast cells 
trehalose competes with molecular chaperones for binding with these patches of hydrophobic 




partially folded and unfolded protein species [74-77] - either soluble or extracted from protein 
aggregates with the help of molecular chaperones [61] (Figure 1.1A). Importantly, it has been 
demonstrated that a caloric restriction (CR) diet and certain genetic interventions affecting 
trehalose synthesis or degradation extend longevity of chronologically aging yeast because they 
simultaneously: 1) increase the intracellular concentration of trehalose by 70-160% (above its level 
detected in yeast cultured under non-CR conditions) in chronologically ʺyoungʺ, proliferating 
cells; and 2) reduce the intracellular concentration of trehalose by 60-80% (below a threshold 
observed in yeast cultured under non-CR conditions) in chronologically ʺoldʺ, non-proliferating 
cells [61]. These findings suggest the existence of at least two ʺcheckpointsʺ during the lifespan of 
a chronologically aging yeast cell at which the intracellular concentration of trehalose (which 
depends on a balance between trehalose synthesis and degradation) defines its longevity by 
modulating cellular proteostasis. It seems that one of these checkpoints exists early in life of a 
chronologically aging yeast cell (i.e., prior to entry into a non-proliferative state), whereas the 
other checkpoint occurs late in its life (i.e., after such cell enters a non-proliferative state). 
 
1.1.4 Protein import into the peroxisome impacts longevity-defining processes in other 
cellular compartments 
The efficiency of peroxisomal protein import has been shown to decline with the 
chronological age of a eukaryotic cell [57, 58, 78, 79]; such import is driven by Pex5p and Pex7p, 
the peroxisomal targeting signal type 1 (PTS1) and PTS2 cytosolic shuttling receptors, respectively 
[80-82]. Recent findings support the view that the age-dependent efficiency of protein import into 
the peroxisome defines the efficiencies of fatty acid oxidation, hydrogen peroxide turnover and 
anaplerotic metabolism within this organelle; these metabolic processes are known to modulate 
the dynamic communications of peroxisomes with other cellular compartments via a unidirectional 
or bidirectional flow of certain soluble metabolites and lipids [20, 57, 58, 65, 85-89]. By 
influencing longevity-defining cellular processes confined to these other compartments, the 
metabolic processes within the peroxisome cause the development of a pro- or anti-aging cellular 
pattern [20, 54, 57, 58, 65, 83-89]. 
Altogether, these findings suggest a model for how the age-dependent efficiency of 
peroxisomal protein import in chronologically aging yeast defines the age-related metabolic 




compartments and ultimately establishing a pro- or anti-aging cellular pattern (Figure 1.1B). The 
model envisions that chronologically ʺyoungʺ yeast cells develop and maintain an anti-aging 
cellular pattern in part because in these cells the efficiency of Pex5p- and Pex7p-dependent 
peroxisomal protein import exceeds a threshold. Specifically, such ʺyoungʺ cells are proficient in 
peroxisomal import of the following proteins: 1) catalase Cta1p and peroxiredoxin Pmp20p, both 
required for decomposition of hydrogen peroxide and other reactive oxygen species (ROS) within 
the peroxisome; 2) Fox1p, Fox2p and Fox3p, enzymes involved in peroxisomal β-oxidation of 
fatty acids to acetyl-CoA; and 3) the citrate synthase Cit2p and acetyl-carnitine synthase Cat2p, 
both facilitating the replenishment of tricarboxylic acid (TCA) cycle intermediates destined for 
mitochondria by catalyzing the anaplerotic conversion of acetyl-CoA to citrate and acetyl- 
carnitine, respectively [14, 20, 57, 58, 85, 90-92] (Figure 1.1B). The efficient peroxisomal import 
of all these proteins in chronologically ʺyoungʺ yeast cells enables the establishment of an anti- 
aging cellular pattern by: 1) minimizing the oxidative damage to peroxisomal proteins and 
membrane lipids; 2) maintaining the intracellular concentration of peroxisomally produced 
hydrogen peroxide at a threshold which is insufficient to damage cellular macromolecules but can 
activate transcription of nuclear genes essential for cell survival, thus promoting the longevity- 
extending cellular process of “stress-response hormesis”; 3) stimulating the TCA cycle and 
electron transport chain (ETC) in mitochondria, thus enabling to sustain mitochondrially generated 
ROS at a non-toxic level which is sufficient to stimulate transcription of nuclear genes encoding 
stress-protecting and other anti-aging proteins [20, 23, 57, 58, 65, 92] (Figure 1.1B). 
Noteworthy, peroxisomes in yeast house the polyamine oxidase Fms1p, an enzyme involved 
in the synthesis of spermidine [17, 93]. This natural polyamine has been shown to extend longevity 
of chronologically aging yeast by stimulating the essential cytoprotective cellular process of 
autophagy [13, 94, 95] (Figure 1.1B). Because the intracellular concentration of spermidine in 
chronologically ʺ youngʺ yeast exceeds that in chronologically ʺ oldʺ yeast [13], one could speculate 
that peroxisomal import of Fms1p early in life of a chronologically aging yeast cell is more 
efficient than it is late in life, after entry of a chronologically aging yeast cell population into a 
non-proliferative state. In this scenario, chronologically ʺyoungʺ yeast cells develop and maintain 
an anti-aging cellular pattern in part because they are proficient in peroxisomal import of a protein 
needed for the synthesis of a natural polyamine which promotes the longevity-extending cellular 





Figure 1.1. Cell-autonomous mechanisms 
define longevity of chronologically aging yeast 
by orchestrating trehalose metabolism and 
metabolic processes confined to peroxisomes. 
(A) A model for molecular mechanisms through 
which trehalose regulates the process of cellular 
aging in yeast by modulating protein folding, 
misfolding, unfolding, refolding, oxidative 
damage, solubility and aggregation in 
chronologically ʺyoungʺ and ʺoldʺ cells. (B) A 
model for how the age-dependent efficiency of 
peroxisomal protein import in chronologically 
aging yeast defines the age-related metabolic 
pattern of peroxisomes, thus impacting longevity- 
defining processes in other cellular compartments 
and ultimately establishing a pro- or anti-aging 
cellular pattern. Activation arrows and inhibition 
bars denote pro-aging processes (displayed in 
blue color) or anti-aging processes (displayed in 
red color). Please see text for additional details. 
Ac-Carnitine, acetyl-carnitine; Ac-CoA, acetyl- 
CoA; DAG, diacylglycerol; ER, endoplasmic 
reticulum; ETC, electron transport chain; EtOH, 
ethanol; FFA, non-esterified (ʺfreeʺ) fatty acids; 
LD, lipid droplet; ROS, reactive oxygen species; 
TAG, triacylglycerols; TCA, tricarboxylic acid 
cycle; ΔΨm, electrochemical potential across the 
inner mitochondrial membrane. This figure is 
prepared by Anna Leonov, Amanda Piano and 
Veronika Svistkova and has been published in Arlia-Ciommo A, Leonov A, Piano A, Svistkova V, Titorenko VI. Cell- 




Our model further posits that in chronologically ʺoldʺ yeast cells the efficiencies of Pex5p- 
and Pex7p-dependent peroxisomal import of Cta1p, Pmp20p, Fox1p, Fox2p, Fox3p, Cit2p and 
Cat2p markedly decline (Figure 1.1B). Such deterioration of peroxisomal protein import below a 
threshold in these cells causes the development of a pro-aging cellular pattern by: 1) elevating the 
intracellular concentration of peroxisomally produced hydrogen peroxide above a cytotoxic level, 
thus increasing the extent of oxidative damage to cellular macromolecules; 2) reducing the 
efficiency of Fox1p-, Fox2p- and Fox3p-driven peroxisomal oxidation of fatty acids derived from 
triacylglycerols that are synthesized in the endoplasmic reticulum (ER) and deposited within lipid 
droplets (LD) – thus elevating the concentrations of non-esterified (ʺfreeʺ) fatty acids and 
diacylglycerol, both of which are known to elicit an age-related form of liponecrotic programmed 
cell death (PCD); 3) diminishing the replenishment of TCA cycle intermediates destined for the 




mitochondria, lower electrochemical potential across the inner mitochondrial membrane (IMM), 
promote mitochondrial fragmentation, cause the efflux of cytochrome c and other pro-apoptotic 
proteins from fragmented mitochondria, and ultimately elicit an age-related form of apoptotic PCD 
[14, 20, 23, 54, 57, 58, 65, 84, 91, 92, 96-103] (Figure 1.1B). 
Furthermore, our model envisions that chronologically ʺoldʺ yeast cells develop and 
maintain a pro-aging cellular pattern in part because they exhibit a low efficiency of peroxisomal 
import of the polyamine oxidase Fms1p; this enzyme is known to be required for the synthesis of 
spermidine, a natural polyamine which promotes an aging-decelerating cellular process of 
autophagy [13, 17, 93-95] (Figure 1.1B). 
Noteworthy, both chronologically ʺyoungʺ and ʺoldʺ yeast cells grown in a nutrient-rich 
medium under longevity-shortening non-CR conditions have been shown to accumulate ethanol, 
a product of glucose fermentation [23, 84]. Ethanol is known to repress the synthesis of Fox1p, 
Fox2p and Fox3p, thereby suppressing Fox1p-, Fox2p- and Fox3p-driven peroxisomal oxidation 
of fatty acids [90, 104] (Figure 1.1B). By suppressing peroxisomal oxidation of fatty acids to 
acetyl-CoA in chronologically ʺyoungʺ cells under non-CR conditions, the accumulated ethanol 
attenuates the anaplerotic conversion of acetyl-CoA to citrate and acetyl-carnitine - thus inhibiting 
an aging-decelerating cellular process of the replenishment of TCA cycle intermediates destined 
for mitochondria [57, 58, 90, 104] (Figure 1.1B). Moreover, by suppressing peroxisomal oxidation 
of fatty acids to acetyl-CoA in chronologically ʺoldʺ cells under non-CR conditions, the 
accumulated ethanol also elevates the concentrations of non-esterified (ʺfreeʺ) fatty acids and 
diacylglycerol - thus triggering an age-related form of liponecrotic PCD (Figure 1.1B) [14, 23, 54, 
57, 58, 84, 103]. It should be stressed that neither chronologically ʺyoungʺ nor chronologically 
ʺoldʺ yeast cells grown under longevity-extending CR conditions amass ethanol [23, 84]. Such 
inability of yeast cells limited in calorie supply to accumulate ethanol is one of the reasons of why 
they can develop and maintain an anti-aging cellular pattern throughout lifespan [23, 54, 57, 58, 
84] (Figure 1.1B). 
In sum, it is conceivable that there are at least two checkpoints during the lifespan of a 
chronologically aging yeast cell at which the age-dependent efficiency of peroxisomal protein 
import defines the age-related metabolic pattern of peroxisomes, thus impacting longevity- 
defining processes in other cellular compartments and ultimately establishing a pro- or anti-aging 




aging yeast cell (i.e., prior to an arrest of cell growth and division), whereas the other checkpoint 
exists late in its life (i.e., following such arrest). 
 
1.1.5 Coupled mitochondrial respiration, mitochondrial membrane potential and 
mitochondrial ROS production affect longevity-defining processes in other cellular locations 
The functional state of mitochondria and mitochondrial ROS production early in life of a 
chronologically aging yeast cell, prior to entry into a non-proliferative state, have been shown to 
define the length of time during which this cell remains viable after such entry - i.e., define 
longevity of chronologically aging yeast [3, 14, 23, 31, 49-51, 53, 55, 56, 62, 64, 68, 69, 70-73, 
105-108].  One  key  feature  of  the  longevity-defining  functional  state  of  mitochondria  in 
chronologically ʺyoungʺ, proliferating yeast cells is the capacity of electron transport along the 
respiratory chain coupled to ATP synthesis [3, 14, 23, 49-51, 62, 64, 70, 72, 73, 106, 107]. Another 
such key feature is the value of mitochondrial membrane potential; it depends on a balance 
between the capacities of ETC-driven proton transport from the matrix to the intermembrane space 
and proton translocation across the IMM in the opposite direction [3, 14, 23, 50, 51, 56, 64, 70]. 
Moreover, the longevity-defining process of mitochondrial ROS production in chronologically 
ʺyoungʺ yeast cells depends on the efficiency of coupling between the ETC and oxidative 
phosphorylation (OXPHOS) system in mitochondria [50, 51]. 
Recent studies revealed how various genetic, dietary and pharmacological interventions 
having diverse effects on the ETC, OXPHOS system and/or ROS production in mitochondria of 
chronologically ʺyoungʺ yeast impact yeast longevity [3, 14, 23, 31, 49-51, 53, 55, 56, 62, 64, 68, 
69, 70-73, 105-108]. These studies suggest a model for how coupled mitochondrial respiration, 
mitochondrial membrane potential maintenance and mitochondrial ROS production early in life 
of chronologically aging yeast cells define their longevity. This model is depicted schematically 
in Figure 1.2. The model envisions that chronologically ʺyoungʺ yeast cells cultured under non- 
CR conditions develop and maintain a pro-aging cellular pattern because the capacities of these 
mitochondrial processes in such cells are below a certain level (Figure 1.2; these capacities are 
displayed in green color) [23, 53, 62, 72, 73]. Furthermore, the model posits that chronologically 
ʺyoungʺ yeast cells in which the capacities of these mitochondrial processes exceed a critical 
threshold develop and maintain an anti-aging cellular pattern; this is because such capacities have 




longevity-defining processes in other cellular locations (Figure 1.2; these capacities are displayed 
in red color) [14, 23, 50, 51, 56, 62, 64, 70, 73, 107]. The model also predicts that a significant 
further increase in the capacities of coupled mitochondrial respiration, mitochondrial membrane 
potential maintenance and mitochondrial ROS production above a critical threshold in 
chronologically ʺyoungʺ yeast cells has a negative impact on their longevity (Figure 1.2; these 
capacities are displayed in blue color) [14, 23, 64, 107]. 
The capacities of coupled mitochondrial respiration, mitochondrial membrane potential 
maintenance and mitochondrial ROS production in chronologically ʺyoungʺ yeast cells are 
modulated by several ʺupstreamʺ pathways (Figure 1.2). These longevity-defining pathways 
include: 1) the nutrient- and energy-sensing TOR (target of rapamycin) signaling pathway, which 
through the rapamycin-sensitive protein kinase Tor1p inhibits mitochondrial translation of the 
OXPHOS enzymes encoded by mitochondrial DNA (mtDNA) [14, 50, 51, 56, 62]; 2) a CR 
pathway, whose ability to modulate coupled mitochondrial respiration, mitochondrial membrane 
potential maintenance and mitochondrial ROS production in chronologically ʺyoungʺ yeast cells 
is mediated in part by Tor1p [3, 14, 23, 33, 50-52, 56, 62]; 3) a pathway for the maintenance of 
mitochondrial genome integrity and copy number, which is orchestrated by the mitochondrial 
base-excision repair enzyme Ntg1p [108]; 4) the mitophagy pathway of mitochondrial quality 
control responsible for autophagic degradation of aged, dysfunctional or damaged mitochondria - 
which requires the receptor protein Atg32p on the surface of mitochondria destined for such 
degradation [70]; and 5) a pathway for specific remodeling of the membrane lipidome of 
mitochondria - which is stimulated in response to accumulation of the exogenously added 
lithocholic acid (LCA), an anti-aging natural compound, predominantly in the IMM [64, 107] 
(Figure 1.2). Noteworthy, some of these ʺupstreamʺ pathways overlap; such convergent pathways 
modulating the capacities of coupled mitochondrial respiration, mitochondrial membrane potential 
maintenance and mitochondrial ROS production in chronologically ʺ youngʺ yeast include the TOR 
and CR pathways [3, 14, 23, 33, 50-52, 56, 62], as well as the TOR and Ntg1p-governed pathways 
[108]. In contrast, it seems that other ʺupstreamʺ pathways modulating the capacities of these three 
longevity-defining mitochondrial processes do not converge and act in synergy; such ʺparallelʺ 
pathways include: 1) a CR pathway and an LCA-driven pathway for remodeling of the membrane 




Figure 1.2. The functional state of 
mitochondria and mitochondrial ROS 
production in chronologically ʺyoungʺ 
yeast cells define their longevity by 
orchestrating numerous ʺdownstreamʺ 
cellular processes. A model for how coupled 
mitochondrial respiration, mitochondrial 
membrane potential maintenance and 
mitochondrial ROS production early in life of 
chronologically aging yeast cells, prior to 
entry into a non-proliferative state, define their 
viability after such entry - i.e., define their 
longevity. Activation arrows and inhibition 
bars denote pro-aging processes (displayed in 
blue color) or anti-aging processes (displayed 
in red color). Please see text for additional 
details. CR, caloric restriction; D, diauxic 
growth phase; DAG, diacylglycerol; EtOH, 
ethanol; FFA, non-esterified (ʺfreeʺ) fatty 
acids; IMM, inner mitochondrial membrane; 
L, logarithmic growth phase; LCA, lithocholic acid; LD, lipid droplet; PD, post-diauxic growth phase; PS, 
phosphatidylserine; ROS, reactive oxygen species; ST, stationary growth phase; ΔΨm, electrochemical potential 
across the IMM. 
 
 
The capacities of coupled mitochondrial respiration, mitochondrial membrane potential 
maintenance and mitochondrial ROS production in chronologically ʺ youngʺ yeast cells define their 
longevity by orchestrating numerous ʺdownstreamʺ cellular processes throughout lifespan - i.e., 
prior to entry into a non-proliferative state and after such entry (Figure 1.2). Among them are the 
following ʺdownstreamʺ processes (Figure 1.2): 1) the maintenance of trehalose homeostasis, a 
longevity-defining process known to modulate proteostasis in chronologically ʺyoungʺ and ʺoldʺ 
cells [23, 61] (Figure 1.1A); 2) the maintenance of the homeostasis of glycogen, a reserve 
carbohydrate whose elevated level in chronologically ʺyoungʺ and ʺoldʺ cells is a hallmark of 
carbohydrate metabolism remodeling in yeast cultured under CR [23]; 3) the maintenance of the 
homeostasis of neutral lipids deposited within LD, a process known to play an essential role in 




oxidation of fatty acids, a process implicated in yeast chronological aging [14, 23, 91, 92] (Figure 
1.1B); 5) the maintenance of the homeostasis of non-esterified (ʺfreeʺ) fatty acids and 
diacylglycerol, whose reduced levels in chronologically ʺyoungʺ and ʺoldʺ cells are characteristic 
of lipid metabolism remodeling in yeast cultured under CR - a pattern likely linked to the 
demonstrated abilities of both lipid species to elicit an age-related form of liponecrotic PCD [14, 
23, 103] (Figure 1.1B); 6) the maintenance of a balance between the relative rates of glycolysis 
and gluconeogenesis, a process known to impact the level of ethanol in chronologically ʺyoungʺ 
and ʺoldʺ yeast - thus defining the extent to which this product of glucose fermentation suppresses 
the longevity-extending process of peroxisomal oxidation of fatty acids [14, 23] (Figure 1.1B); 7) 
the longevity-extending process of mitochondrial translation [23, 50, 51, 56]; 8) the maintenance 
of a balance between the relative rates of mitochondrial fusion and fission, a process known to 
define the size and number of mitochondria, the length of mitochondrial cristae extending from 
the IMM, and the level of ATP synthesized in mitochondria of chronologically ʺyoungʺ and ʺoldʺ 
yeast [14, 23, 64, 70]; 9) the development of an age-related pattern of susceptibility to chronic 
oxidative, thermal and osmotic stresses [3, 14, 23, 33, 50, 56, 59, 62]; 10) an age-related form of 
apoptotic PCD, which in chronologically ʺ youngʺ yeast is manifested in such early hallmark events 
of this PCD as the fragmentation of a tubular mitochondrial network into individual mitochondria, 
release of cytochrome c from mitochondria into the cytosol and phosphatidylserine (PS) 
translocation from the inner to the outer leaflet of the plasma membrane [14, 23] (Figure 1.1B); 
and 11) the development of a pattern of cell susceptibility to an age-related forms of apoptotic and 
liponecrotic PCD elicited by an exposure to exogenous hydrogen peroxide or palmitoleic acid, 
respectively [14, 23, 59, 103]. 
The molecular mechanisms through which the capacity of mitochondrial ROS production 
in chronologically ʺyoungʺ yeast cells defines their longevity have begun to emerge; they involve 
communication between mitochondria and the nucleus via two signaling pathways [71, 108]. In 
one of these signaling pathways, hormetic concentrations of ROS released from mitochondria 
trigger a pro-longevity transcriptional program in the nucleus by stimulating Gis1p, Msn2p and 
Msn4p [68, 71, 108]; these transcriptional factors are known to activate expression of numerous 
genes essential for the resistance to various stresses, stationary phase survival, carbohydrate 
metabolism, nutrient sensing and chronological longevity assurance [109-111]. Another 




chronologically ʺyoungʺ yeast cells involves a cascade of events within the nucleus. In this 
cascade, the DNA damage response (DDR) kinase Tel1p responds to hormetic concentrations of 
ROS released from mitochondria by phosphorylating and activating the DDR kinase Rad53p. 
Active Rad53p then phosphorylates and inactivates the histone demethylase Rph1p confined to 
subtelomeric chromatin regions, thereby repressing their transcription, minimizing telomeric DNA 
damage and ultimately extending longevity of chronologically aging yeast [68, 71]. Noteworthy, 
it seems that the Tel1p-Rad53p-Rph1p signaling pathway overlaps with and is regulated by the 
ʺupstreamʺ Ntg1p-governed pathway (Figure 1.2) for the maintenance of mitochondrial genome 
integrity and copy number [108]. 
Altogether, these findings suggest that there is a checkpoint early in life of chronologically 
aging yeast cells (i.e., prior to entry into a non-proliferative state) at which the capacities of coupled 
mitochondrial respiration, mitochondrial membrane potential maintenance and mitochondrial 
ROS production define their viability after such entry - i.e., define their longevity. It seems that 
the capacities of these three mitochondrial processes at such checkpoint define yeast longevity by 
orchestrating several ʺdownstreamʺ processes taking place in various cellular locations throughout 
lifespan, before an arrest of cell growth and division and following such arrest. 
 
1.1.6 Metabolite flow within glycolytic and non-glycolytic pathways of carbohydrate 
metabolism defines the establishment of a pro- or anti-aging cellular pattern 
Recent studies provided evidence that the relative rates of reactions comprising glycolytic 
and non-glycolytic pathways of carbohydrate metabolism, as well as the intracellular 
concentrations of some key intermediates in these pathways, define the development and 
maintenance of a pro- or anti-aging cellular pattern in chronologically aging yeast [3, 10, 23, 33, 
52, 54, 57, 58, 63, 65-67, 69, 84, 112-117]. The major findings of these studies can be summarized 
as follows: 1) the establishment of a certain metabolic pattern of such coordinated pathways early 
in life of chronologically aging yeast cells, prior to entry into a non-proliferative state, defines their 
longevity; and 2) some dietary, genetic and pharmacological interventions extend yeast longevity 
by causing a specific remodeling of such metabolic pathways in chronologically ʺyoungʺ, 
proliferating cells [23, 52, 66, 67, 69, 112-117]. These findings suggest a model for how metabolic 




metabolism modulates longevity-defining cellular processes. This model is depicted schematically 
in Figure 1.3. 
 
Figure 1.3. The coordinated 
metabolite flow within glycolytic and 
non-glycolytic  pathways of 
carbohydrate metabolism defines yeast 
longevity by modulating vital cellular 
processes. A model for how metabolic flux 
within the network integrating glycolytic 
and non-glycolytic pathways of 
carbohydrate metabolism in 
chronologically ʺyoungʺ, proliferating 
yeast cells define the development and 
maintenance of a pro- or anti-aging cellular 
pattern throughout lifespan before an arrest 
of cell growth and division and after such 
arrest. Activation arrows and inhibition 
bars denote pro-aging processes (displayed 
in blue color) or anti-aging processes 
(displayed in red color). Please see text for 
additional details. Ac-CoA, acetyl-CoA; 
DHAP, dihydroxyacetone phosphate; 
EtOH, ethanol; GA-3-P, glyceraldehyde-3- 
phosphate; GLR, glutathione reductase; PCD, programmed cell death; TCA, tricarboxylic acid; TORC1, target of 
rapamycin complex 1; TRR, thioredoxin reductase. 
 
 
The model posits that glucose, the primary carbon source used in most assays for 
investigating yeast chronological aging under laboratory conditions, is initially converted to 
pyruvate via the glycolytic pathway and enters the pentose phosphate pathway (PPP) [23, 25, 27, 
30, 33, 57, 66] (Figure 1.3). In chronologically ʺ youngʺ yeast cells progressing through logarithmic 
(L) phase, the PPP generates not only ribose-5-phosphate for nucleic acid synthesis but also 
NADPH, the primary source of cellular reducing equivalents required for the reductive synthesis 
of fatty acids, sterols and some amino acids [60, 63, 66, 118]. Importantly, NADPH - which is 




electron donor essential for sustaining cellular redox homeostasis via thioredoxin and glutathione 
reductase systems [63, 66, 118] (Figure 1.3). These two NADPH-dependent systems have been 
shown to reduce the extent of oxidative damage to numerous thiol-containing cytosolic, nuclear 
and mitochondrial proteins in chronologically ʺyoungʺ yeast cells; as such, both reductase systems 
play essential roles in longevity assurance and underlie, in part, the robust longevity-extending 
effect of CR [63, 66] (Figure 1.3). 
After chronologically aging yeast cells consume glucose during L phase, they enter diauxic 
(D) and then post-diauxic (PD) phases of slow growth [23, 25, 30, 33]. During D and PD phases, 
prior to an arrest of cell growth and division and entry into the non-proliferative stationary (ST) 
phase, the pyruvate formed by glycolysis can enter several alternative pathways of carbon 
metabolism; all these pathways have been implicated in modulating various longevity-defining 
cellular processes [3, 10, 23, 33, 52, 54, 57, 58, 63, 65-67, 69, 84, 112-117]. One of these 
alternative metabolic pathways is fermentation leading to the formation of ethanol and/or acetic 
acid in the cytosol of a chronologically ʺyoungʺ yeast cell; the nature of a product of such 
fermentation depends on the type of a synthetic or nutrient-rich growth medium used and/or 
aeration conditions applied [3, 10, 23, 33, 52, 112-115, 117] (Figure 1.3). As discussed above, the 
level of ethanol in chronologically aging yeast defines the extent to which it suppresses the 
longevity-extending process of peroxisomal oxidation of fatty acids [14, 23] (Figure 1.1B); the 
steady-steady state level of this product of glucose fermentation depends on the relative enzymatic 
activities of Adh1p and Adh2p, which are required for ethanol formation or oxidation, respectively 
[3, 23, 52, 112, 117] (Figure 1.3). Acetic acid, the alternative product of glucose fermentation in 
the cytosol of chronologically ʺyoungʺ yeast cells, shortens their longevity – likely because it can 
elicit an age-related form of apoptotic PCD [3, 27, 113-115] (Figure 1.3). Of note, the Ald6p- 
dependent acetaldehyde dehydrogenase reaction in the cytosol of these cells yields not only acetic 
acid but also NADPH [60, 66, 118] (Figure 1.3). As discussed above, the NADPH-dependent 
thioredoxin and glutathione reductase systems are vital for longevity assurance and are essential 
for the longevity-extending effect of CR because they reduce the extent of oxidative damage to 
many thiol-containing cellular proteins in chronologically ʺ youngʺ yeast cells [63, 66, 118] (Figure 
1.3). Moreover, acetic acid can be converted to acetyl-CoA in the nucleo-cytosolic Acs2p- 
dependent reaction [116, 118]. The acetyl-CoA formed in the nucleus has been shown to shorten 




selectively suppressing transcription of the ATG5, ATG7, ATG11 and ATG14 genes; these genes 
encode proteins needed for the longevity-extending process of autophagy [116] (Figure 1.3). It 
remains to be determine what are the relative impacts of acetic acid (a pro-aging metabolite), 
NADPH (an anti-aging metabolite) and acetyl-CoA (a pro-aging metabolite) on longevity of 
chronologically aging yeast. 
The model depicted in Figure 1.3 further envisions that glucose fermentation to glycerol in 
the cytosol of a chronologically ʺyoungʺ yeast cell operates as a longevity-extending cellular 
process - likely because it reduces metabolite flow into the longevity-shortening cellular process 
of glucose fermentation to ethanol and/or acetic acid [52, 113] (Figure 1.3). The term ʺphantom 
carbon sourceʺ has been coined for defining this aspect of the essential longevity-extending role 
of glycerol in yeast [52]. Glycerol formed by glucose fermentation in the cytosol of a 
chronologically ʺ youngʺ yeast cell has been proposed to extend it lifespan also because it is known 
to reduce cell susceptibility to chronic oxidative, thermal and osmotic stresses [52] (Figure 1.3). 
Furthermore, glucose fermentation to glycerol in chronologically ʺ youngʺ yeast cells may also play 
an essential role in longevity assurance by maintaining an NAD+/NADH ratio characteristic of an 
anti-aging cellular pattern [52] (Figure 1.3). 
In addition to being converted to ethanol, acetic acid, NADPH and/or acetyl-CoA, the 
pyruvate formed by glycolysis can enter the gluconeogenesis pathway leading to the formation of 
glucose; in chronologically aging yeast, this newly synthesized glucose can be further used for the 
synthesis of trehalose [23, 61, 62, 117] (Figure 1.3). As discussed above [23, 61] (Figure 1.1A): 
1) in chronologically ʺyoungʺ yeast cells progressing through D and PD growth phases, trehalose 
plays an essential longevity-extending role by promoting the maintenance of cellular proteostasis, 
whereas 2) in chronologically ʺ oldʺ, non-proliferating cells, trehalose plays a key role in shortening 
longevity because it impairs the chaperone-assisted refolding of misfolded, partially folded and 
unfolded protein species (Figure 1.3). 
In chronologically ʺyoungʺ yeast cells progressing through D and PD growth phases, the 
pyruvate formed by glycolysis - as well as the acetaldehyde and acetate derived from it - can also 
fuel several longevity-defining metabolic processes in mitochondria. One of these metabolic 
processes is the TCA cycle. Two intermediates of the cycle, malate and isocitrate, can be used to 
form NADPH in the Mae1p- and Idp1p-dependent reactions, respectively [60, 66, 118] (Figure 




PD growth phases can also be formed in the Ald4p-dependent acetaldehyde dehydrogenase 
reaction and in the Pos5p-dependent NADH kinase reaction [60, 66, 118] (Figure 1.3). As 
discussed above, NADPH can play a vital longevity-extending role by being used for a 
thioredoxin- and glutathione reductase-driven decrease in the extent of oxidative damage to thiol- 
containing mitochondrial proteins and proteins in other cellular locations [63, 66, 118] (Figure 
1.3). Moreover, the oxaloacetate and α-ketoglutarate intermediates of the TCA cycle in 
mitochondria of chronologically ʺyoungʺ yeast cells progressing through D and PD growth phases 
are known to be used for the synthesis of amino acids [60, 118, 119] (Figure 1.3). After their exit 
from mitochondria to the cytosol, some of these amino acids - including aspartate, asparagine, 
glutamate and glutamine - cause a significant increase in protein kinase activity of the TOR 
complex 1 (TORC1) on the surface of vacuoles [20, 119-124] (Figure 1.3). The resulting 
stimulation of the TOR signaling pathway in chronologically ʺyoungʺ yeast cells is known to 
initiate the establishment of a pro-aging cellular pattern by: 1) activating the longevity-shortening 
process of protein synthesis in the cytosol; 2) suppressing the longevity-extending process of 
autophagy in vacuoles; 3) inhibiting the longevity-extending process of transcription of numerous 
stress-response genes in the nucleus; and 4) suppressing the longevity-extending process of protein 
synthesis in mitochondria [20, 50, 51, 119-124] (Figure 1.3). 
Taken together, these findings strongly suggest that there are several checkpoints early in 
life of chronologically aging yeast cells - during L, D and PD phases preceding entry into the non- 
proliferative ST phase - at which the coordinated metabolite flow within glycolytic and non- 
glycolytic pathways of carbohydrate metabolism defines yeast longevity. It seems that at each of 
these early-life checkpoints some key intermediates in such pathways affect - in a different manner 
and in a concentration-dependent fashion - the vital processes of cell metabolism, growth, 
proliferation, stress resistance, macromolecular homeostasis, survival and death. By modulating 
such longevity-defining cellular processes throughout lifespan - prior to an arrest of cell growth 
and division and following such arrest - these key metabolic intermediates define the development 
and maintenance of a pro- or anti-aging cellular pattern. 
 
1.1.7 A stepwise progression of a biomolecular network of cellular aging through a series of 




The above analysis of the current knowledge about cell-autonomous mechanisms 
underlying chronological aging in yeast suggests the existence of several lifespan checkpoints that 
are critically important for establishing the pace of such aging. A recently reported ability of a 
natural chemical compound to extend longevity of chronologically aging yeast only if added at 
some of these checkpoints [59] supports the notion that a stepwise progression through such 
checkpoints may define the development and maintenance of a pro- or anti-aging cellular pattern. 
Therefore, we extend the recently proposed network theories of yeast chronological aging [3, 20, 
23, 58, 59, 61, 62, 125-127] by putting forward a concept of a biomolecular network underlying 
the chronology of cellular aging in yeast. This concept is depicted schematically in Figure 1.4. The 
concept posits that the network progresses through a series of the early-life checkpoints (that exist 
in L, D and PD phases) and late-life checkpoints (that exist in ST phase). At each of these 
checkpoints, the intracellular concentrations of some key intermediates and products of certain 
metabolic pathways - as well as the rates of coordinated flow of such metabolites within an intricate 
network of intercompartmental (i.e., organelle-organelle and organelle-cytosol) communications - 
are monitored by some checkpoint-specific ʺmaster regulatorʺ proteins (Figure 1.4). The concept 
further envisions that, because each of these master regulator proteins is known for its essential 
role in longevity regulation, their synergistic action at certain early-life and late-life checkpoints 
modulates the rates and efficiencies of progression of such essential processes as cell metabolism, 
growth, proliferation, stress resistance, macromolecular homeostasis, survival and death (Figure 
1.4). The concept predicts that, by modulating these vital cellular processes throughout lifespan - 
prior to an arrest of cell growth and division and following such arrest - the checkpoint-specific 
master regulator proteins orchestrate the development and maintenance of a pro- or anti-aging 
cellular pattern and, thus, define longevity of chronologically aging yeast (Figure 1.4). 
In the proposed concept of a biomolecular network underlying the chronology of cellular 
aging in yeast, the key intermediates and products of longevity-defining metabolic pathways 
include the following metabolites: NADPH (an anti-aging metabolite), glycerol (an anti-aging 
metabolite), trehalose (an anti-aging metabolite in ʺ youngʺ cells but a pro-aging metabolite in ʺoldʺ 
cells), acetyl-carnitine (an anti-aging metabolite), citrate (an anti-aging metabolite), hydrogen 
peroxide (an anti-aging metabolite if it is maintained at an ʺadaptiveʺ level eliciting a hormetic 
response but a pro-aging metabolite if it amasses above a cytotoxic level), spermidine (an anti- 




CoA (a pro-aging metabolite), non-esterified fatty acids (pro-aging metabolites), diacylglycerol (a 
pro-aging metabolite) and amino acids (pro-aging metabolites) (Figure 1.4). The proposed concept 
posits that these key metabolites undergo an age-related flow within an intricate network of 
intercompartmental communications; such unidirectional and bidirectional flow of the critical 
metabolites between different cellular compartments connects mitochondria and the nucleus, 
peroxisomes and the nucleus, vacuoles and the nucleus, the cytosol and the nucleus, mitochondria 
and peroxisomes, lipid droplets and peroxisomes, mitochondria and vacuoles, peroxisomes and 
the cytosol, mitochondria and the cytosol, and vacuoles and the cytosol (Figure 1.4). In the 
proposed concept, a CR diet and some pharmacological interventions (such as rapamycin and 
LCA) - as well as some other environmental cues (such as the intake of certain dietary supplements 
and hormetic environmental stresses) - extend longevity of chronologically aging yeast by altering 
the age-related dynamics of changes in the intracellular concentrations of the key metabolites 
and/or by modulating the intercompartmental flow of these critical metabolites (Figure 1.4). The 
following proteins and protein complexes operate as checkpoint-specific master regulators that - 
according to the proposed concept - respond to age-related changes in the intracellular 
concentrations of the key metabolites and in the intensity of their intercompartmental flow by 
modulating the longevity-defining processes of cell metabolism, growth, proliferation, stress 
resistance, macromolecular homeostasis, survival and death: 1) thioredoxin and glutathione 
reductase systems (anti-aging master regulators); 2) Rim15p, Msn2p, Msn4p and Gis1p (anti-aging 
master regulators); 3) Tel1p and Rad53p (anti-aging master regulators); 4) components of the ATG 
protein machinery involved in the essential cytoprotective cellular process of autophagy (anti- 
aging master regulators); 5) Rph1p (a pro-aging master regulator); 6) Iki3p and Sas3p (pro-aging 
master regulators); and 7) TORC1 and protein kinase A (PKA) (pro-aging master regulators) 
(Figure 1.4). Future studies are likely to reveal some other checkpoint-specific master regulator 
proteins. Finally, the proposed concept posits that the checkpoint-specific master regulators define 
longevity of chronologically aging yeast by orchestrating certain ʺdownstreamʺ cellular processes 
and features throughout lifespan - i.e., prior to entry into a non-proliferative state and after such 
entry (Figure 1.4). These ʺdownstreamʺ processes and features include (Figure 1.4): 1) 
susceptibility to chronic oxidative, thermal and osmotic stresses; 2) oxidative damage to numerous 
thiol-containing cytosolic, nuclear and mitochondrial proteins; 3) cellular proteostasis, which 




oxidative damage, solubility and aggregation; 4) transcription of subtelomeric chromatin regions, 
which defines the extent of age-related telomeric DNA damage; 5) protein synthesis in the cytosol; 
6) protein synthesis in mitochondria; 7) autophagy, an essential mechanism of cellular quality 
control responsible for the autophagic degradation of aged, dysfunctional and damaged 
macromolecules and organelles; and 8) liponecrotic and apoptotic forms of age-related PCD. 
Figure 1.4. A concept 
of a biomolecular network 
underlying chronological 
aging in yeast. A model for 
how a stepwise progression of 
a biomolecular network of 
cellular aging through a series 
of lifespan checkpoints is 
monitored by some 
checkpoint-specific ʺmaster 
regulatorʺ proteins. The model 
posits that a synergistic action 
of these master regulator 
proteins at several early-life 
and late-life checkpoints 
modulates certain vital cellular 
processes throughout lifespan - 
thereby orchestrating the 
development and maintenance 
of a pro- or anti-aging cellular 
pattern and, thus, defining 
longevity of chronologically 
aging yeast. Activation arrows 
and inhibition bars denote pro- 
aging processes (displayed in blue color) or anti-aging processes (displayed in red color). Pro-aging or anti-aging 
master regulator proteins are displayed in blue color or red color, respectively. Ac-Carnitine, acetyl-carnitine; Ac- 
CoA, acetyl-CoA; CR, caloric restriction; D, diauxic growth phase; DAG, diacylglycerol; ETC, electron transport 
chain; EtOH, ethanol; FFA, non-esterified (ʺfreeʺ) fatty acids; GLR, glutathione reductase; L, logarithmic growth 
phase; LCA, lithocholic acid; LD, lipid droplet; PD, post-diauxic growth phase; PKA, protein kinase A; TAG, 
triacylglycerols; TCA, tricarboxylic acid cycle; ST, stationary growth phase; TORC1, target of rapamycin complex 1; 
TRR, thioredoxin reductase; ΔΨm, electrochemical potential across the inner mitochondrial membrane. 
 
 
In sum, emergent evidence supports the view that the processes of cell metabolism, growth, 
proliferation, stress resistance, macromolecular homeostasis, survival and death in chronologically 
aging yeast are integrated into a biomolecular network of cellular aging. Recent findings imply 
that a stepwise progression of this network through a series of the early-life and late-life 
checkpoints is monitored by some checkpoint-specific master regulator proteins; these proteins act 
in synergy to orchestrate the development and maintenance of a pro- or anti-aging cellular pattern 
and, thus, to define longevity of chronologically aging yeast. The major challenge now is to 




lifespan checkpoints is monitored and controlled by a distinct set of master regulator proteins - is 
a program. We hypothesize that, although yeast chronological aging is a gradual and controllable 
process progressing through a series of consecutive lifespan checkpoints, it is not a program aimed 
at the termination of lives of individual yeast cells and of their organized populations. Rather, 
chronological aging in yeast is probably due to the inability of chronologically ʺyoungʺ, 
proliferating cells to maintain the capacities of some crucial cellular processes above a critical 
threshold; these key cellular processes may include ones that ensure robust cell growth and 
proliferation, implement a spatiotemporal control of cell development and differentiation into 
quiescent and non-quiescent cell populations, and limit an age-related accumulation of molecular 
and cellular damage. The proposed here hypothesis also posits that the extreme cellular stress 
caused by the excessive accumulation of such damage in chronologically ʺoldʺ, non-proliferating 
cells may activate pathways known to orchestrate the apoptotic, regulated necrotic, autophagic 
and/or liponecrotic subroutines of PCD; these subroutines are believed to constitute modules that 
are dynamically integrated into a so-called PCD network [103, 128-135]. In sum, the hypothesis 
of non-programmed chronological aging in yeast envisions that: 1) the processes of cell 
metabolism, growth, proliferation, stress response, macromolecular homeostasis, development and 
differentiation have evolved in the course of natural selection within diverse ecosystems (and 
perhaps under laboratory conditions) as programs aimed at sustaining the long-term survival of 
individual yeast cells under various environmental conditions; 2) the processes of various 
subroutines of PCD have evolved throughout natural selection within different ecosystems (and 
perhaps under laboratory conditions) as ʺaltruisticʺ programs aimed at sustaining the long-term 
survival of organized yeast populations (such as colonies and biofilms of yeast cells attached to 
solid surfaces) by eliminating individual yeast cells that are damaged, unable to mate and 
reproduce, poorly adapted to diverse environmental conditions, and/or release excessive quantities 
of ROS and other harmful metabolites (for a comprehensive discussion of this topic, see refs. [136, 
137]); and 3) a trade-off between these programs aimed at sustaining the long-term survival of 
individual yeast cells or that of organized yeast populations under diverse environmental 
conditions drives the evolution of yeast longevity towards maintaining a finite yeast chronological 
lifespan within an ecosystem. The proposed here hypothesis of non-programmed chronological 




1.1.8 Caloric  restriction  and  dietary  restriction  delay  aging  in  evolutionarily  distant 
eukaryotes, including S. cerevisiae, by remodeling metabolism and organelle dynamics 
Aging of unicellular and multicellular eukaryotic organisms is an intricate biological 
phenomenon [138, 139]. It is believed to be caused by an age-dependent, progressive dysregulation 
of many processes within a eukaryotic cell [1, 2, 20, 23, 57, 61, 84, 138-140]. The rates, 
efficiencies and spatiotemporal organization of all these cellular processes throughout the 
organismal lifespan are modulated by only a few nutrient- and energy-sensing signaling pathways 
that converge into a network; this evolutionarily conserved network integrates the insulin/insulin- 
like growth factor 1, AMP-activated protein kinase/target of rapamycin and cAMP/protein kinase 
A (cAMP/PKA) pathways [1, 2, 20, 140]. The flow of information along the signaling network of 
cellular aging can be modulated by certain dietary interventions that can extend lifespan and/or 
delay the onset of various age-related physiological changes in yeast, nematodes, fruit flies, mice 
and primates. These dietary interventions are known to prolong both longevity and healthspan in 
organisms across phyla by beneficially influencing pathologies and diseases of old age [1, 2, 138- 
141]. These interventions include: 1) caloric restriction (CR), a dietary regimen that limits the 
intake of calories without reducing the supply of amino acids, vitamins and other nutrients [1, 2, 
57, 140, 141]; and 2) dietary restriction (DR), a group of nutrient intake interventions that limit 
the supply of certain amino acids or vitamins and/or alter the balance of dietary components, but 
do not reduce overall food or calorie intake [1, 138-141]. 
The molecular and cellular mechanisms underlying the robust longevity-extending and 
health-improving  effects  of  CR  and  certain  DR  regimens  have  begun  to  emerge.  These 
mechanisms involve several distinct, evolutionarily conserved ways of modulating the flow of 
information along the signaling network, which orchestrates a pro- or anti-aging cellular pattern 
by controlling numerous longevity-defining cellular processes [1, 2, 20, 138-141]. Among these 
cellular processes are certain pathways of lipid metabolism and interorganellar transport [14, 23, 
57, 84, 142, 143]. Although it remains to be seen if these various pathways can play casual roles 
in defining longevity and/or healthspan, recent findings suggest that at least some of them can. In 
fact, it has been demonstrated that: 1) sphingolipid metabolism defines  yeast chronological 
lifespan by modulating many vital cellular processes [144, 145]; 2) the lipolysis of triacylglycerols 
(TAG), a major class of neutral lipids, defines the longevity of the nematode Caenorhabditis 




pro-longevity process of autophagy [146, 147]; and 3) the concentration of long-chain fatty acids 
in plasma is a probable biomarker of longevity in various species of mammals [148]. 
It needs to be emphasized that: 1) lipid metabolism and transport within a cell are governed 
by an intricate network of interorganellar communications integrating the endoplasmic reticulum 
(ER), lipid droplets (LD), peroxisomes, mitochondria and the plasma membrane (PM) [20, 57, 
145] (Figure 1.5); 2) the proper functioning of this network is essential for maintaining lipid 
homeostasis in all of these cellular organelles and membranes [20, 57, 145] (Figure 1.5); and 3) 
the efficacy of maintaining lipid homeostasis in some or all of these cellular organelles and 
membranes defines the lifespan of chronologically aging yeast [20, 57, 145]. A current view of 
how the network integrating lipid metabolism and transport in different cellular locations 
maintains lipid homeostasis in various cellular organelles and membranes is summarized in a 
model; this model is depicted schematically in Figure 1.5. 
 
Figure 1.5. Outline of a network 
governing lipid metabolism and transport within 
the endoplasmic reticulum (ER), lipid droplets 
(LD), peroxisomes, mitochondria and the plasma 
membrane (PM). The proper functioning of this 
intricate network is necessary for maintaining lipid 
homeostasis in all these cellular organelles and 
membranes. The PA, PS, PC and PI classes of 
phospholipids are synthesized exclusively in the ER; 
these are then transported to mitochondria via 
mitochondria-ER junctions and to the PM via PM- 
ER junctions. The PE and CL classes of 
phospholipids are formed only in the inner 
mitochondrial membrane (IMM); PE is then 
transported from mitochondria to the ER via 
mitochondria-ER junctions and from the ER to the 
PM via PM-ER junctions. The neutral lipids TAG 
and EE are synthesized in the ER and then deposited 
within LD. The lipolytic hydrolysis of TAG and EE 
in LD generates FFA; these are then get imported 
and oxidized by peroxisomes. Peroxisomally 
produced acetyl-CoA is converted to citrate  and 
acetyl-carnitine, whose subsequent delivery to 
mitochondria enables to maintain the efficient 
synthesis of PE and CL in the IMM. The use of 
peroxisomally produced acetyl-CoA for the synthesis of FFA in the cytosol allows FFA to enter the biosynthetic 
pathways for phospholipids and neutral lipids in the ER. See text for additional details. Abbreviations: Ac-CoA, acetyl- 
CoA; ADHAP, acyl dihydroxyacetone phosphate; CDP-DAG, cytidine diphosphate-diacylglycerol; CL, cardiolipin; 
EE, ergosteryl esters; FA-CoA, fatty acid-CoA; FFA, non-esterified (free) fatty acids; LPA, lysophosphatidic acid; 
MLCL, monolysocardiolipin; OMM, outer mitochondrial membrane; PA, phosphatidic acid; PC, 
phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, 




The model posits that: 1) after being synthesized in the ER, the phosphatidic acid (PA), 
phosphatidylserine (PS), phosphatidylcholine (PC) and phosphatidylinositol (PI) classes of 
phospholipids are transported to mitochondria via mitochondria-ER junctions and to the PM via 
PM-ER junctions; 2) following the synthesis of the phosphatidylethanolamine (PE) class of 
phospholipids in the inner mitochondrial membrane (IMM) from PS formed in the ER, PE is 
transported from mitochondria to the ER via mitochondria-ER junctions and subsequently from 
the ER to the PM via PM-ER junctions; 3) cardiolipin (CL), a signature phospholipid class of the 
mitochondrion, is synthesized in the IMM from PA, which is formed in the ER and then delivered 
to mitochondria via mitochondria-ER junctions; 4) after being synthesized in the ER, the neutral 
lipids triacylglycerols (TAG) and ergosteryl esters (EE) are deposited within LD; 5) the physical 
contact existing between peroxisomes and LD stimulates the lipolytic conversion of TAG and EE 
to free fatty acids, which then get imported and oxidized by peroxisomes; 6) the anaplerotic 
conversion of acetyl-CoA to citrate and acetyl-carnitine in peroxisomes enables the replenishment 
of tricarboxylic acid (TCA) cycle intermediates destined for mitochondria, thereby allowing one 
to maintain the efficient synthesis of PE and CL in the IMM; and 7) a pool of peroxisomally 
produced acetyl-CoA is also used in the cytosol for the synthesis of fatty acids, which then get 
imported by the ER, where they enter the biosynthetic pathways for phospholipids and neutral 
lipids [20, 57, 145] (Figure 1.5). 
Recent studies in the Titorenko laboratory of how CR influences a pattern of metabolism 
and organelle dynamics in the chronologically aging yeast S. cerevisiae have revealed that this 
low-calorie diet alters age-related dynamics of certain cellular processes [20, 23, 61, 84, 149, 150]. 
Among these cellular processes are ethanol metabolism, glycogen and trehalose metabolism, lipid 
synthesis and degradation, ROS homeostasis maintenance, mitochondrial morphology control, 
mitochondrial functionality preservation, stress response control, cell cycle regulation, quiescence 
maintenance, and apoptotic and liponecrotic death subroutines [20, 23, 61, 84, 149, 150]. It 
remained unclear how CR coordinates the spatiotemporal dynamics of all these cellular processes 
to delay yeast chronological aging. One of the objectives of my thesis work was therefore to 





1.1.9 A  mechanism  underlying  the  longevity-extending  effect  of  lithocholic  acid  in 
chronologically aging yeast 
In a high-throughput screen for chemical compounds that can slow down aging in S. 
cerevisiae by specifically targeting lipid metabolism and interorganellar transport, the Titorenko 
laboratory identified lithocholic acid (LCA), a bile acid, as one of them [14]. Studies in the 
laboratory suggested a mechanism through which LCA prolongs the longevity of chronologically 
aging yeast under CR conditions by altering mitochondrial lipidome and functionality [14, 64, 103, 
107). With the help of subcellular fractionation by differential centrifugation, organelle separation 
by equilibrium density gradient centrifugation and subsequent mass spectrometric measurement 
of LCA in purified cellular organelles, it was demonstrated that exogenously added LCA enters 
yeast cells and accumulates in mitochondria, but not in any other organelle [64, 103] (Figure 1.6). 
Using subfractionation of purified mitochondria followed by mass spectrometric quantitation of 
LCA in different mitochondrial subcompartments, it was revealed that confined to the 
mitochondria, LCA resides mainly in the IMM; a smaller portion of this bile acid also associates 
with the outer mitochondrial membrane (OMM) [64,103] (Figure 1.6). Mass spectrometric 
analyses of mitochondrial membrane lipidomes provided evidence that the pools of LCA confined 
to the IMM and OMM alter the phospholipid composition of mitochondrial membranes. 
Specifically, LCA elicits a rise in the relative level of PS and a decline in the relative level of PE 
within mitochondrial membranes; it was proposed that LCA may cause these changes by 
decelerating the Psd1-dependent reaction, leading to the conversion of PS to PE [64, 103] (Figure 
1.6). Furthermore, LCA causes a rise in the relative level of PG and a decline in the relative level 
of CL within mitochondrial membranes; it is believed that LCA may trigger these changes by 
slowing down the Crd1-dependent reaction resulting in the synthesis of CL from PG [64, 103] 
(Figure 1.6). Moreover, LCA increases the relative level of PC, as well as reduces the relative 
levels of both CL and monolysocardiolipin (MLCL) within mitochondrial membranes; one could 
envisage that LCA may elicit these changes by reducing the availability of newly synthesized CL 
for the Cld1- and Taz1-driven reactions that enable a PC-dependent remodeling of the acyl chains 
of CL [64, 103] (Figure 1.6). In addition, LCA was found to increase the relative level of PA within 
mitochondrial membranes [64, 103] (Figure 1.6). It was suggested that the observed LCA-driven 
reduction in the relative level of CL within the IMM may cause such an effect by mitigating a CL- 




Figure 1.6. A mitochondria-based 
mechanism through which LCA prolongs the 
longevity of chronologically aging yeast. 
Exogenously added LCA enters a yeast cell, 
where it is sorted to mitochondria, but not to any 
other organelle. Mitochondria-associated LCA is 
located predominantly in the inner mitochondrial 
membrane (IMM) and resides in the outer 
mitochondrial membrane (OMM). LCA drives a 
remodeling of the mitochondrial membrane 
lipidome, thereby enlarging mitochondria, 
reducing their number and causing a build-up 
within their matrix of cristae disconnected from 
the IMM. These major changes in mitochondrial 
abundance and morphology elevate mitochondrial 
respiration, membrane potential, ATP synthesis 
and reactive oxygen species (ROS) levels in 
chronologically “old” cells, thereby enhancing 
their long-term stress resistance and viability. 
Moreover, the LCA-elicited remodeling of the 
mitochondrial membrane lipidome mitigates 
mitochondrial fragmentation, thus slowing down 
an age-related form of apoptotic programmed cell 
death. All  these  distinctive alterations in vital 
mitochondrial processes and features seen in yeast 
cells permanently exposed  to  exogenous LCA 
extend their chronological lifespan. See the text 
for additional details. Abbreviations: CDP-DAG, 
cytidine diphosphate-diacylglycerol; CL, 
cardiolipin;  ER,  endoplasmic  reticulum;  ETC, 
electron transport chain; MLCL, monolysocardiolipin; PA, phosphatidic acid; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; ΔΨ, 
electrochemical membrane potential. 
 
 
to be promoted by the Ups1 protein, which shuttles PA between the two mitochondrial 
membranes [151-153] (Figure 1.6). The resulting acceleration of PA transport from the OMM to 
the IMM, in synergy with the LCA-stimulated movement of PA from the ER to the OMM via 
mitochondria-ER junctions, may elicit the observed rise in the relative level of PA within 
mitochondrial membranes [64, 103] (Figure 1.6). The observed remodeling of the mitochondrial 
membrane lipidome in yeast cells permanently exposed to LCA progresses with their 
chronological age and triggers major age-related changes in mitochondrial abundance and 
morphology, including: 1) an expansion of both mitochondrial membranes, which leads to a 
considerable enlargement of mitochondria; 2) a shift in the balance between the opposing 
processes of mitochondrial fission and fusion towards fusion, which causes a substantial decline 
in mitochondrial number; 3) a significant decrease in the fraction of mitochondria with cristae that 




mitochondrial matrix of cristae disconnected from the inner boundary membrane [64, 103] (Figure 
1.6). In synergy, the major changes triggered by LCA in the mitochondrial membrane lipidome 
and the ensuing vast changes in mitochondrial morphology elicit a distinct set of alterations in the 
age-related chronology of several mitochondrial processes; these vital mitochondrial processes 
include respiration, the preservation of electrochemical membrane potential, the synthesis of ATP 
and the maintenance of ROS homeostasis [64, 103] (Figure 1.6). Because a permanent exposure 
of yeast to LCA stimulates all these mitochondrial processes in chronologically “old” cells, they 
exhibit higher long-term stress resistance and viability than yeast cells cultured without LCA [64, 
103] (Figure 1.6). Moreover, a shift is elicited by LCA in the balance between the opposing 
processes of mitochondrial fission and fusion towards fusion attenuates mitochondrial 
fragmentation, thus slowing down the release of pro-apoptotic proteins from mitochondria and 
decelerating an age-related form of apoptotic programmed cell death [64, 103, 107] (Figure 1.6). 
By promoting the long-term stress resistance and viability of chronologically aging yeast cells and 
by slowing down their age-related apoptotic death, the permanent exposure of these cells to LCA 
extends their longevity [64, 103, 107] (Figure 1.6). 
Based on the above findings, we hypothesized that the LCA-driven changes in 
mitochondrial lipidome may alter mitochondrial proteome, thus eliciting changes in mitochondrial 
functionality and delaying yeast chronological aging. One of the objectives of my thesis work was 
therefore to test this hypothesis by investigating how certain mutations that eliminate enzymes 
involved in mitochondrial phospholipid metabolism influence the mitochondrial proteome. 
Moreover, as detailed below in the thesis, our recent studies have indicated that under CR 
conditions LCA influences not only the aforesaid processes in mitochondria but also some other 
cellular processes that take place in several cellular compartments. Based on these recent studies, 
we hypothesized that LCA may delay chronological aging of yeast limited in calorie supply also 
because it affects these other cellular processes confined to various cellular locations. My other 
objective was therefore to test this hypothesis by investigating mechanisms through which LCA 
controls the spatiotemporal dynamics of these other cellular processes in different cellular 
locations under CR conditions. 
 
1.1.10 Reversible phosphorylation of mitochondrial proteins regulates various processes 




The phosphorylation of cellular proteins is the most common reversible post-translational 
modification that 1) is controlled by a balance between activities of numerous protein kinases and 
phosphatases; 2) influences protein activity, stability, ligand interaction and localization; and 3) is 
involved in the maintenance of cellular homeostasis in response to various changes in metabolic, 
energy or stress status of a cell [154]. The dysregulation of reversible protein phosphorylation is 
known to be a cause or consequence of many human diseases, including muscular dystrophy, 
diabetes, stroke, inflammatory and autoimmune diseases, neurodegenerative diseases, and 
different forms of cancer [155]. Reversible protein phosphorylation has been implicated in almost 
every process confined to mitochondria, including mitochondrial protein import, oxidative 
phosphorylation, TCA cycle, steroid biosynthesis, DNA replication, fission, mitophagic 
degradation, and mitochondria-controlled apoptosis [156-162]. 
Several mitochondrial processes in animal cells are regulated by protein kinase A (PKA), 
which can be found both on the mitochondrial surface and in the mitochondrial matrix [160]. PKA 
that is attached to the outer face of metazoan mitochondria with the help of AKAP121 (the PKA- 
anchoring protein 121) and some AKAPs can phosphorylate the following mitochondrial proteins: 
1) the dynamin-like GTPase Drp1, thereby attenuating the recruitment of Drp1 to mitochondrial 
fission sites on the organelle surface, weakening mitochondrial fission and stimulating cell 
survival; 2) the pro-apoptotic protein Bad on the outer mitochondrial membrane, thus inhibiting 
the apoptotic activity of Bad in mammalian cells; 3) the pro-apoptotic protein Bax, therefore 
stimulating its recruitment to mitochondrial surface, eliciting the efflux of cytochrome c and 
promoting apoptotic cell death of mammalian cells; 4) the pro-apoptotic protein Bim, as a result 
protecting it from proteasomal degradation and accelerating apoptosis in cells of mammals; and 5) 
the steroidogenic acute regulatory (StAR) protein, thereby promoting cholesterol transport from 
cytosol to mitochondria (Figure 1.7A) [157, 160, 161]. PKA that resides in the matrix of 
mammalian mitochondria can phosphorylate the following mitochondrial proteins: 1) several 
protein components of the electron transport chain (ETC) and TCA cycle enzymes, thereby 
modulating oxidative phosphorylation and ATP synthesis; 2) IF1 (an ATPase inhibitory factor 1), 
thus increasing both the ATP hydrolytic and ATP synthetic activities of respiratory complex V, 
and adjusting the glycolytic and mitochondrial oxidative phosphorylation fluxes to physiological 




TFAM degradation and attenuating the TFAM-dependent replication of mitochondrial DNA 
(Figure 1.7B) [157, 160, 161]. 
 
Figure 1.7. Several mitochondrial processes in animal cells are regulated by protein kinase A (PKA), 
which can be found both on the mitochondrial surface (A) and in the mitochondrial matrix (B). See text for 
more details. Abbreviations: AKAP, PKA-anchoring protein; CC, cytochrome c; mtDNA, mitochondrial DNA; sAC, 
soluble adenylyl cyclase; TFAM, mitochondrial transcription factor A). From reference [160]. 
 
 
In the yeast S. cerevisiae, reversible protein phosphorylation has been implicated in 
adjusting the rates and efficiencies of mitochondrial protein import [156, 158, 159, 162] and 
autophagic degradation of mitochondria [157] to physiological demands of a cell in response to 
various changes in its metabolic, energy or stress status. At high concentrations of glucose in 
culture medium, S. cerevisiae cells use mainly glycolysis to metabolize this fermentable carbon 
source and maintain mitochondrial respiration at low level [158]. Under such glucose-rich 
conditions, a catalytic activity of the adenylyl cyclase is amplified and the resulting rise in the 
concentration of cAMP stimulates PKA in the cytosol [158, 159]. Active PKA phosphorylates the 
cytosolic precursors of Tom40 (which is phosphorylated at serine 54) and Tom22 (which is 
phosphorylated at threonine 76), two core protein components of the translocase of the outer 
membrane (TOM) complex that is responsible for the import of most mitochondrial proteins 
(Figure 1.8A) [156-159]. Such PKA-dependent phosphorylation of Tom40 and Tom22 diminishes 
their delivery to and/or integration into the outer mitochondrial membrane, thus precluding the 
assembly of the mature TOM complex and impairing mitochondrial import of most mitochondrial 
proteins (Figure 1.8A) [156-159]. Furthermore, active PKA phosphorylates the Tom70 import 
receptor for the metabolite carrier proteins of the inner mitochondrial membrane [156-160]. 




complexes formed between cytosolic metabolite carrier precursors and the cytosolic chaperone 
Hsp70, the delivery of these metabolite carriers into the inner mitochondrial membrane is impeded 
(Figure 1.8B) [156-159]. 
Yeast cells cultured in glucose-rich media undergo not only the activation of cytosolic PKA 
but also the palmitoylation of Yck1 and Yck2, two homologous isoforms of the casein kinase type 
1 (CK1) [156-159, 162]. After being attached to the plasma membrane, a substantial fraction of 
the palmitoylated Yck1 and Yck2 re-locates to the outer mitochondrial membrane (Figure 1.8C) 
[156-159, 162]. Yck1 on the mitochondrial surface phosphorylates the Tom22 component of the 
TOM complex at threonine 57, thereby enhancing Tom22 interaction with the Tom20 component 
of this complex, promoting TOM complex assembly and stimulating mitochondrial protein import 
(Figure 1.8C) [156-159, 162]. Thus, the PKA-dependent impairment of mitochondrial protein 
import in yeast cells cultured in glucose-rich media is balanced by the Yck1-driven activation of 
this import; it is conceivable that the existence of such balance allows to adjust the rate and 
efficiency of mitochondrial protein import to metabolic requirements of cells that ferment glucose 
(Figure 1.8C) [156-159, 162]. 
Figure 1.8. Cytosolic protein 
kinase A (PKA), the Yck1 isoform of the 
casein kinase type 1 (CK1) attached to the 
mitochondrial surface and the  catalytic 
subunit Cka2 of  cytosolic casein kinase 
type 2 (CK2) regulate mitochondrial 
protein import by phosphorylating some 
protein subunits of the translocase of the 
outer membrane (TOM) complex or the 
Mim1 protein component of the MIM 
(Mim1-containing) complex. See text for 




The  reversible  phosphorylation  of  mitochondrial  proteins  (and,  thus,  mitochondrial 
functionality)  is  linked  not  only  to  metabolic  requirements  of  yeast  cells  but  also  to  the 
proliferation and regulated death of these cells [159]. This link is mediated by the  catalytic 
subunit Cka2 of casein kinase type 2 (CK2); Cka2 phosphorylates the following two mitochondrial 
proteins: 1) the cytosolic precursors of the Tom22 component of the TOM complex (as well as the 
assembled form of Tom22) at serine 44 and serine 46, thus augmenting Tom22 interaction with 
the  Tom20  component  of  this  complex,  enhancing  TOM  complex  assembly and  activating 
mitochondrial protein import; and 2) the Mim1 component of the MIM complex at serine 16 and 
serine 14, thereby stabilizing Mim1, activating Mim1-dependent mitochondrial import of Tom20 
and Tom70 precursors, promoting TOM complex assembly and stimulating mitochondrial protein 
import (Figure 1.8D) [156-159, 162]. Thus, akin to mitochondrial protein phosphorylation by 
Yck1 bound to the outer mitochondrial membrane, mitochondrial protein phosphorylation by 
cytosolic Cka2 activates protein import into mitochondria and promote mitochondrial biogenesis. 
The Cka2-dependent phosphorylation of the Atg32 protein attached to the outer surface of 
yeast mitochondria also regulates mitophagy, an essential mechanism of mitochondrial quality and 
quantity control that is responsible for the selective autophagic degradation of aged, dysfunctional, 
damaged or excessive mitochondria [157]. Atg32 is a mitochondrial receptor for mitophagic 
removal of yeast mitochondria under nitrogen starvation conditions and in chronologically old 
cells [163]. Mitophagy-promoting stimuli are detected by the cell-surface stress sensor Sln1, which 
in response activates the high osmolarity glycerol (HOG) signaling pathway; the HOG pathway is 
an evolutionarily conserved mitogen-activated protein kinase (MAPK) cascade also known for its 
essential role in hyperosmotic stress response (Figure 1.9) [163]. After being phosphorylated and 
activated by the MAPK kinase (MAPKK) Pbs2, the MAPK Hog1 stimulates the  catalytic subunit 
Cka2 of CK2; Cka2 then phosphorylates Atg32 at serine 114 and serine 119 (Figure 1.9) [163]. 
The Cka2-dependent phosphorylation of Atg32 at serine 114 is needed for its interaction with 
Atg11, which then recruits mitochondria to the pre-autophagosomal structure where the 
mitochondria-enclosing autophagosome is generated in preparation to its degradation by vacuolar 




Figure 1.9. The 
Cka2-dependent 
phosphorylation of the 
Atg32 protein attached 
to the outer surface of 
yeast mitochondria also 
regulates mitophagy, an 
essential mechanism of 
mitochondrial quality 
and   quantity   control. 
See text for more details. 










Recent proteomics analyses of mitochondria purified from S. cerevisiae cells have revealed 
numerous protein kinases, protein phosphatases and their accessory proteins associated with these 
organelles (Table 1.1) [156]. Some of these proteins have been found only in mitochondria of yeast 
cells; they include the following proteins: 1) two redundant protein kinases (i.e. Pkp1 and Pkp2) 
and two redundant protein phosphatases (i.e. Ptc5 and Ptc6) essential for the regulation of the 
pyruvate dehydrogenase complex in the mitochondrial matrix; 2) the protein kinase Fmp48 and 
the protein phosphatase Ptc7 of presently unknown function (Table 1.1) [156, 164, 165]. In 
contrast, many of these mitochondria-associated protein kinases, protein phosphatases and their 
accessory proteins 1) have also been found in other cellular locations; and 2) have been shown to 
participate in essential cellular processes most of which have not been directly linked to 
mitochondria. They include the following proteins: 1) the nutrient-sensing protein kinases Psk2, 
Snf1 and Tor2 that have been implicated in the regulation of carbohydrate and lipid metabolism, 
cell growth and stress response; 2) Fus3 and Smk1, two MAPKs implicated in mating and 
sporulation (respectively); 3) Mec1 and Tel1, two protein kinases involved in the regulation of 
telomere length and the DNA-damage response checkpoint; 4) Vps15, a protein kinase implicated 
in vacuolar protein sorting; and 5) Yck1 and Yck2, two protein kinases involved in cell 
morphogenesis, septin assembly, endocytic trafficking, glucose sensing and glucose repression of 
respiratory metabolism (as discussed above, Yck1 has recently been implicated in adjusting the 




[156, 164, 165]. Altogether, these findings allow to speculate that some (or many) of these 
mitochondria-associated protein kinases, protein phosphatases and their accessory proteins 1) may 
somehow regulate mitochondrial functionality in yeast cells (in addition to their established 
involvement in regulating cellular proteins not directly linked to mitochondria); and 2) may control 
communications between mitochondria and various other compartments of a yeast cell [156]. 
Table 1.1. Protein kinases, 
protein phosphatases and 
their accessory proteins 
found  in the 
mitochondrial proteome 
of Saccharomyces 
cerevisiae. See text for 






















Because LCA triggers major changes in the age-related chronology of several vital 
processes taking place in mitochondria, we hypothesized that LCA may cause these changes by 
eliciting a reversible phosphorylation of some mitochondrial proteins. One of the objectives of my 
thesis work was therefore to test this hypothesis by investigating if an exposure of chronologically 
aging yeast to LCA prompts such phosphorylation. 
 
1.2    Thesis outline and contributions of colleagues 
Chapter 1 outlines two ways of studying yeast aging, two groups of mechanisms underlying 
yeast chronological and replicative aging, the essential role of intracellular trehalose in maintaining 




longevity-defining processes that take place in other cellular compartments, the importance of 
several mitochondrial processes in orchestrating longevity-defining processes in other cellular 
locations, the essential role of metabolite flow within glycolytic and non-glycolytic pathways of 
carbohydrate metabolism in establishing a pro- or anti-aging cellular pattern, a stepwise 
progression of a biomolecular network of cellular aging through a series of lifespan checkpoints 
defines longevity of chronologically aging yeast, mechanisms through which CR and DR delay 
aging in evolutionarily distant eukaryotes by remodeling metabolism and organelle dynamics, and 
a mitochondria-based mechanism underlying the longevity-extending effect of LCA in 
chronologically aging yeast. I wrote sections 1.1, 1.1.1, 1.1.4, 1.1.5, 1.1.6, 1.1.7 and prepared 
Figures 1.2-1.4 for Chapter 1; Anna Leonov, Amanda Piano and Veronika Svistkova wrote 
sections 1.1.2, 1.1.3 and prepared Figure 1.1 for Chapter 1; all these sections and figures of Chapter 
1 have been published in Arlia-Ciommo A, Leonov A, Piano A, Svistkova V, Titorenko VI. Cell- 
autonomous mechanisms of chronological aging in the yeast Saccharomyces cerevisiae. Microb 
Cell. 2014; 1(6):163-178. I also wrote sections 1.1.8, 1.1.9 and prepared Figures 1.5, 1.6 for 
Chapter 1; these sections and figures of Chapter 1 have been published in Arlia-Ciommo A, Piano 
A, Svistkova V, Mohtashami S, Titorenko VI. Mechanisms underlying the anti-aging and anti- 
tumor effects of lithocholic bile acid. Int J Mol Sci. 2014;15(9):16522-43. 
The objective of studies described in Chapter 2 was to investigate mechanisms through 
which CR slows down yeast chronological aging by orchestrating age-related dynamics of ethanol 
metabolism, glycogen and trehalose metabolism, lipid synthesis and degradation, ROS 
homeostasis maintenance, mitochondrial morphology control, mitochondrial functionality 
preservation, and apoptotic and liponecrotic death subroutines. Our investigation revealed that CR 
extends longevity of chronologically aging yeast by remodeling carbohydrate and lipid 
metabolism, affecting certain interorganellar communications, changing morphologies and 
functional states of peroxisomes and mitochondria, and delaying the age-related onsets of 
apoptotic and liponecrotic forms of regulated cell death (RCD). I conducted experiments shown 
in figures 2.1, 2.2, 2.3, 2.5, 2.6, 2.7, 2.8, 2.9, 2.11, 2.14, 2.15, 2.17, 2.19, and prepared these figures. 
The experiments shown in figures 2.2E-2.2H, 2.4, 2.6A-2.6C, 2.10, 2.11B, 2.12, 2.13, 2.16, 2.18 
were carried out by Simon Bourque, Anna Leonov, Adam Beach, Vincent Richard, Simon 
Bourque, Michelle Burstein, Pavlo Kyryakov, Alejandra Gomez-Perez, Olivia Koupaki and 




Leonov A, Beach A, Richard VR, Bourque SD, Burstein MT, Kyryakov P, Gomez-Perez A, 
Koupaki O, Feldman R, Titorenko VI. Caloric restriction delays yeast chronological aging by 
remodeling carbohydrate and lipid metabolism, altering peroxisomal and mitochondrial 
functionalities, and postponing the onsets of apoptotic and liponecrotic modes of regulated cell 
death. Oncotarget. 2018; 9(22):16163-84. Dr. Titorenko provided intellectual leadership of this 
project; he also edited the first draft of Chapter 2 and the entire manuscript of the above article. 
The objective of studies described in Chapter 3 was to use a mass spectrometry-based 
quantitative analysis of the water-soluble cellular metabolome for the investigation of how CR and 
the longevity-extending tor1Δ mutation (which eliminates the Tor1 protein kinase known to 
orchestrate the nutrient- and energy-sensing TOR [target of rapamycin] pro-aging signaling 
pathway) affect the concentrations of various water-soluble metabolites at consecutive stages of 
the chronological aging process in S. cerevisiae. Our investigation provided the first evidence that 
both the longevity-extending diet CR and the-longevity extending mutation tor1 establish a 
similar pattern of relative concentrations of methionine metabolism intermediates through the 
entire process of chronological aging in S. cerevisiae. We hypothesized that the observed 
redirection of metabolite flow from the biosynthesis of methionine and spermidine to the 
biosynthesis of cysteine and glutathione may represent an anti-aging pattern characteristic of the 
ʺmetabolic signatureʺ of longevity extension in chronologically aging yeast cells placed on the CR 
diet or having the TOR pro-aging signaling pathway inhibited. We also proposed future studies to 
test this hypothesis. I conducted all experiments described in this Chapter and prepared all figures 
and tables. Dr. Titorenko provided intellectual leadership of this project; he also edited the first 
draft of Chapter 3. 
The objective of studies described in Chapter 4 was to use a mass spectrometry-based 
quantitative analysis for the investigation of how certain mutations that eliminate enzymes 
involved in mitochondrial phospholipid metabolism influence the mitochondrial proteome and 
how they affect the geroprotective efficiency of LCA in chronologically aging yeast. Based on 
recent findings by the Titorenko laboratory, we hypothesized that the LCA-driven alterations in 
mitochondrial lipidome may have a causal role in the age-related remodeling of proteome, thereby 
altering mitochondrial functionality to delay chronological aging in S. cerevisiae. Our 
investigation revealed that LCA-driven specific changes in the composition of mitochondrial 




increasing concentration of many mitochondrial proteins. We also demonstrated that this 
remodeling of mitochondrial proteome is essential for the ability of LCA to delay aging. I 
conducted experiments shown in figures 4.2-4.7 and prepared these figures. Figure 4.1 was 
prepared by Anna Leonov and me. The experiment shown in figure 4.8 were carried out by Pavlo 
Kyryakov, Pamela Dakik, Melissa McAuley, Younes Medkour and Tamara Di Maulo. All findings 
described in Chapter 4 have been published in Leonov A, Arlia-Ciommo A, Bourque SD, Koupaki 
O, Kyryakov P, Dakik P, McAuley M, Medkour Y, Mohammad K, Di Maulo T, Titorenko VI. 
Specific changes in mitochondrial lipidome alter mitochondrial proteome and increase the 
geroprotective efficiency of lithocholic acid in chronologically aging yeast. Oncotarget. 2017; 
8(19):30672-91. Dr. Titorenko provided intellectual leadership of this project; he also edited the 
first draft of Chapter 4 and the entire manuscript of the above article. 
The objective of studies described in Chapter 5 was to test our hypothesis that LCA may 
delay chronological aging of yeast limited in calorie supply because it controls the spatiotemporal 
dynamics  of  several  cellular  processes  outside  of  mitochondria.  Our  investigation  revealed 
mechanisms by which LCA delays yeast chronological aging under CR conditions by altering the 
spatiotemporal dynamics of a cellular network that integrates certain pathways of lipid and 
carbohydrate  metabolism,   some  intercompartmental  communications,  specific  aspects  of 
mitochondrial morphology and functionality, and liponecrotic and apoptotic modes of RCD. I 
conducted experiments shown in figures 5.3, 5.11-5.13, 5.19-5.21 and prepared these figures. I 
also prepared figures 5.1, 5.2, 5.5, 5.22 that depict various models of cellular processes controlled 
by LCA. Together with Simon Bourque, Vincent Richard and Karamat Mohammad, I performed 
experiments shown in figures 5.4, 5.7, 5.10 and prepared these figures. Experiments shown in 
figures  5.6,  5.8,  5.9,  5.14-5.18  were  carried  out  by Alexander  Goldberg,  Pavlo  Kyryakov, 
Alejandra Gomez-Perez and Olivia Koupaki. All findings described in Chapter 5 have been 
published in Arlia-Ciommo A, Leonov A, Mohammad K, Beach A, Richard VR, Bourque SD, 
Burstein MT, Goldberg AA, Kyryakov P, Gomez-Perez A, Koupaki O, Titorenko VI. Mechanisms 
through  which  lithocholic  acid  delays  yeast  chronological  aging  under  caloric  restriction 
conditions. Oncotarget (2018) 9 (79):34945-71. Dr. Titorenko provided intellectual leadership of 
this project; he also edited the first draft of Chapter 5 and the entire manuscript of the above article. 
The objective of studies described in Chapter 6 was to test our hypothesis that LCA may 




that LCA elicits the establishment of a distinct phosphoprotein profile of mitochondria, which 
significantly differs from the phosphoprotein profile of mitochondria in yeast cells cultured 
without LCA. I conducted all experiments described in this Chapter and prepared all figures and 
tables. Dr. Titorenko provided intellectual leadership of this project; he also edited the first draft 




2 Caloric restriction delays yeast chronological aging by remodeling carbohydrate and 
lipid metabolism, altering peroxisomal and mitochondrial functionalities, and 
postponing the onsets of apoptotic and liponecrotic modes of regulated cell death 
 
2.1 Introduction 
As described in the Introduction section, recent studies in the Titorenko laboratory of 
how CR influences a pattern of metabolism and organelle dynamics in the chronologically aging 
yeast S. cerevisiae have revealed that this low-calorie diet alters age-related dynamics of ethanol 
metabolism, lipid synthesis and degradation, trehalose metabolism, ROS homeostasis 
maintenance, mitochondrial morphology control, mitochondrial functionality preservation, stress 
response control, cell cycle regulation, quiescence maintenance, and apoptotic and liponecrotic 
death subroutines. Because it remained unclear how CR coordinates the spatiotemporal dynamics 
of all these cellular processes to delay yeast chronological aging, the objectives of studies 
described in this chapter was to investigate mechanisms through which CR orchestrates these 
various processes to slow down yeast chronological aging. 
 
2.2 Materials and methods 
2.2.1 Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 
ura30) from Open Biosystems/Dharmacon (a part of GE Healthcare) was grown in YP medium 
(1% yeast extract, 2% peptone; both from Fisher Scientific; #BP1422-2 and #BP1420-2, 
respectively) initially containing 0.2% (w/v), 0.5% (w/v), 1% (w/v) or 2% (w/v) glucose (#D16- 
10; Fisher Scientific) as carbon source. Cells were cultured at 30oC with rotational shaking at 200 
rpm in Erlenmeyer flasks at a ″flask volume/medium volume″ ratio of 5:1. 
 
2.2.2 Chronological life span assay 
A sample of cells was taken from a culture at a certain time-point. A fraction of the sample 
was diluted to determine the total number of cells using a hemocytometer. Another fraction of the 
cell sample was diluted, and serial dilutions of cells were plated in duplicate onto YP plates 
containing 2% glucose as carbon source. After 2 d of incubation at 30oC, the number of colony 




viable cells in a sample. For each culture, the percentage of viable cells was calculated as follows: 
(number of viable cells per ml/total number of cells per ml) × 100. The percentage of viable cells 
in mid-logarithmic phase was set at 100%. The life span curves were validated using a 
LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's instructions. 
 
2.2.3 Ethanol concentration measurement 
For measuring ethanol and acetic acid concentrations, 1-ml aliquots of yeast cultures were 
centrifuged, and supernatants frozen at -80oC. The supernatants were subjected to gas 
chromatography using an Agilent 6890 Networked GC system equipped with a Supelco Equity-1 
(0.32 mm × 30 cm) column and FID detector. Ethanol and acetic acid concentrations were 
calculated using the Chemstation 3 software (Agilent). 
 
2.2.4 Measurement of trehalose and glycogen concentrations 
2 × 109 cells were harvested by centrifugation for 1 min at 16,000 × g at 4oC. The cell pellet 
was washed three times in ice-cold PBS (20 mM KH2PO4/KOH (pH 7.5) and 150 mM NaCl) and 
then resuspended in 200 μl of ice-cold SHE solution (50 mM NaOH and 1 mM EDTA). 800 μl of 
ice-cold SHE solution were added to the cell suspension. The resulting alkali extract was incubated 
at 60oC for 30 min to destroy endogenous enzyme activities and pyridine nucleotides. The extract 
was neutralized by adding 500 μl of THA solution (100 mM Tris/HCl (pH 8.1) and 50 mM HCl). 
The extract was then divided into 150 μl aliquots, quickly frozen in liquid nitrogen and stored at - 
80oC prior to use. 
To measure trehalose concentration, 50 μl of alkali extract were added to 150 μl of trehalose 
reagent (25 mM KH2PO4/KOH (pH 7.5) and 0.02% BSA) with or without 15 mU trehalase. The 
mixture was incubated for 60 min at 37oC. 800 μl of glucose reagent (100 mM Tris/HCl (pH 8.1), 
2 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.2 mM NADP
+, and mixture of hexokinase (7 U) and 
glucose-6-phosphate dehydrogenase (8 U)) were added, and the mixture was incubated for 30 min 
at 25oC. The NADPH generated from NADP+ was measured fluorimetrically (excitation at 365 
nm, emission monitored at 460 nm). 
To measure glycogen concentration, 50 μl of alkali extract were added to 500 μl of glycogen 
reagent (50 mM sodium acetate (pH 4.6) and 0.02% BSA; with and without 5 μg/ml 




reagent (100 mM Tris/HCl (pH 8.1), 2 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.2 mM NADP
+, and 
mixture of hexokinase (7 U) and glucose-6-phosphate dehydrogenase (8 U)) were added, and the 
mixture was incubated for 30 min at 25oC. The NADPH generated from NADP+ was measured 
fluorimetrically (excitation at 365 nm, emission monitored at 460 nm). 
 
2.2.5 Lipid extraction, separation by thin-layer chromatography (TLC), visualization and 
quantitation 
The recovered pellet of membranes (total cellular membranes, membranes of the purified 
ER or membranes of purified LD) that contained 1 mg of membrane protein was resuspended in 
1.0 ml of chloroform/methanol (1:1; vol/vol). After incubation on ice for 15 min with occasional 
agitation, the samples were subjected to centrifugation at 20,000 × g for 15 min at 4oC. The 
chloroform phase was separated and dried under nitrogen. The lipid film was dissolved in 100 μl 
of chloroform. 25 μl of each sample were spotted on 60-Å silica gel plates for TLC (Whatman). 
The lipids were developed in the chloroform/acetone (4.6:0.4) [vol/vol] solvent system, detected 
using 5% phosphomolybdic acid in ethanol and visualized by heating for 30 min at 110°C. The 
lipids were quantitated by densitometric analysis of TLC plates, using lipid standards in the 0.1– 
0.5 μg range for calibration. 
 
 
2.2.6 Electron microscopy and morphometric analysis 
Whole cells were fixed in 1.5% KMnO4 for 20 min at room temperature, dehydrated by 
successive incubations in increasing concentrations of ethanol, and embedded in Poly/Bed 812 
epoxy resin (Polysciences). Ultrathin sections were cut using an Ultra-Cut E Microtome (Reichert- 
Jung). Silver/gold thin sections from the embedded blocks were examined in a transmission 
electron microscope (JEM-2000FX; JEOL). For morphometric analysis of random electron 
microscopic sections of cells, 12- × 14-cm prints and 8- × 10-cm negatives of 35–40 cell sections 
of each strain at 24,000–29,000 magnification were scanned and converted to digitized images 
with a ScanJet 4400c (Hewlett-Packard) and Photoshop 6.0 software (Adobe Systems, Inc.). 
Quantitation of digitized images was performed using the Discovery Series Quantity One 1-D 




2.2.7 Cellular respiration measurement 
A sample of cells was taken from a culture at a certain time-point. Cells were pelleted by 
centrifugation and resuspended in 1 ml of fresh YP medium containing 0.05% glucose. Oxygen 
uptake by cells was measured continuously in a 2-ml stirred chamber using a custom-designed 
biological oxygen monitor (Science Technical Center of Concordia University) equipped with a 
Clark-type oxygen electrode. 
 
2.2.8 Fluorescence microscopy 
BODIPY 493/503 (Invitrogen) staining for monitoring neutral lipids deposited in lipid 
droplets and DHR (Sigma) staining for ROS were performed according to established procedures 
[23]. The mitochondrial membrane potential () was measured in live yeast by fluorescence 
microscopy of Rhodamine 123 (R123) staining. For R123 staining, 5 × 106 cells were harvested 
by centrifugation for 1 min at 21,000 × g at room temperature and then resuspended in 100 μl of 
50 mM sodium citrate buffer (pH 5.0) containing 2% glucose. R123 (Invitrogen) was added to a 
final concentration of 10 μM. Following incubation in the dark for 30 min at room temperature, 
the cells were washed twice in 50 mM sodium citrate buffer (pH 5.0) containing 2% glucose and 
then analyzed by fluorescence microscopy. Images were collected with a Zeiss Axioplan 
fluorescence microscope (Zeiss) mounted with a SPOT Insight 2-megapixel color mosaic digital 
camera (Spot Diagnostic Instruments). For evaluating the percentage of BODIPY 493/503-, DHR- 
and R123-positive cells, the UTHSCSA Image Tool (Version 3.0) software was used to calculate 
both the total number of cells and the number of stained cells. Fluorescence of individual DHR- 
or R123-positive cells in arbitrary units was determined by using the UTHSCSA Image Tool 
software (Version 3.0). In each of 3 independent experiments, the value of median fluorescence 
was calculated by analyzing at least 800-1000 cells that were collected at each time-point. The 
median fluorescence values were plotted as a function of the number of days cells were cultured. 
 
2.2.9 Immunofluorescence microscopy 
Cell cultures were fixed in 3.7% formaldehyde for 45 min at room temperature. The cells 
were washed in solution B (100 mM KH2PO4/KOH pH 7.5, 1.2 M sorbitol), treated with 
Zymolyase 100T (MP Biomedicals, 1 μg Zymolyase 100T/1 mg cells) for 30 min at 30oC and then 




0.25 μg/μl in TBSB buffer [20 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mg/ml BSA]) was used as 
a primary antibody. Alexa Fluor 568 goat anti-mouse IgG (Invitrogen, 2 μg/μl in TBSB buffer) 
was used as a secondary antibody. The labeled samples were mounted in mounting solution (16.7 
mM Tris/HCl pH 9.0, 1.7 mg/ml p-phenylenediamine, 83% glycerol). Images were collected with 
a Zeiss Axioplan fluorescence microscope (Zeiss) mounted with a SPOT Insight 2-megapixel color 
mosaic digital camera (Spot Diagnostic Instruments). 
 
2.2.10 ATP measurement 
2 × 109 cells were harvested by centrifugation for 1 min at 16,000 × g at 4oC. The cell pellet was 
washed three times in ice-cold PBS (20 mM KH2PO4/KOH (pH 7.5) and 150 mM NaCl) and then 
resuspended in 200 μl of ice-cold SHE solution (50 mM NaOH and 1 mM EDTA). 800 μl of ice- 
cold SHE solution were added to the cell suspension. The resulting alkali extract was incubated at 
60oC for 30 min to destroy endogenous enzyme activities and pyridine nucleotides. The extract 
was neutralized by adding 500 μl of THA solution (100 mM Tris/HCl (pH 8.1) and 50 mM HCl). 
The extract was then divided into 150 μl aliquots, quickly frozen in liquid nitrogen and stored at - 
80oC prior to use. For ATP measurement, 1 µl of alkali extract was added to 1 µl ATP reagent (50 
mM Tris-HCl (pH 8.1), 3 mM MgCl2, 0.2 mM glucose, 0.04% BSA, 0.05 mM NADP
+, 10 µg/ml 
hexokinase, 2 µg/ml glucose-6-phosphate dehydrogenase). Following a 30-min incubation at 
25oC, the reaction was stopped by adding 1 µl of 0.15 M NaOH and heating at 80o C for 20 min. 
A 1 µl aliquot was transferred 100 µl of reagent containing 100 µg/ml hexokinase and 20 µg/ml 
glucose-6-phosphate dehydrogenase. The reaction mixture was incubated for 1 h at 38oC. The 
NADPH generated from NADP+ was measured fluorimetrically (excitation at 365 nm, emission 
monitored at 460 nm). 
 
2.2.11 Total cell lysates preparation 
Total cell lysates were made by vortexing the cells in TCL buffer (25 mM Tris/HCl pH 
8.5, 150 mM NaCl, 1 mM EDTA, 0.1 mM DTT, 4% CHAPS, 1 mM PMSF, protease inhibitor 
cocktail [Sigma]) with glass beads three times for 1 min. Lysates were then centrifuged for 3 min 




2.2.12 Cell viability assay for monitoring the susceptibility of yeast to a mode of cell death 
induced by palmitoleic acid (POA) 
A sample of cells was taken from a culture on a certain day of culturing. A fraction of the 
sample was diluted to determine the total number of cells using a hemocytometer. 8 × 107 cells 
were harvested by centrifugation for 1 min at 21,000 × g at room temperature and resuspended in 
8 ml of YP medium containing 0.2% glucose as carbon source. Each cell suspension was divided 
into 8 equal aliquots. Three pairs of aliquots were supplemented with POA (#P9417; Sigma) from 
a 50-mM stock solution (in 10% chloroform, 45% hexane and 45% ethanol; #650498, #248878 
and #34852, respectively; all from Sigma). The final concentration of POA was 0.05 mM, 0.1 mM 
or 0.15 mM for each pair of aliquots; in all these aliquots, the final concentrations of chloroform, 
hexane and ethanol were 0.03%, 0.135% and 0.135%, respectively. One pair of aliquots was 
supplemented only with chloroform, hexane and ethanol added to the final concentrations of 
0.03%, 0.135% and 0.135%, respectively. All aliquots were then incubated for 2 h at 30oC on a 
Labquake rotator (#400110; Thermolyne/Barnstead International) set for 360o rotation. Serial 
dilutions of cells were plated in duplicate onto plates containing YP medium with 2% glucose as 
carbon source. After 2 d of incubation at 30oC, the number of colony forming units (CFU) per 
plate was counted. The number of CFU was defined as the number of viable cells in a sample. For 
each aliquot of cells exposed to POA, the % of viable cells was calculated as follows: (number of 
viable cells per ml in the aliquot exposed to POA/number of viable cells per ml in the control 
aliquot that was not exposed to POA) × 100. 
 
2.2.13 Cell viability assay for monitoring the susceptibility of yeast to a mode of cell death 
induced by hydrogen peroxide 
A sample of cells was taken from a culture on a certain day of culturing. A fraction of the 
sample was diluted to determine the total number of cells using a hemocytometer. 8 × 107 cells 
were harvested by centrifugation for 1 min at 21,000 × g at room temperature and resuspended in 
8 ml of YP medium containing 0.2% glucose as carbon source. Each cell suspension was divided 
into 8 equal aliquots. Three pairs of aliquots were supplemented with hydrogen peroxide (#H325- 
500; Fisher Scientific) to the final concentration of 0.5 mM, 1.5 mM or 2.5 mM for each pair. One 
pair of aliquots remained untreated. All aliquots were then incubated for 2 h at 30oC on a Labquake 




cells were plated in duplicate onto plates containing YP medium with 2% glucose as carbon source. 
After 2 d of incubation at 30oC, the number of CFU per plate was counted. The number of CFU 
was defined as the number of viable cells in a sample. For each aliquot of cells exposed to hydrogen 
peroxide, the % of viable cells was calculated as follows: (number of viable cells per ml in the 
aliquot exposed to hydrogen peroxide/number of viable cells per ml in the control aliquot that was 
not exposed to hydrogen peroxide) × 100. 
 
2.2.14 Statistical analysis 
Statistical analysis was performed using Microsoft Excel's (2010) Analysis ToolPak - 
VBA. All data on cell survival are presented as mean ± SEM. The p values for comparing the 
means of two groups using an unpaired two-tailed t test were calculated with the help of the 
GraphPad Prism 7 statistics software. The logrank test for comparing each pair of survival curves 
was performed with GraphPad Prism 7. Two survival curves were considered statistically different 
if the p value was less than 0.05. 
 
2.2.15 Miscellaneous procedures 
Enzymatic activity of cytochrome c oxidase measurement [166], a measurement of 
succinate dehydrogenase enzymatic activity [167], enzymatic activity of aconitase measurement 
[168], SDS-PAGE and immunoblotting [169], subcellular fractionation of yeast [170], purification 





2.3.1 Rapid consumption of ethanol by yeast cultured under CR conditions is an essential 
contributing factor to chronological aging delay by CR 
The Titorenko laboratory has previously found that wild-type (WT) cells of yeast grown 
under CR conditions on 0.2% or 0.5% glucose quickly consume ethanol, a product of glucose 
fermentation by these cells [23]. Because WT yeast cultures grown under non-CR conditions on 
1% or 2% glucose did not consume (and therefore accumulated) ethanol for many days of culturing 
[23], we hypothesized that the fast consumption of ethanol by WT yeast limited in calorie supply 




hypothesis, ethanol accumulation by yeast cells cultured in calorie-rich medium may be 
responsible for the accelerated chronological aging of non-CR yeast [23, 84, 149]. This hypothesis 
posits that 1) a genetic intervention that lowers ethanol concentration in non-CR yeast cultures will 
extend longevity of chronologically aging yeast; whereas 2) a genetic intervention that rises 
ethanol concentration in such cultures will shorten yeast chronological lifespan (CLS) [23, 84, 
149]. To test this hypothesis, we assessed how a single-gene-deletion mutation eliminating either 
the Adh1 or the Adh2 isozyme of alcohol dehydrogenase influences ethanol concentrations in CR 
and non-CR yeast cultures and how each of these mutations affects CLS of CR and non-CR yeast. 
Adh1 is known to catalyze acetaldehyde conversion to ethanol, whereas Adh2 is involved in the 
reverse process of ethanol conversion to acetaldehyde (Figure 2.1) [172]. Both these alcohol 
dehydrogenase isozymes are assimilated into a network of metabolic pathways and interorganellar 
communications taking place in cells of chronologically aging S. cerevisiae (Figure 2.1) [23, 20, 
149, 172-175]. 
We found that, although the adh1Δ mutation decreases and the adh2Δ mutation increases 
ethanol concentration in yeast cultures during logarithmic (L) phase of growth under CR on 0.2% 
or 0.5% glucose, ethanol is rapidly and completely consumed by adh1Δ and adh2Δ cells (as well 
as by WT cells) during subsequent diauxic (D) phase of culturing under CR conditions (Figures 
2.2A and 2.2B, respectively). Not only the adh1Δ and adh2Δ mutations had no effect on the rapid 
consumption of ethanol under CR conditions, but they also did not affect the CLS of yeast placed 
on a low-calorie diet (Figures 2.2E, 2.2F, 2.2I and 2.2J). 
Despite the adh1Δ and adh2Δ mutations did not influence ethanol concentration in post- 
logarithmic CR yeast cultures and had no effect on yeast CLS under CR conditions, each of them 
differently affected ethanol concentration and CLS under non-CR conditions on 1% or 2% glucose. 
adh1Δ significantly decreased ethanol concentration in non-CR yeast during all phases of culturing 
(Figures 2.2C and 2.2D) and increased the CLS of non-CR yeast (Figures 2.2G, 2.2H, 2.2K and 
2.2L). In contrast, adh2Δ significantly increased ethanol concentration in non-CR yeast during all 
phases of culturing (Figures 2.2C and 2.2D) and decreased the CLS of non-CR yeast (Figures 
2.2G, 2.2H, 2.2K and 2.2L). 
In sum, these findings indicate that CR delays yeast chronological aging in part because 




Figure  2.1.  The  Adh1- 
and Adh2-dependent 
metabolism of ethanol is 
integrated into a network which 
also assimilates the synthesis and 
degradation of glycogen and 
trehalose, the synthesis of neutral 
lipids TAG and EE in the ER, the 
lipolytic degradation of TAG and 
EE in LD, and the Fox1-, Fox2- 
and Fox3-dependent β-oxidation 
of FFA in peroxisomes. The 
names of metabolites integrated 
into this network and pertinent to 
this  study  are  displayed  in  red 
color. The Adh1 isozyme of alcohol dehydrogenase catalyzes the conversion of acetaldehyde to ethanol, whereas the 
Adh2 isozyme of alcohol dehydrogenase is involved in a reverse process of ethanol conversion to acetaldehyde. 
Abbreviations: Ac-CoA, acetyl-CoA; AcOH, acetic acid; DAG, diacylglycerols; EE, ergosteryl esters; ER, 




Figure 2.2. Effects 
of the adh1Δ and adh2Δ 
mutations on ethanol 
concentration and CLS 
under CR and non-CR 
conditions. WT, adh1Δ and 
adh2Δ cells were cultured in 
the nutrient-rich YP medium 
under CR (the initial 
concentration of glucose was 
0.2% or 0.5%) or non-CR (the 
initial concentration of 
glucose was 1% or 2%) 
conditions. A-D. Ethanol 
concentrations in yeast 
cultures grown under CR or 
non-CR conditions and 
recovered on different days of 
culturing.     E-H.     Survival 
curves of chronologically aging WT, adh1Δ and adh2Δ strains. Data are presented as means ± SEM (n = 4). I-L. p 
Values for different pairs of survival curves of WT, adh1Δ and adh2Δ strains cultured under CR or non-CR conditions. 
Survival curves shown in E-H were compared. Two survival curves were considered statistically different if the p 
value was less than 0.05. The p values for comparing pairs of survival curves using the logrank test were calculated 
as described in Materials and Methods. Abbreviations: L, D, PD and ST, logarithmic, diauxic, post-diauxic and 




2.3.2 Ethanol concentration controls the homeostasis of glycogen and trehalose in yeast 
cultured under non-CR conditions 
Both the Adh1-dependent conversion of acetaldehyde to ethanol and the Adh2-driven 




pathways for glycogen and trehalose synthesis and degradation (Figure 2.1) [23, 149, 172, 176]. 
Glycogen and trehalose are the major stores of glucose in yeast cells [23, 149, 176, 177]. Trehalose 
in yeast is also involved in the development and maintenance of an anti-aging cellular pattern 
because this carbohydrate 1) protects cells and proteins from various stresses [19]; 2) preserves 
cellular proteostasis by suppressing the misfolding, aggregation and oxidative damage of newly 
synthesized polypeptides [61, 149, 179]; and 3) enables a re-entry of quiescent cells into the 
proliferative cell cycle in response to a supply of nutrients [150, 180, 181]. 
Because the pathways of ethanol, glycogen and trehalose metabolism are integrated into a 
network and play essential roles in yeast chronological aging, we hypothesized that the extent of 
ethanol accumulation by yeast cells cultured under non-CR conditions may influence glycogen 
and/or trehalose homeostasis in yeast cells. Our hypothesis posits that genetic interventions that 
decrease or increase ethanol concentration in non-CR yeast cultures will differently affect the 
concentrations of glycogen and/or trehalose in yeast cells cultured in calorie-rich medium. To test 
this hypothesis, we examined how the adh1Δ mutation (which decreases ethanol concentration in 
non-CR yeast; Figures 2.2C and 2.2D) and the adh2Δ mutation (which increases ethanol 
concentration in non-CR yeast; Figures 2.2C and 2.2D) affect glycogen and trehalose abundance 
in yeast cultured under non-CR conditions. 
 
Figure 2.3. Effects of the 
adh1Δ and adh2Δ mutations on 
glycogen and trehalose concentrations 
in non-CR yeast. WT, adh1Δ and 
adh2Δ cells were cultured in the 
nutrient-rich YP medium under non-CR 
conditions on 2% glucose. Glycogen (A) 
and trehalose (B) concentrations in non- 
CR yeast recovered on different days of 
culturing are shown. Glycogen and 
trehalose concentrations were measured 
as described in Materials and Methods. 
Abbreviations: L, D, PD and ST, 
logarithmic, diauxic, post-diauxic and 
stationary growth phases (respectively). 
 
 
We found that the adh1Δ mutation has the following effects on glycogen and trehalose in 
non-CR yeast cultured on 2% glucose: 1) it elicits a buildup of glycogen during post-diauxic (PD) 
phase of culturing and shifts glycogen consumption by adh1Δ cells to stationary (ST) phase 




substantially increases the concentration of trehalose during PD and ST phases (Figure 2.3B). In 
contrast, the adh2Δ mutation affected glycogen and trehalose abundance in non-CR yeast cultured 
on 2% glucose as follows: 1) it accelerated the consumption of glycogen during D and PD phases 
(Figure 2.3A); and 2) it significantly decreased trehalose concentration during PD and ST phases 
(Figure 2.3B). 
These findings support our hypothesis that ethanol concentration in non-CR yeast cells 
regulates glycogen and trehalose homeostasis in these cells. 
 
2.3.3 Ethanol concentration regulates the homeostasis of neutral lipids, free fatty acids and 
diacylglycerols, in non-CR yeast 
The network integrating ethanol, glycogen and trehalose metabolism also incorporates the 
metabolic pathways for the synthesis and degradation of the following lipid classes: 1) the so- 
called ″neutral″ (uncharged) lipids triacylglycerols (TAG) and ergosteryl esters (EE), both of 
which are first synthesized in the endoplasmic reticulum (ER) and then deposited in lipid droplets 
(LD); and 2) free fatty acids (FFA) and diacylglycerols (DAG), both of which can be used for 
TAG synthesis in the ER and can also be formed as the products of TAG lipolysis in LD (FFA can 
also undergo β-oxidation in peroxisomes) (Figure 2.1) [23, 149, 173-175]. TAG synthesis from 
FFA and DAG in the ER, LD-confined TAG lipolysis into FFA and DAG, and the peroxisomal 
oxidation of FFA are known to be longevity assurance processes in chronologically aging yeast 
[20, 23, 149, 173-175]. 
Given that the metabolic pathways for ethanol, TAG, EE, FFA and DAG synthesis and 
degradation are assimilated into a network and define longevity of chronologically aging yeast, 
one may assume that ethanol concentration in non-CR yeast may play an important role in the 
maintenance of TAG, EE, FFA and DAG homeostasis. To test this assumption, we assessed the 
effects of the adh1Δ and adh2Δ mutations on the abundance of LD, TAG, EE, FFA and DAG in 
non-CR yeast. 
We found that in yeast cultured under non-CR conditions on 2% glucose, the adh1Δ 
mutation stimulates LD degradation, promotes TAG and EE lipolysis, and accelerates FFA and 
DAG consumption during ST phase (Figures 2.4A-2.4E); this mutation decreases ethanol 




has the following effects in non-CR yeast cultured on 2% glucose: 1) it suppresses LD degradation 
during late ST phase; 2) it slows down TAG and EE lipolysis during ST phase; and 3) it rises FFA 
Figure 2.4. Effects of the 
adh1Δ and adh2Δ mutations on the 
abundance of LD, TAG, EE, FFA 
and DAG in non-CR yeast. WT, 
adh1Δ and adh2Δ cells were cultured in 
the nutrient-rich YP medium under 
non-CR conditions on 2% glucose. The 
percentage of cells with LD (A) as well 
as TAG  (B), EE  (C), FFA  (D)  and 
DAG (E) concentrations in whole cells 
recovered on different days of culturing 
are shown. The abundance of LD and 
the concentrations of TAG, EE, FFA 
and DAG in whole cells were measured 
as described in Materials and Methods. 
Abbreviations: DAG, diacylglycerols; 
EE, ergosteryl esters; FFA, free fatty 
acids; LD, lipid droplets; L, D, PD and 
ST, logarithmic, diauxic, post-diauxic and stationary growth phases (respectively); TAG, triacylglycerols. These 




and DAG concentrations during PD phase and decelerates their consumption during 
subsequent ST phase (Figures 2.4A-2.4E); this mutation increases ethanol concentration in non- 
CR yeast (Figures 2.2C and 2.2D). 
In sum, these findings confirm our assumption that ethanol concentration in non-CR yeast 
cells is an important contributing factor to the maintenance of TAG, EE, FFA and DAG 
homeostasis. 
 
2.3.4 Ethanol lowers concentrations of enzymes involved in the peroxisomal oxidation of 
FFA to cause FFA accumulation in non-CR yeast 
Our previous study has revealed that in chronologically aging yeast the CR diet 1) elicits a 
rapid and complete exhaustion of ethanol during D phase; 2) increases the concentrations of the 
core enzymes of peroxisomal fatty acid β-oxidation Fox1, Fox2 and Fox3 (Figure 2.1) during D, 
PD and ST phases; and 3) stimulates a fast depletion of FFA during PD phase [23]. Ethanol has 
been shown to decrease the levels of Fox1, Fox2 and Fox3 in methylotrophic yeast capable of 
using methanol as sole source of carbon and energy [182, 183]. Altogether, these findings 




and 2.2D) may decrease the abundance of Fox1, Fox2 and Fox3; the resulting decline in the 
peroxisomal β-oxidation of FFA may instigate the accumulation of FFA seen in non-CR yeast 
[23]. 
If this hypothesis is correct, then 1) a genetic intervention that decreases ethanol 
concentration in non-CR yeast cultures (such as the adh1Δ mutation) will increase the levels of 
Fox1, Fox2 and Fox3 in yeast cultured in calorie-rich medium; whereas 2) a genetic intervention 
that increases ethanol concentration in these cultures (such as the adh2Δ mutation) will decrease 
the levels of Fox1, Fox2 and Fox3 in non-CR yeast. In support of this hypothesis, the adh1Δ 
mutation caused an increase in the concentrations of Fox1, Fox2 and Fox3 in non-CR yeast 
cultured on 1% or 2% glucose, while the adh2Δ mutation had the opposite effect on the 
concentrations of these enzymes in yeast under non-CR conditions (Figures 2.5A, 2.5D, 2.5E, 
2.5H, 2.5I, 2.5L and 2.5M). 
Figure 2.5. Effects 
of the adh1Δ and adh2Δ 
mutations on the 
concentrations of Fox1, 
Fox2 and Fox3 in yeast 
cultured under CR or non- 
CR conditions. WT, adh1Δ 
and adh2Δ cells were 
cultured in the nutrient-rich 
YP medium under CR (the 
initial concentration of 
glucose was 0.2% or 0.5%) 
or non-CR (the initial 
concentration of glucose was 
1% or 2%) conditions. A. 
Western blot analysis of 
Fox1, Fox2, Fox3 and actin 
in total cell lysates was 
performed as described in 
Materials and Methods.  B- 
M. Immunoblots shown in A 
were used to calculate the 
relative levels of Fox1, Fox2 
and Fox3 in total cell lysates 
as described in Materials and 




We therefore concluded that ethanol decreases the concentrations of Fox1, Fox2 and Fox3 
in non-CR yeast cells, thus decelerating the peroxisomal β-oxidation of FFA and eliciting a buildup 





2.3.5 In CR yeast, the peroxisomal β-oxidation of FFA is a longevity assurance process that 
controls neutral lipids synthesis in the ER and neutral lipids lipolysis in LD 
Since CR diet elicits a substantial increase in the concentrations of the core enzymes of 
peroxisomal fatty acid β-oxidation Fox1, Fox2 and Fox3 (Figure 2.5) [23], one may assume that 
the β-oxidation of FFA in peroxisomes may be a longevity assurance process in chronologically 
aging yeast limited in calorie supply. In support of this assumption, we found that the fox1Δ, fox2Δ 
and fox3Δ mutations significantly shorten the CLS of yeast cultured under CR on 0.2% glucose 
(Figures 2.6A and 2.6B). 
Figure 2.6. Effects of the 
fox1Δ, fox2Δ and fox3Δ 
mutations on CLS, LD 
abundance, and TAG, 
EE,    FFA    and    DAG 
concentrations in yeast 
cultured under CR 
conditions. WT, fox1Δ, 
fox2Δ and fox3Δ cells were 
cultured in the nutrient- 
rich YP medium under CR 
conditions on 0.2% 
glucose. A.  Survival 
curves of chronologically 
aging WT, fox1Δ, fox2Δ 
and fox3Δ strains. Data are 
presented as means ± SEM 
(n = 4). B. p Values for 
different pairs of survival 
curves of WT, fox1Δ, 
fox2Δ and fox3Δ strains. 
Survival curves shown in 
A were compared. Two 
survival curves were 
considered       statistically 
different if the p value was less than 0.05. The p values for comparing pairs of survival curves using the logrank test 
were calculated as described in Materials and Methods. The percentage of cells with LD (C) as well as TAG (D), EE 
(E), FFA (F) and DAG (G) concentrations in whole cells recovered on different days of culturing are shown. Data are 
presented as means ± SEM (n = 4). The abundance of LD and the concentrations of TAG, EE, FFA and DAG in whole 
cells were measured as described in Materials and Methods. H. Spectra of lipids that were extracted from the ER or 
LD purified from WT, fox1Δ, fox2Δ and fox3Δ cells. Cells were recovered on different days of culturing, and the ER 
and LD were purified as described in Materials and Methods. The equivalent of 200 µg of ER proteins and the 
equivalent of 20 µg of LD proteins were used for lipid extraction and analysis by thin-layer chromatography, as 
described in Materials and Methods. A representative of 3 independent experiments is shown. Abbreviations: DAG, 
diacylglycerols; EE, ergosteryl esters; ER, endoplasmic reticulum; FFA, free fatty acids; LD, lipid droplets; L, D, PD 
and ST, logarithmic, diauxic, post-diauxic and stationary growth phases (respectively); TAG, triacylglycerols. 




FFA that undergo the β-oxidation in peroxisomes are formed in LD as the products of 
neutral lipid lipolysis, a process which also generates DAG and ergosterol (ERG) from TAG and 
EE (respectively) (Figure 2.1) [23, 149, 173-175]. Moreover, LD-derived FFA are utilized for 
neutral lipids synthesis in the ER using DAG and ERG as the co-substrates for TAG and EE 
formation (respectively) (Figure 2.1) [23, 149, 173-175]. Thus, the β-oxidation of FFA in 
peroxisomes, lipolysis of neutral lipids in LD and synthesis of neutral lipids in the ER are 
integrated into an intricate metabolic network (Figure 2.1). We therefore hypothesized that the 
fox1Δ, fox2Δ and fox3Δ mutations may alter the concentrations of all these lipid classes (i.e. FFA, 
DAG, TAG and EE). Our hypothesis posits that the rate of the peroxisomal β-oxidation of FFA 
may influence the rates of neutral lipids synthesis in the ER and neutral lipids lipolysis in LD. In 
support of this hypothesis, we found that in chronologically aging CR yeast the fox1Δ, fox2Δ and 
fox3Δ mutations 1) prevent an age-related depletion of LD during PD and ST phases (Figure 2.6C); 
2) eliminate an age-related decline in the cellular concentrations of TAG and EE during PD and 
ST phases (Figures 2.6D and 2.6E); 3) elicit an accumulation of TAG and EE in the ER during PD 
phase (Figure 2.6H); 4) cause a buildup of TAG and EE in LD during ST phase (Figure 2.6H); 5) 
increase the cellular concentrations of FFA and DAG during PD and ST phases (Figures 2.6F and 
2.6G); 6) prompt an accumulation of FFA and DAG in the ER during D and PD phases (Figure 
2.6H); and 7) promote a deposition of FFA and DAG in LD during PD and ST phases (Figure 
2.6H). 
 
2.3.6 A weakening of peroxisomal fatty acid β-oxidation elicits negative feedback loops that 
regulate the metabolism and transport of several lipid classes in the ER and LD 
A close association of peroxisomes with LD in chronologically aging yeast causes an 
intrusion of peroxisomes into the neutral lipid core of LD, thus forming so-called ″pexopodia″ 
(Figures 2.7A-2.7C; Figure 2.8) [184]. Pexopodia stimulate the lipolysis of neutral lipids within 
LD, thereby increasing the supply of FFA for β-oxidation in peroxisomes [184]. The fox1Δ, fox2Δ 
and fox3Δ mutations impair peroxisomal fatty acid β-oxidation, thus eliciting a deposition of 
electron-dense arrays of FFA (termed ″gnarls″) and non-degraded neutral lipids within LD 




We have used electron microscopy to monitor age-related changes in the abundance of 
pexopodia and LD-confined gnarls in WT, fox1Δ, fox2Δ and fox3Δ cells cultured under CR on 
0.2% glucose. 
We found that pexopodia amass in WT, fox1Δ, fox2Δ and fox3Δ cells during L and D phases 
(Figure 2.7D), concomitantly with an increase of FFA and DAG in whole cells (Figures 2.6F and 
2.6G), the ER (Figure 2.6H) and LD (Figure 2.6H). 
During the following PD phase, pexopodia disappeared in WT cells (Figure 2.7D); such 
disappearance of pexopodia in WT cells during PD phase coincided with 1) a depletion of FFA 
and DAG in whole WT cells (Figures 2.6F and 2.6G), the ER of WT (Figure 2.6H) and LD of WT 
(Figure 2.6H); 2) an exhaustion of TAG and EE in whole WT cells (Figures 2.6D and 2.6E) and 
the ER of WT (Figure 2.6H); 3) a decrease of TAG and EE concentrations in LD of WT (Figure 
2.6H; both TAG and EE were completely depleted in LD of WT by the beginning of the ensuing 
ST phase); and 4) a lack of gnarls in LD of WT (Figure 2.7E). In contrast, pexopodia became more 
abundant in fox1Δ, fox2Δ and fox3Δ mutant cells during PD phase (Figure 2.7D), concomitantly 
with 1) a rise of FFA and DAG in whole mutant cells (Figures 2.6F and 2.6G), the ER of mutants 
(Figure 2.6H) and LD of mutants (Figure 2.6H); 2) an increase in TAG and EE concentrations in 
whole mutant cells (Figures 2.6D and 2.6E), the ER of mutants (Figure 2.6H) and LD of mutants 
(Figure 2.6H); and 3) an expansion of gnarls in LD of mutants (Figure 2.7E). 
Figure 2.7. Effects of the fox1Δ, fox2Δ and 
fox3Δ mutations on age-related changes in 
the abundance of pexopodia and LD- 
confined gnarls in yeast cultured under CR 
conditions. WT, fox1Δ, fox2Δ and fox3Δ cells 
were cultured in the nutrient-rich YP medium 
under CR conditions on 0.2% glucose. A-C. 
Transmission electron micrographs of 
chronologically aging fox1Δ (A), fox2Δ (B) 
and fox3Δ (C) cells recovered on day 7. Each 
of the two panels for fox1Δ, fox2Δ and fox3Δ 
cells shows a different magnification of the 
same electron micrograph. The percentage of 
WT, fox1Δ, fox2Δ and fox3Δ cells with 
pexopodia (D) and LD-confined gnarls (E) in 
yeast recovered on different days of culturing 
are presented. Images like the representative 
images shown in A, B and C were quantified 
as described in Materials and Methods. Data 
are presented as means ± SEM (n = 3). 
Abbreviations: L, D, PD and ST, logarithmic, 





During the subsequent ST phase, the abundance of pexopodia in fox1Δ, fox2Δ and fox3Δ 
mutant cells remained unchanged (Figure 2.7D), whereas the abundance of gnarls within LD of 
these cells significantly increased (Figure 2.7E). Such deposition of gnarls within LD of fox1Δ, 
fox2Δ and fox3Δ mutant cells during ST phase coincided with 1) a rise of FFA and DAG in whole 
mutant cells (Figures 2.6F and 2.6G) and LD of mutants (Figure 2.6H); 2) an increase of ERG in 
LD of mutants (Figure 2.6H); 3) an absence of FFA in the ER of mutants (Figure 2.6H); 4) a slight 
increase in DAG concentrations in the ER of mutants (Figure 2.6H); and 5) a lack of significant 
changes in TAG and EE concentrations in whole mutant cells (Figures 2.6D and 2.6E), the ER of 
mutants (Figure 2.6H) and LD of mutants (Figure 2.6H). 
Figure 2.8. A mechanism 
through which a decline in 
the peroxisomal β-oxidation 
of FFA elicits negative 
feedback loops that regulate 
the metabolism and 
transport of several lipid 
classes in the ER and LD. A 
weakening of the peroxisomal 
β-oxidation of FFA causes an 
accumulation of FA-CoA in 
pexopodia, which represent 
intrusions of peroxisomes into 
the neutral lipid core of LD. 
This creates several negative 
feedback loops whose action 
ultimately   causes   an   age- 
related build-up of FFA and DAG in the ER and LD. Blue arrows next to the names of Fox1, Fox2 and Fox3 indicate 
that a decline in the peroxisomal β-oxidation of FFA is due to a decrease in the concentrations of the core enzymes of 
such oxidation. Red arrows next to the names of lipid classes denote those of them whose concentrations are increased. 
Inhibition bars displayed in green color signify negative feedback loops. See text for more details. Abbreviations: Ac- 
CoA, acetyl-CoA; DAG, diacylglycerols; EE, ergosteryl esters; ERG, ergosterol; ER, endoplasmic reticulum; FA- 
CoA, acyl-CoA esters; FFA, free fatty acids; LD, lipid droplets; LD, lipid droplet; TAG, triacylglycerols. 
 
 
In sum, these findings suggest that a decline in the peroxisomal β-oxidation of FFA causes 
a build-up of fatty acyl-CoA esters (FA-CoA) in pexopodia, which represent intrusions of 
peroxisomes into the neutral lipid core of LD. This creates a negative feedback loop which 
mitigates the transport of FA-CoA to pexopodia from associated LD, where these FA-CoA are 
formed from FFA derived from neutral lipids (Figure 2.8). This, in turn, elicits an accumulation of 
gnarls (the electron-dense arrays of FFA [184]) in LD, thereby instigating a series of negative 
feedback loops. These feedback loops attenuate the lipolysis of neutral lipids in LD, transport of 




ERG in the ER (Figure 2.8). Due to the action of such negative feedback mechanism regulating 
lipid metabolism and transport in several organelles, a decline in peroxisomal fatty acid β- 
oxidation in chronologically aging yeast causes an age-related build-up of FFA and DAG in the 
ER and LD (Figure 2.8). 
 
2.3.7 Three possible mechanisms through which peroxisomal fatty acid β-oxidation may 
define yeast CLS 
As we have found, the β-oxidation of FFA in peroxisomes is a longevity assurance process 
in chronologically aging yeast cultured under CR-conditions (Figures 2.6A and 2.6B). It is 
conceivable that there may be at least three different mechanisms by which peroxisomal fatty acid 
β-oxidation defines longevity of chronologically aging yeast. These possible mechanisms are 
outlined below. 
First mechanism: the final product of peroxisomal fatty acid β-oxidation is acetyl-CoA, 
which is transported to mitochondria after being formed in peroxisomes (Figure 2.9). 
Mitochondrial oxidation of the peroxisomally generated pool of acetyl-CoA through the TCA 
cycle provides reducing equivalents for the synthesis of ATP via oxidative phosphorylation [23, 
149, 172, 176]. Acetyl-CoA that is used for the synthesis of ATP in mitochondria is also made 
within these organelles as the product of oxaloacetate and acetate oxidation (Figure 2.9) [23, 149, 
172, 176]. It is feasible that an ample amount of ATP is generated in mitochondria of CR yeast 
because of the oxidation of acetyl-CoA made in peroxisomes, not due to the oxidation of acetyl- 
CoA produced in mitochondria. Thus, peroxisomal fatty acid β-oxidation may regulate longevity- 
defining processes inside and outside of mitochondria and influence yeast CLS under CR 
conditions because such oxidation may be responsible for the synthesis of the bulk of cellular ATP 
(Figure 2.9). 
Second mechanism: mitochondrial oxidation of the peroxisomally produced pool of acetyl- 
CoA may also be essential for the demonstrated ability of yeast mitochondria to maintain the shape 
of a tubular network under CR conditions [23]; in chronologically aging non-CR yeast, this 
network is fragmented into individual mitochondria [23]. Because mitochondrial morphology 
depends on a balance between the processes of mitochondrial fission and fusion [185, 186], it is 
conceivable that mitochondrial oxidation of peroxisomally produced acetyl-CoA in CR yeast may 




opposing process of mitochondrial fission elicits mitochondrial fragmentation and promotes a 
mitochondria-controlled apoptotic mode of age-related RCD (Figure 2.9) [187-196]. Thus, it is 
also plausible that mitochondrial oxidation of peroxisomally produced acetyl-CoA may be 





droplets; TAG, triacylglycerols. 
 
Figure 2.9. Possible mechanisms 
through which the β-oxidation of 
FFA in peroxisomes may define 
longevity of chronologically aging 
yeast. The names of metabolites 
whose concentrations depend on the 
extent of peroxisomal fatty acid β- 
oxidation are displayed in red color. 
There may be at least three different 
mechanisms through which the 
concentrations of these metabolites 
may define yeast chronological 
lifespan (CLS). These mechanisms 
are numbered. See text for more 
details. Abbreviations: Ac-CoA, 
acetyl-CoA; AcOH, acetic acid; CR, 
caloric restriction; DAG, 
diacylglycerols; EE, ergosteryl esters; 
ER, endoplasmic reticulum; ERG, 
ergosterol; FFA, free fatty acids; FA- 
CoA, fatty acyl-CoA esters; LD, lipid 
 
Third mechanism: we have revealed that 1) a decline in peroxisomal fatty acid β-oxidation 
in chronologically aging yeast causes an age-related build-up of FFA and DAG in the ER and LD 
(Figure 2.8); and 2) CR stimulates peroxisomal fatty acid β-oxidation and decreases the 
concentrations of FFA and DAG in chronologically aging yeast [14, 23]. An exposure of yeast 
cells to exogenous FFA and DAG is known to elicit a ″liponecrotic″ mode of age-related RCD 
[14, 103, 197, 198]. Therefore, it is possible that the abilities of CR to stimulate peroxisomal fatty 
acid β-oxidation and to decrease the concentrations of FFA and DAG may delay the age-related 
onset of the liponecrotic mode of RCD (Figure 2.9). 
In a series of experiments outlined below, we assessed how each of the three mechanisms 




2.3.8 The β-oxidation of FFA in peroxisomes defines the CLS of CR yeast in part because 
it is essential for mitochondrial functionality and ATP synthesis in mitochondria 
To assess the first proposed mechanism (Figure 2.9), we tested if the fox1Δ, fox2Δ and 
fox3Δ mutations can alter mitochondrial functionality and decrease the concentration of cellular 
ATP, which in CR yeast is produced mainly in mitochondria [174, 199]. The fox1Δ, fox2Δ and 
fox3Δ mutations deplete the peroxisomally generated pool of acetyl-CoA by impairing 
peroxisomal fatty acid β-oxidation (Figure 2.9) [174, 199]. As we demonstrated, each of these 
mutations significantly shortens the CLS of yeast cultured under CR on 0.2% glucose (Figures 
2.6A and 2.6B). 
We assessed how the fox1Δ, fox2Δ and fox3Δ mutations influence age-related changes in 
the following vital traits of mitochondrial functionality: 1) oxygen consumption by cells, which in 
yeast cultured in media with low (0.2%) glucose concentration is mainly due to mitochondrial 
respiration [172, 200]; 2) the electrochemical potential (ΔΨ) across the inner mitochondrial 
membrane; and 3) cellular concentration of ATP, which in yeast cultured in media with low 
glucose concentration is generated mainly in mitochondria [172, 200]. We found that in CR yeast 
cultured on 0.2% glucose, the fox1Δ, fox2Δ and fox3Δ mutations 1) markedly amplify 
mitochondrial respiration (Figure 2.10A) and ΔΨ (Figure 2.10B) during L and D phases; 2) elicit 
an abrupt decline in mitochondrial respiration (Figure 2.10A) and ΔΨ (Figure 2.10B) during PD 
phase. Although neither of these mutations altered the concentration of mitochondrially 
synthesized ATP during L phase and in the beginning of D phase, all three mutations decreased 
ATP production in mitochondria by the end of D phase and caused a rapid decline in mitochondrial 
ATP synthesis during PD and ST phases (Figure 2.10C). 
The fox1Δ, fox2Δ and fox3Δ mutations cause a sharp increase of mitochondrially produced 
ROS during L and D phases in yeast cultured under CR conditions on 0.2% glucose (Figure 
2.10D). In agreement with an essential role that excessive concentrations of mitochondrial ROS 
play in oxidative damage to mitochondrial proteins [200, 201], the sharp increase of mitochondrial 
ROS seen in fox1Δ, fox2Δ and fox3Δ cells during L and D phases coincided with a rapid 
inactivation of several enzymes involved in the electron transport chain (ETC) and/or TCA cycle 
in mitochondria; such inactivation of mitochondrial ETC and TCA enzymes in fox1Δ, fox2Δ and 
fox3Δ cells continued during the subsequent PD phase (Figures 2.10E-2.10G). The protein 





Effects of the fox1Δ, 
fox2Δ and fox3Δ 
mutations on vital traits 
of mitochondrial 
functionality, including 
ATP synthesis, in yeast 
cultured under CR 
conditions. WT, fox1Δ, 
fox2Δ and fox3Δ cells 
were cultured in the 
nutrient-rich YP medium 
under CR conditions on 
0.2% glucose. The rate of 
oxygen consumption by 
cells (A), electrochemical 
potential (ΔΨ) across the 
IMM (B), cellular ATP 
concentration (C), cellular 
ROS concentration (D), enzymatic activity of cytochrome c oxidase (CCO) in purified mitochondria (E), enzymatic 
activity of succinate dehydrogenase in purified mitochondria (SDH) (F), and enzymatic activity of aconitase (ACO) 
in total cell lysates (G) were measured as described in Materials and Methods. The ACO activity was measured with 
or without the reactivation agents Fe3+ and Na2S. Data are presented as means ± SEM (n = 5 for A; n = 3 for B-G; ns, 
not significant; ** < 0.01; *** < 0.001). Abbreviations: L, D, PD and ST, logarithmic, diauxic, post-diauxic and 
stationary growth phases (respectively); IMM, inner mitochondrial membrane; ROS, reactive oxygen species. These 




and  fox3Δ  cells  included  cytochrome  c  oxidase  (CCO)  (Figure  2.10E),  succinate 
dehydrogenase (SDH) (Figure 2.10F) and aconitase (ACO) (Figure 2.10G), all of which are known 
to be highly susceptible to ROS-inflicted oxidative damage [23, 200-203]. We found that the 
enzymatic activity of ACO, which in fox1Δ, fox2Δ and fox3Δ cells is rapidly decreased in vivo 
during D and PD phases, can be markedly increased in vitro by incubating lysates of these cells 
with Fe3+  and S2-  (Figure 2.10G); such incubation in vitro is known to restore the oxidative 
damage-dependent loss of one iron from the [4Fe-4S] cluster of ACO [204]. This observation 
confirms our assumption that the rapid inactivation of mitochondrial ACO seen in fox1Δ, fox2Δ 
and fox3Δ cells is due to ROS-inflicted oxidative damage to mitochondrial proteins in these cells. 
Altogether, these findings support the notion that mitochondrial oxidation of acetyl-CoA 
pool generated in peroxisomal fatty acid β-oxidation is 1) essential for maintaining mitochondrial 
functionality; and 2) responsible for the synthesis of the bulk of cellular ATP fueled by the TCA 




2.3.9 Peroxisomal fatty acid β-oxidation contributes to yeast CLS extension under CR 
conditions by weakening the fragmentation of a mitochondrial network and postponing the 
onset of age-related apoptotic RCD 
To assess the second proposed mechanism (Figure 2.9), we initially tested if the fox1Δ, 
fox2Δ and fox3Δ mutations influence the demonstrated ability [23] of yeast mitochondria to 
maintain the shape of a continuous tubular network under CR conditions. We found that in CR 
yeast cultured on 0.2% glucose 1) none of these mutations alters the concentration of porin (an 
abundant mitochondrial protein) and, thus, none of them influences the abundance of mitochondria 
(Figure 2.11A); and 2) each of these mutations elicits the fragmentation of the mitochondrial 
network into individual mitochondria during PD phase (Figures 2.11B and 2.11C), concurrently 
with an abrupt decline in mitochondrial functionality and ATP synthesis (Figure 2.10). 
Figure 2.11. 
Effects of the fox1Δ, fox2Δ 
and  fox3Δ   mutations  on 
mitochondrial abundance 
and  morphology,  and  on 
cell  susceptibility  to 
mitochondria-controlled 
apoptotic   RCD   in   yeast 
cultured under  CR 
conditions. WT, fox1Δ, 
fox2Δ and fox3Δ cells were 
cultured in the nutrient-rich 
YP medium under CR 
conditions on 0.2% glucose. A. The concentrations of porin and actin in total cell lysates were assessed by 
immunoblotting, as described in Materials and Methods. B. Mitochondrial morphology was visualized with the help 
of indirect immunofluorescence microscopy using primary antibodies against porin, as described in Materials and 
Methods. C. The percentage of cells exhibiting fragmented mitochondria was calculated. At least 500 cells of each 
strain were used for quantitation. Data are presented as means ± SEM (n = 3; ** < 0.01). D. An assay for measuring 
clonogenic survival of cells treated for 2 h with 2.5 mM hydrogen peroxide was performed as described in Materials 
and Methods. Data are presented as means ± SEM (n = 3; ns, not significant; * < 0.05; ** < 0.01). Abbreviations: L, 
D, PD and ST, logarithmic, diauxic, post-diauxic and stationary growth phases (respectively). Experiments in B were 
performed by Adam Beach, Pavlo Kyryakov and Alejandra Gomez-Perez. 
 
 
We then tested how the fox1Δ, fox2Δ and fox3Δ mutations influence the susceptibility of 
CR yeast to mitochondria-controlled apoptotic RCD induced by a short-term exposure of cells to 
exogenous hydrogen peroxide; this mode of age-related RCD has been linked to mitochondrial 
network fragmentation, mitochondrial outer membrane permeabilization and the efflux of several 
pro-apoptotic proteins from the intermembrane space of fragmented mitochondria [23, 187-196, 




decreases clonogenic survival of cells briefly (for 2 h) treated with hydrogen peroxide if these cells 
were recovered during D or PD phase of culturing (Figure 2.11D); and 2) does not alter clonogenic 
survival of cells subjected to such treatment if these cells were recovered during L or ST phase of 
culturing (Figure 2.11D). 
Figure 2.12. Effects of 
the single-gene-deletion 
mutations eliminating different 
protein components of the 
mitochondrial fission or fusion 
machine on mitochondrial 
morphology and CLS in yeast 
cultured under CR conditions. 
WT, dnm1, mdv1, caf4, 
fzo1, ugo1, mgm1, mdm30, 
pcp1 and fis1 cells were 
cultured in the nutrient-rich YP 
medium under CR conditions on 
0.2% glucose. A. Mitochondrial 
morphology was visualized with 
the help of indirect 
immunofluorescence microscopy 
using primary antibodies against 
porin, as described in Materials 
and Methods. B-D. Survival curves of chronologically aging WT and mutant cells. Data are presented as means ± 
SEM (n = 3). E-G. p Values for different pairs of survival curves of WT and mutant strains. Survival curves shown 
in B-D were compared. Two survival curves were considered statistically different if the p value was less than 0.05. 
The p values for comparing pairs of survival curves were calculated as described in Materials and Methods. 
Abbreviations: L, D, PD and ST, logarithmic, diauxic, post-diauxic and stationary growth phases (respectively). These 
experiments were performed by Michelle Burstein, Pavlo Kyryakov and Alejandra Gomez-Perez. 
 
 
Figure 2.13. Effects of the single-gene- 
deletion mutations eliminating different 
protein components of the mitochondrial 
fission or fusion machine on 
mitochondrial morphology in yeast 
cultured under CR conditions. WT, 
dnm1, mdv1, caf4, fzo1, ugo1, 
mgm1, mdm30, pcp1 and fis1 cells 
were cultured in the nutrient-rich YP 
medium under CR conditions on 0.2% 
glucose. Mitochondrial morphology was 
visualized with the help of indirect 
immunofluorescence microscopy using 
primary antibodies against porin, as 
described in Materials and Methods and 
shown in Figure 2.12A. The percentage of 
cells exhibiting fragmented mitochondria 
was calculated. At least 500 cells of each 
strain were used for quantitation. Data are 
presented as means ± SEM (n = 3; ** < 
0.01; *** < 0.001). These experiments were 




These findings suggest that in CR yeast mitochondrial oxidation of acetyl-CoA that is 
generated in peroxisomal fatty acid β-oxidation 1) is essential for preventing mitochondrial 
network fragmentation during D and PD phases; and 2) is indispensable for the CR-dependent 
delay of the onset of age-related apoptotic RCD during these phases of culturing. 
We have previously hypothesized that the abilities of CR to attenuate mitochondrial 
network fragmentation and to delay the onset of a mitochondria-controlled mode of the age-related 
apoptotic RCD may be required for the ability of this low-calorie diet to extend yeast CLS [23, 
205]. To test this hypothesis, we examined how the single-gene-deletion mutations eliminating 
protein components of the mitochondrial fission or fusion machine influence the extent of yeast 
CLS extension by CR; a balance between the processes of mitochondrial fission and fusion is 
known to define mitochondrial morphology [185, 186]. We found that in CR yeast cultured on 
0.2% glucose 1) the dnm1, mdv1 and caf4 mutations, which eliminate different components 
of the mitochondrial fission machine [191], stimulate the formation of net-like mitochondria 
(Figure 2.12A; Figure 2.13) and increase the efficiency with which CR extends yeast CLS (Figures 
2.12B and 2.12E); 2) the fzo1, ugo1, mgm1, mdm30 and pcp1 mutations, which eliminate 
different components of the mitochondrial fusion machine [191], elicit mitochondrial network 
fragmentation (Figure 2.12A; Figure 2.13) and decrease the efficiency of yeast CLS extension by 
CR (Figures 2.12C and 2.12F); and 3) the fis1 mutation, which eliminates a component of the 
mitochondrial fission machine (however, impairs mitochondrial fission only in exponentially 
growing yeast but not in yeast committed to apoptotic RCD) [191], causes mitochondrial network 
fragmentation (Figure 2.12A; Figure 2.13) and lowers the efficiency with which CR extends yeast 
CLS (Figures 2.12D and 2.12G). 
In sum, these findings support the view that mitochondrial oxidation of acetyl-CoA that is 
produced during peroxisomal fatty acid β-oxidation makes an essential contribution to the CR- 
dependent extension of yeast CLS because it averts mitochondrial network fragmentation during 
D and PD phases, thereby delaying the onset of an age-related mode of apoptotic RCD during 
these phases of culturing. 
 
2.3.10 Peroxisomal fatty acid β-oxidation contributes to the CR-dependent extension of 




To assess the third proposed mechanism (Figure 2.9), we initially examined if the fox1Δ, 
fox2Δ and fox3Δ mutations affect the susceptibility of CR yeast to liponecrotic RCD; this mode of 
age-related RCD can be elicited by a short-term exposure of yeast cells to exogenous FFA and 
DAG [14, 103, 197, 198]. We found that in CR yeast cultured on 0.2% glucose, each of these 
mutations 1) substantially reduces clonogenic survival of cells briefly (for 2 h) treated with 
palmitoleic acid (POA; a monounsaturated FFA) if these cells were recovered during late PD phase 
(on day 6 of culturing) or during ST phase (on days 7 to 10 of culturing) (Figure 2.14); and 2) has 
no effect on clonogenic survival of cells subjected to treatment with POA if these cells were 
collected during L, D or early PD phase of culturing (Figure 2.14). As we demonstrated, the fox1Δ, 
fox2Δ and fox3Δ mutations 2) significantly shorten the CLS of CR yeast (Figures 2.6A and 2.6B); 
and 2) increase the cellular concentrations of FFA and DAG during PD and ST phases (Figures 
2.6F and 2.6G). 
Figure 2.14. Effects of the fox1Δ, 
fox2Δ and fox3Δ mutations on 
cell susceptibility to liponecrotic 
RCD in yeast cultured under CR 
conditions. WT, fox1Δ, fox2Δ and 
fox3Δ cells were cultured in the 
nutrient-rich YP medium under CR 
conditions on 0.2% glucose. An 
assay for measuring clonogenic 
survival of cells treated for 2 h with 
0.15   mM   palmitoleic   acid,   a 
monounsaturated FFA, was 
performed as described in Materials and Methods. Data are presented as means ± SEM (n = 3; ns, not significant; * < 
0.05; ** < 0.01; *** < 0.001). Abbreviations: L, D, PD and ST, logarithmic, diauxic, post-diauxic and stationary 
growth phases (respectively). 
 
 
Taken together, these findings support the view that the β-oxidation of FFA in peroxisomes 
is necessary for the CR-dependent extension of yeast CLS in part because it allows to maintain 
low concentrations of FFA and DAG during PD and ST phases, thereby postponing the onset of 
an age-related mode of liponecrotic RCD. 
We have previously hypothesized that the ability of CR to decrease the cellular 
concentrations of FFA and DAG during PD and ST phases may be essential for the CR-dependent 
extension of yeast CLS because it lowers the susceptibility of CR yeast to age-related liponecrotic 
RCD during these phases of culturing [23, 14, 103, 197, 198, 205]. To test this hypothesis, we 
examined how the single-gene-deletion mutations eliminating redundant enzymes involved in 




of FFA, DAG and TAG in CR yeast; 2) the susceptibility of CR yeast to liponecrotic RCD elicited 
by a short-term treatment of cells with POA, a monounsaturated FFA; and 3) the extent of yeast 
CLS extension by CR. The synthesis of TAG from FFA and DAG in the ER is catalyzed by Dga1, 
Are1 and Are2 (Figure 2.15) [173-175, 206, 207]. The lipolytic degradation of TAG into FFA and 
DAG in LD is catalyzed by the TAG lipases Tgl1, Tgl3, Tgl4 and Tgl5 (Figure 2.15) [173-175, 
206-210]. 
Figure 2.15. TAG synthesis from FFA and DAG in the ER and TAG lipolysis into FFA and 
DAG in LD are catalyzed by redundant enzymes. See text for more details. Abbreviations: 









Figure 2.16. Effects of the 
dga1Δ, are1Δ, are2Δ, tgl1Δ, tgl3Δ, tgl4Δ 
and tgl5Δ mutations on FFA, DAG and 
TAG concentrations in yeast cultured 
under CR conditions. WT, dga1Δ, 
are1Δ, are2Δ, tgl1Δ, tgl3Δ, tgl4Δ and 
tgl5Δ cells were cultured in the nutrient- 
rich YP medium under CR conditions on 
0.2% glucose. FFA (A and D), DAG (B 
and E) and TAG (C and F) concentrations 
in whole cells recovered on different days 
of culturing are shown. Data are presented 
as means ± SEM (n = 3). The 
concentrations of FFA, DAG and TAG in 
whole cells were measured as described in 
Materials  and  Methods.  Abbreviations: 
DAG, diacylglycerols; FFA, free fatty acids; L, D, PD and ST, logarithmic, diauxic, post-diauxic and stationary growth 
phases (respectively); TAG, triacylglycerols. These experiments were performed by Simon Bourque, Adam Beach 
and Pavlo Kyryakov. 
 
 
Figure 2.17. Effects of the dga1Δ, are1Δ, are2Δ, tgl1Δ, 
tgl3Δ, tgl4Δ and tgl5Δ mutations on cell susceptibility to 
liponecrotic RCD in yeast cultured under CR conditions. WT, 
dga1Δ, are1Δ, are2Δ, tgl1Δ, tgl3Δ, tgl4Δ and tgl5Δ cells were 
cultured in the nutrient-rich YP medium under CR conditions on 
0.2% glucose. An assay for measuring clonogenic survival of cells 
treated for 2 h with 0.15 mM palmitoleic acid, a monounsaturated 
FFA, was performed as described in Materials and Methods. Data 
are presented as means ± SEM (n = 3; ns, not significant; * < 0.05; 
** < 0.01). Abbreviations: L, D, PD and ST, logarithmic, diauxic, 




Figure 2.18. Effects of the 
dga1Δ, are1Δ, are2Δ, tgl1Δ, 
tgl3Δ, tgl4Δ and tgl5Δ 
mutations on CLS in yeast 
cultured under CR 
conditions. WT, dga1Δ, 
are1Δ, are2Δ, tgl1Δ, tgl3Δ, 
tgl4Δ and tgl5Δ cells were 
cultured in the nutrient-rich 
YP medium under CR 
conditions on 0.2% glucose. 
A, B. Survival curves of 
chronologically aging WT 
and mutant cells. Data are 
presented as means ± SEM (n 
= 3). C, D. p Values for 
different pairs of survival 
curves of WT and mutant 
strains. Survival  curves 
shown    in    A,    B     were 
compared. Two survival curves were considered statistically different if the p value was less than 0.05. The p values 
for comparing pairs of survival curves using the logrank test were calculated as described in Materials and Methods. 
Abbreviations: L, D, PD and ST, logarithmic, diauxic, post-diauxic and stationary growth phases (respectively). These 
experiments were performed by Pavlo Kyryakov and Alejandra Gomez-Perez. 
 
We found that in CR yeast cultured on 0.2% glucose, the dga1, are1 and are2 
mutations (which eliminate redundant ER enzymes involved in TAG synthesis from FFA and 
DAG) exhibit the following effects: 1) they increase the concentrations of FFA (Figure 2.16A) and 
DAG (Figure 2.16B) during L, D and PD phases; 2) they decrease TAG concentration during D 
and PD phases (Figure 2.16C); 3) they make cells progressing through PD and ST phases more 
sensitive to liponecrotic RCD (Figure 2.17A); and 4) they significantly shorten yeast CLS (Figures 
2.18A and 2.18C). We also found that in CR yeast cultured on 0.2% glucose, the tgl1, tgl3, 
tgl4 and tgl5 mutations (which eliminate redundant LD lipases catalyzing the degradation of 
TAG into FFA and DAG) display the following effects: 1) they decrease the concentrations of 
FFA (Figure 2.16D) and DAG (Figure 2.16E) during L, D and PD phases; 2) they increase TAG 
concentration during L, D, PD and ST phases (Figure 2.16F); 3) they make cells advancing through 
PD and ST phases more resistant to liponecrotic RCD (Figure 2.17B); and 4) they significantly 
extend yeast CLS (Figures 2.18B and 2.18D). 
In sum, these findings imply that peroxisomal fatty acid β-oxidation makes an essential 
contribution to yeast CLS extension by CR in part because it decreases the cellular concentrations 
of FFA and DAG during PD and ST phases [172, 177], thus slowing down the onset of an age- 






This study revealed that CR delays yeast chronological aging via mechanisms that 
coordinate the spatiotemporal dynamics of various cellular processes. Our comparative analyzes 
of morphological, biochemical and cell biological properties of CR and non-CR yeast advancing 
through different stages of the aging process suggest a hypothetical model for such mechanisms. 
This model is depicted schematically in Figure 2.19. 
Figure 2.19. 
Mechanisms through 
which CR delays yeast 
chronological aging by 
coordinating the 
spatiotemporal dynamics 
of various cellular 
processes. CR orchestrates 
the development and 
maintenance of distinct 




in yeast cells advancing 
through D, PD and ST 
phases of culturing. 
Throughout different 
stages of chronological 
aging, these CR-driven 
patterns 1) delay the age- 
related onsets of apoptotic 
and liponecrotic modes of 
regulated cell death, thereby decreases the risk of cell death; and 2) preserve cellular proteostasis, thus actively 
increasing the chance of survival. Because CR decreases the risk of death and actively increases the chance of survival 
throughout chronological lifespan, this low-calorie diet extends longevity of chronologically aging yeast. The 
thickness of black arrows is proportional to the rates of processes. Arrows next to the names of affected processes 
denote those of them that are intensified (red arrows) or weakened (blue arrows). Arrows next to the names of affected 
metabolites signify those of them whose concentrations are increased (red arrows) or decreased (blue arrows). 
Inhibition bars are displayed in red color. Please see text for additional details. Abbreviations: Ac-CoA, acetyl-CoA; 
AcOH, acetic acid; DAG, diacylglycerols; D, PD and ST, diauxic, post-diauxic and stationary growth phases 
(respectively); ER, endoplasmic reticulum; FA-CoA, acyl-CoA esters; FFA, free fatty acids; LD, lipid droplets; TAG, 
triacylglycerols; TCA, tricarboxylic cycle. 
 
 
The model posits that CR orchestrates the development and maintenance of an aging- 
delaying cellular pattern throughout yeast chronological lifespan before an arrest of cell growth 
and division (i.e. during D and PD phases of culturing) and after such arrest (i.e. during ST phase 
of culturing) (Figure 2.19). CR elicits the stepwise development and maintenance of this cellular 




and lipid metabolism; 2) interorganellar communications involving unidirectional and 
bidirectional movements of certain metabolites between the ER and the cytosol, the ER and LD, 
LD and peroxisomes, and peroxisomes and mitochondria; and 3) a balance between the processes 
of mitochondrial fission and fusion (Figure 2.19). These CR-driven patterns of metabolism, 
interorganellar communications and mitochondrial morphology delay the age-related onsets of 
apoptotic and liponecrotic modes of RCD throughout different stages of chronological aging 
(Figure 2.19). Moreover, CR lowers the concentration of mitochondrially produced ROS and rises 
trehalose concentration, thereby preserving cellular proteostasis and actively increasing the chance 
of survival. Because CR decreases the risk of cell death and actively increases the chance of cell 
survival throughout chronological lifespan (i.e. during D, PD and ST phases of culturing), this 
low-calorie diet extends yeast CLS. 
Specifically, we found that non-CR yeast cells progressing through D phase of culturing 
accumulate ethanol, a product of glucose fermentation (Figure 2.19). Such accumulation of ethanol 
in non-CR yeast during D phase elicits a decline in the concentrations of the core enzymes of 
peroxisomal fatty acid β-oxidation Fox1, Fox2 and Fox3. The decline of Fox1, Fox2 and Fox3 in 
non-CR yeast during D phase decelerates peroxisomal fatty acid β-oxidation, thus lowering the 
pool of peroxisomally produced acetyl-CoA available for mitochondrial oxidation (Figure 2.19). 
The ensuing weakening of mitochondrial functionality in non-CR yeast during D phase is 
manifested as a decline in mitochondrial respiration, ΔΨ, TCA and ATP synthesis, as well as a 
rise in mitochondrially produced ROS. Because of the decline in mitochondrial functionality and 
ATP synthesis taking place in non-CR cells during D phase, their mitochondrial network 
undergoes fragmentation; this initiates the onset of the mitochondria-controlled apoptotic mode of 
RCD and increases the risk of death (Figure 2.19). Due to the rise in mitochondrially produced 
ROS occurring in non-CR cells during D phase, their proteins undergo oxidative damage; this 
impairs cellular proteostasis and decreases the chance of survival (Figure 2.19). Owing to the 
ability of CR to accelerate ethanol consumption and to cause ethanol depletion during D phase, 
this low-calorie diet 1) preserves mitochondrial respiration, ΔΨ, TCA and ATP synthesis during 
D phase; 2) prevents mitochondrial network fragmentation during D phase by shifting a balance 
between the processes of mitochondrial fission and fusion toward fusion; 3) allows to maintain the 
concentration of mitochondrially produced ROS during D phase below a toxic threshold (Figure 




apoptotic RCD and to maintain cellular proteostasis, thus decreasing the risk of death and actively 
increasing the chance of survival for cells advancing through D phase of culturing (Figure 2.19). 
Because ethanol concentration remains high in non-CR yeast cells progressing through PD 
phase of culturing, the risk of death for these cells remains elevated due to the accelerated onset of 
the mitochondria-controlled apoptotic mode of RCD (Figure 2.19). In contrast, CR decreases the 
risk of death during PD phase by allowing to delay the onset of this mode of mitochondria- 
controlled RCD (Figure 2.19). Furthermore, the high concentration of ethanol in non-CR yeast 
cells advancing through PD phase weakens the β-oxidation of FFA in peroxisomes and causes an 
accumulation of FA-CoA in pexopodia (Figure 2.19). Such accumulation of FA-CoA in pexopodia 
of non-CR yeast progressing through PD phase creates several negative feedback loops whose 
action elicits a build-up of FFA and DAG in the ER and LD (Figure 2.19). This build-up of FFA 
and DAG in non-CR yeast accelerates the onset of the liponecrotic mode of RCD during PD phase, 
thus increasing the risk of death during this phase of culturing (Figure 2.19). In contrast, CR 
decreases the risk of death during PD phase by 1) promoting peroxisomal fatty acid β-oxidation; 
2) preventing FA-CoA accumulation in pexopodia; 3) allowing to maintain low concentrations of 
FFA and DAG; and, ultimately 4) delaying the onset of liponecrotic RCD (Figure 2.19). Moreover, 
CR actively increases the chance of survival for cells advancing through PD phase of culturing 
because this low-calorie diet significantly increases the concentration of trehalose, thereby 
preserving cellular proteostasis (Figure 2.19). 
The risk of death for non-CR yeast cells during ST phase remains high because of the 
accelerated onsets of both apoptotic and liponecrotic modes of RCD (Figure 2.19). However, we 
found that liponecrotic RCD is a prevailing mode of death in non-CR yeast advancing through ST 
phase (compare Figures 2.11C and 2.14). This finding indicates that the apoptotic and liponecrotic 
modes of RCD may have different relative contributions to the age-related death of non-CR yeast 
at different periods of CLS. The apoptotic mode of RCD predominates during D phase, apoptotic 
and liponecrotic RCD modes equally increase the risk of death during PD phase, whereas the 
liponecrotic mode of RCD prevails during ST phase (Figure 2.19). This is like the ″big P″ and 
″small p″ modes of death in the nematode Caenorhabditis elegans, which define lifespan earlier 
or later in life (respectively) [211]. Like its effects in yeast progressing through PD phase, CR 
decreases the risk of death during ST phase by allowing to delay the onsets of both apoptotic and 




PD phase, CR increases the chance of survival for yeast progressing through ST phase by rising 
the concentration of trehalose; this allows CR to maintain cellular proteostasis during ST phase 
(Figure 2.19). 
In conclusion, this study provides important new insights into mechanisms through which 
CR delays yeast chronological aging by orchestrating a stepwise remodeling of numerous cellular 
processes that are integrated into an intricate network. These processes are confined to different 




3 A possible “metabolic signature” of longevity extension by caloric restriction and the 




Recent studies have revealed that a characteristic age-related remodeling of the 
composition of water-soluble metabolites (which is further referred to as “the water-soluble 
metabolome”) may play essential roles in regulating cellular aging, influencing age-related 
pathologies and defining organismal longevity in eukaryotic organisms across phyla. It remained 
unclear how CR and some longevity-extending genetic interventions influence the water-soluble 
metabolome of chronologically aging yeast cells. The objectives of studies described in this 
chapter was therefore to use a mass spectrometry-based quantitative analysis of the water-soluble 
cellular metabolome for the investigation of how CR and the longevity-extending tor1Δ mutation 
(which eliminates the Tor1 protein kinase known to orchestrate the nutrient- and energy-sensing 
TOR (target of rapamycin) pro-aging signaling pathway) affect the concentrations of various 
water-soluble metabolites at consecutive stages of the chronological aging process in S. cerevisiae. 
 
3.2 Materials and methods 
3.2.1 Yeast strains, media and growth conditions 
The wild-type (WT) strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 
lys20 ura30) and the tor1 single-gene-deletion mutant strain in the BY4742 genetic 
background from Open Biosystems/Dharmacon (a part of GE Healthcare) were grown in YP 
medium (1% yeast extract, 2% peptone; both from Fisher Scientific; #BP1422-2 and #BP1420-2, 
respectively) initially containing 0.2% (w/v) or 2% (w/v) glucose (#D16-10; Fisher Scientific) as 
carbon source. Cells were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks 
at a ″flask volume/medium volume″ ratio of 5:1. 
 
3.2.2 Sample preparation for mass spectrometry-based metabolomics 
Cells were collected on days 1, 2, 7 and 10 of culturing. After measuring the cell titer, cells 
from 50 ml of a culture were harvested by centrifugation at 5,000 × g for 1 min at 4°C. The pelleted 
cells were rinsed with nanopure water and then collected by centrifugation at 5,000 × g for 1 min 




-80°C. After quenching, cells were aliquoted into 1 ml-fractions and stored at -80°C until the 
extraction of metabolites. 
For metabolite extraction, 5 x 108 cells were spiked with 50 μl of internal standards (0.2 
mg/ml Citric-2,2,4,4-d4, L-Ornitihine-2,3,3,4,4,5,5-d7 HCl, L-glutamic acid 15N and D-glucose 
13C) and disrupted with glass beads for 15 min at 4°C. Lysates were then subjected to 
centrifugation at 20,000 × g at 4°C to remove cell debris and residual glass beads. The supernatant 
was concentrated using a SpeedVac at ambient temperature for 2 h. Metabolite extracts were 
diluted in 40 μl of 1:1 Acetonitrile/H2O (1:1) for HILIC or MeOH/H2O (1:1) for RP-C18 HPLC. 
Samples were kept at 4°C prior to LC-MS/MS. 
 
3.2.3 LC-MS/MS analysis 
LC-MS/MS data were acquired using an Agilent 1100 HPLC system (Agilent 
Technologies, CA, USA) interfaced with an LTQ Orbitrap Velos mass spectrometer (Thermo 
Fisher Scientific, Waltham, MA, USA). 
LC separation was carried out using a ZIC-pHILIC column (Merck SeQuant, Umeå, 
Sweden; 150 × 2.1 mm, 5 μm particle size). Acetonitrile (A) and 20 mM ammonium bicarbonate 
buffer, pH 7.8 (B) were used as the mobile phase, with an elution gradient of 90% A to 10% A in 
20 min at a flow rate of 200 µl/min. LC separation was also carried out using a reverse phase 
column (Agilent Technologies, CA, USA; Zorbax C18 SB-300, 150 x 2.1 mm, 5 μm). Nanopure 
water with 0.1% formic acid (A) and acetonitrile (B) were used as the mobile phase, with an elution 
gradient of 80% A to 20% A in 15 min at a flow rate of 200 µl/min. Mass spectrometric analyses 
were performed with a Thermo Orbitrap Velos mass spectrometer equipped with a HESI-II ion 
source (#10145339; Thermo Scientific). Metabolites were detected by top 5 data dependent FT- 
MS/MS at a resolution of 60,000 for MS scans and 30,000 for dependent MS/MS. Fragmentation 
was carried out using HCD at a normalized collision energy of 35. Samples were analyzed in both 
positive and negative ionization modes. 
Acquired mass spectra were converted from proprietary Thermo RAW format to either 
mzXML using MSConvert as part of the ProteoWizard suite (freely available from  
http://proteowizard.sourceforge.net/). Data were analyzed using MZmine 2.10. Statistical 









3.3.1 CR elicits major changes in the water-soluble metabolomes of chronologically aging 
WT and tor1Δ cells 
WT and tor1 cells were cultured in the nutrient-rich YP medium initially containing 0.2% 
glucose (CR conditions) or 2% glucose (non-CR conditions). Cells were collected on days 1 
(logarithmic phase), 2 (the beginning of diauxic phase), 7 (the end of post-diauxic phase/the 
beginning of stationary phase) and 10 (stationary phase) of culturing. Cells were recovered on 
different days of culturing because we sought to assess how chronological age of these cells 
influences the effect of CR on the water-soluble metabolome. 
The LC-MS/MS analysis of water-soluble metabolites extracted from these cells revealed 
thousands of metabolites (assigned as well as non-assigned, from both negative and positive 
ionization modes) in extracts of WT and tor1Δ cells. We found that CR causes major changes in 
the water-soluble metabolomes of WT and tor1Δ cells recovered on any of the four consecutive 
phases of chronological aging; indeed, from 50% to 70% of water-soluble metabolites in these 
cells were enriched (i.e. their concentrations were increased by at least 2-fold) or depleted (i.e. 
their concentrations were decreased by at least 2-fold) by the CR diet (Figures 3.1-3.4). 
 
 
Figure 3.1. Scatter plots of normalized peak areas of all LC-MS peaks detected (assigned as well as 
non-assigned, from both negative and positive ionization modes) in extracts of WT and tor1Δ cells. Cells grown 






Figure 3.2. Scatter plots of normalized peak areas of all LC-MS peaks detected (assigned as well as 
non-assigned, from both negative and positive ionization modes) in extracts of WT and tor1Δ cells. Cells grown 
under CR or non-CR conditions were recovered for metabolite extraction on Day 2 (the beginning of post-diauxic 




Figure 3.3. Scatter plots of normalized peak areas of all LC-MS peaks detected (assigned as well as 
non-assigned, from both negative and positive ionization modes) in extracts of WT and tor1Δ cells. Cells grown 
under CR or non-CR conditions were recovered for metabolite extraction on Day 7 (the end of post-diauxic phase of 
culturing/the beginning of stationary phase of culturing). 
 
 
Of note, the longevity-extending tor1Δ mutation did not cause significant changes in the 
water-soluble metabolome of cells cultured under non-CR conditions and recovered on day 1 of 
culturing (only 5%-9% of water-soluble metabolites were enriched or depleted in tor1Δ cells as 








Figure 3.4. Scatter plots of normalized peak areas of all LC-MS peaks detected (assigned as well as 
non-assigned, from both negative and positive ionization modes) in extracts of WT and tor1Δ cells. Cells grown 
under CR or non-CR conditions were recovered for metabolite extraction on Day 10 (stationary phase of culturing). 
 
 
3.3.2 In  chronologically  aging  cells,  CR  establishes  a  distinct  metabolic  pattern  that 
significantly differs from that of cells cultured under non-CR conditions 
The principal components analysis (PCA) of the metabolite concentrations in extracts of 
WT and tor1Δ cells (the metabolites were normalized to an internal standard and auto-scaled) has 
revealed that CR elicits a distinct metabolic pattern that significantly differs from the metabolic 
pattern of these cells cultured under non-CR conditions. Indeed, the PCs of cells cultured under 
CR or non-CR conditions were well separated from each other in both WT and tor1Δ cells 
recovered at any of the 4 days of culturing (Figures 3.5-3.8). Thus, the CR-specific metabolic 
pattern exists in both WT and tor1Δ cells through all phases of the chronological aging process. 
Of note, the longevity-extending tor1Δ mutation did not cause a significant change in the 
pattern of water-soluble metabolites in cells cultured under non-CR conditions and recovered on 
day 1 of culturing; this conclusion is based on the observation that the PCs of WT and tor1Δ cells 
cultured under non-CR conditions were not separated from each other (Figure 3.5). However, 
beginning of day 2 of culturing, the PCs of WT and tor1Δ cells cultured under non-CR conditions 




extend longevity under non-CR conditions coincides (and may cause) the ability of this mutation 
to remodel the pattern of water-soluble metabolites under these conditions. 
Furthermore, only in cells recovered on day 1 of culturing, the PCs of WT and tor1Δ cells 
cultured under CR conditions were slightly separated from each other (Figure 3.5). However, 
beginning of day 2 of culturing, the PCs of WT and tor1Δ cells cultured under CR conditions were 
not separated from each other (Figures 3.6-3.8). Thus, beginning of day 2 of culturing, CR 




Figure 3.5. Scores plots from the principal components analysis (PCA) of the metabolite concentrations 
in extracts of WT and tor1Δ cells (the metabolites were normalized to an internal standard and auto-scaled). 





Figure 3.6. Scores plots from the principal components analysis (PCA) of the metabolite concentrations 
in extracts of WT and tor1Δ cells (the metabolites were normalized to an internal standard and auto-scaled). 
Cells grown under CR or non-CR conditions were recovered for metabolite extraction on Day 2 (the beginning of 








Figure 3.7. Scores plots from the principal components analysis (PCA) of the metabolite concentrations 
in extracts of WT and tor1Δ cells (the metabolites were normalized to an internal standard and auto-scaled). 
Cells grown under CR or non-CR conditions were recovered for metabolite extraction on Day 7 (the end of post- 






Figure 3.8. Scores plots from the principal components analysis (PCA) of the metabolite concentrations 
in extracts of WT and tor1Δ cells (the metabolites were normalized to an internal standard and auto-scaled). 
Cells grown under CR or non-CR conditions were recovered for metabolite extraction on Day 10 (stationary phase 
of culturing). 
 
3.3.3 The   tor1 mutation enriches   and   depletes   distinct   sets   of   metabolites   in 
chronologically aging yeast cultured under non-CR conditions 
The tor1Δ mutation: 1) extends longevity of chronologically aging yeast cultured under 
non-CR conditions on 2% glucose [1-3]; and 2) beginning of day 2 of culturing, causes a 
substantial remodeling of the pattern of water-soluble metabolites in chronologically aging yeast 
cells cultured under non-CR conditions (see section 3.3.2). Our LC-MS/MS analysis has revealed 




the tor1Δ mutation (Table 3.1). Many of these metabolites comprise a network which integrates 
the following pathways of intermediary metabolism: 1) the biosynthesis of methionine from 
aspartate; 2) the biosynthesis of threonine from aspartate; 3) the biosynthesis of both cysteine and 
glutathione from homocysteine, an intermediate in the biosynthetic pathway for methionine; and 
4) the biosynthesis of spermidine and other polyamines from S-adenosylmethionine, an 
intermediate in the biosynthetic pathway for methionine (Figure 3.9). 
Table 3.1. Loading plots from the PCA of the metabolite concentrations in WT and tor1Δ cells. These 
plots have revealed 12 metabolites whose cellular concentrations are increased or decreased to the highest extent by 
the tor1Δ mutation. Cells cultured under non-CR conditions were recovered for metabolite extraction on Day 7 (the 




Figure 3.9. Metabolic pathways for the biosynthesis of methionine and other sulfur amino acids in 




3.3.4 The pathway of methionine metabolism is among metabolic pathways affected the 
most by both CR and the tor1 mutation 
Our metabolite set enrichment analysis (MSEA; also known as the pathway analysis) of 
the water-soluble metabolites identified by LC-MS/MS has revealed that the pathway of 
methionine metabolism is among metabolic pathways affected the most by the extent of calorie 
availability (i.e. CR vs non-CR conditions) and/or by the tor1 mutation (Figures 3.10 – 3.33). 
 
Figure 3.10. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs 
non-CR) and/or by the tor1Δ mutation. In this 
example, tor1Δ cells grown under CR conditions were 
compared to tor1Δ cells grown under non-CR 
conditions. Cells were recovered for metabolite 
extraction on Day 1 (logarithmic phase of culturing). 












Figure 3.11. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs 
non-CR) and/or by the tor1Δ mutation. In this 
example, tor1Δ cells grown under CR conditions were 
compared to tor1Δ cells grown under non-CR 
conditions. Cells were recovered for metabolite 
extraction on Day 1 (logarithmic phase of culturing). 





Figure 3.12. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs 
non-CR). In this example, WT cells grown under CR 
conditions were compared to WT cells grown under 
non-CR conditions. Cells were recovered for metabolite 
extraction on Day 1 (logarithmic phase of culturing). 










Figure 3.13. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs 
non-CR). In this example, WT cells grown under CR 
conditions were compared to WT cells grown under 
non-CR conditions. Cells were recovered for metabolite 
extraction on Day 1 (logarithmic phase of culturing). 











Figure 3.14. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the tor1Δ mutation. In this example, WT cells 
grown under non-CR conditions were compared to 
tor1Δ cells grown under non-CR conditions. Cells were 
recovered for metabolite extraction on Day 1 
(logarithmic phase of culturing). The metabolites were 




Figure 3.15. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the tor1Δ mutation. In this example, WT cells 
grown under non-CR conditions were compared to 
tor1Δ cells grown under non-CR conditions. Cells were 
recovered for metabolite extraction on Day 1 
(logarithmic phase of culturing). The metabolites were 










Figure 3.16. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs 
non-CR) and/or by the tor1Δ mutation. In this 
example, tor1Δ cells grown under CR conditions were 
compared to tor1Δ cells grown under non-CR 
conditions. Cells were recovered for metabolite 
extraction on Day 2 (post-diauxic phase of culturing). 










Figure 3.17. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs 
non-CR) and/or by the tor1Δ mutation. In this 
example, tor1Δ cells grown under CR conditions were 
compared to tor1Δ cells grown under non-CR 
conditions. Cells were recovered for metabolite 
extraction on Day 2 (post-diauxic phase of culturing). 





Figure 3.18. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs 
non-CR). In this example, WT cells grown under CR 
conditions were compared to WT cells grown under 
non-CR conditions. Cells were recovered for metabolite 
extraction on Day 2 (post-diauxic phase of culturing). 











Figure 3.19. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs 
non-CR). In this example, WT cells grown under CR 
conditions were compared to WT cells grown under 
non-CR conditions. Cells were recovered for metabolite 
extraction on Day 2 (the beginning of post-diauxic 
phase of culturing). The metabolites were separated 









Figure 3.20. The metabolite set enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the tor1Δ mutation. In this example, WT cells 
grown under non-CR conditions were compared to 
tor1Δ cells grown under non-CR conditions. Cells were 
recovered for metabolite extraction on Day 2 (the 
beginning of post-diauxic phase of culturing). The 




Figure 3.21. The  metabolite set enrichment 
analysis  [MSEA]  (a.k.a.  the  pathway  analysis)  to 
establish which metabolic pathways are affected the 
most by the tor1Δ mutation. In this example, WT cells 
grown under non-CR conditions were compared to tor1Δ 
cells   grown   under   non-CR   conditions.   Cells   were 
recovered  for  metabolite  extraction  on  Day  2  (the 
beginning  of  post-diauxic  phase  of  culturing).  The 











Figure 3.22.  The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs non- 
CR) and/or by the tor1Δ mutation. In this example, tor1Δ 
cells grown under CR conditions were compared to tor1Δ 
cells grown under non-CR conditions. Cells were 
recovered for metabolite extraction on Day 7 (the end of 
post-diauxic phase of culturing/the beginning of 
stationary phase of culturing). The metabolites were 







Figure 3.23. The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs non- 
CR) and/or by the tor1Δ mutation. In this example, 
tor1Δ cells grown under CR conditions were compared to 
tor1Δ cells grown under non-CR conditions. Cells were 
recovered for metabolite extraction on Day 7 (the end of 
post-diauxic phase of culturing/the beginning of 
stationary phase of culturing). The metabolites were 




Figure 3.24. The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs non- 
CR). In this example, WT cells grown under CR 
conditions were compared to WT cells grown under non- 
CR conditions. Cells were recovered for metabolite 
extraction on Day 7 (the end of post-diauxic phase of 
culturing/the beginning of stationary phase of culturing). 








Figure 3.25. The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs non- 
CR). In this example, WT cells grown under CR 
conditions were compared to WT cells grown under non- 
CR conditions. Cells were recovered for metabolite 
extraction on Day 7 (the end of post-diauxic phase of 
culturing/the beginning of stationary phase of culturing). 









Figure 3.26. The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the tor1Δ mutation. In this example, WT cells 
grown under non-CR conditions were compared to tor1Δ 
cells grown under non-CR conditions. Cells were 
recovered for metabolite extraction on Day 7 (the end of 
post-diauxic phase of culturing/the beginning of 
stationary phase of culturing). The metabolites were 




Figure 3.27.  The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the tor1Δ mutation. In this example, WT cells 
grown under non-CR conditions were compared to tor1Δ 
cells grown under non-CR conditions. Cells were 
recovered for metabolite extraction on Day 7 (the end of 
post-diauxic phase of culturing/the beginning of 
stationary phase of culturing). The metabolites were 









Figure 3.28. The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs non- 
CR). In this example, tor1Δ cells grown under CR 
conditions were compared to tor1Δ cells grown under non- 
CR conditions. Cells were recovered for metabolite 
extraction on Day 10 (stationary phase of culturing). The 










Figure 3.29. The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs non- 
CR). In this example, tor1Δ cells grown under CR 
conditions were compared to tor1Δ cells grown under non- 
CR conditions. Cells were recovered for metabolite 
extraction on Day 10 (stationary phase of culturing). The 




Figure 3.30. The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs non- 
CR). In this example, WT cells grown under CR 
conditions were compared to WT cells grown under non- 
CR conditions. Cells were recovered for metabolite 
extraction on Day 10 (stationary phase of culturing). The 










Figure 3.31. The  metabolite set enrichment 
analysis  [MSEA]  (a.k.a.  the  pathway  analysis)  to 
establish which metabolic pathways are affected the 
most by the extent of calorie availability (i.e. CR vs non- 
CR).  In  this  example,  WT  cells  grown  under  CR 
conditions were compared to WT cells grown under non- 
CR  conditions.  Cells  were  recovered  for  metabolite 
extraction on Day 10 (stationary phase of culturing). The 










Figure 3.32. The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the tor1Δ mutation. In this example, WT cells 
grown under non-CR conditions were compared to tor1Δ 
cells grown under non-CR conditions. Cells were 
recovered for metabolite extraction on Day 10 (stationary 
phase of culturing). The metabolites were separated using 




Figure 3.33. The metabolite set  enrichment 
analysis [MSEA] (a.k.a. the pathway analysis) to 
establish which metabolic pathways are affected the 
most by the tor1Δ mutation. In this example, WT cells 
grown under non-CR conditions were compared to tor1Δ 
cells grown under non-CR conditions. Cells were 
recovered for metabolite extraction on Day 10 (stationary 
phase of culturing). The metabolites were separated using 










3.3.5 In chronologically aging cells, both CR and the tor1 mutation establish a distinct 
pattern of methionine metabolism 
The principal PCA of the concentrations of methionine metabolism intermediates in 
extracts of WT and tor1Δ cells (the metabolites were normalized to an internal standard and auto- 
scaled) has revealed that CR elicits a distinct pattern of methionine metabolism that significantly 
differs from the methionine metabolism pattern of these cells cultured under non-CR conditions. 
Indeed, the PCs of methionine metabolism intermediates in cells cultured under CR or non-CR 
conditions were well separated from each other in both WT and tor1Δ cells recovered on days 1, 
7 and 10 of culturing (Figures 3.34-3.36). Thus, the CR-specific pattern of methionine metabolism 
exists in both WT and tor1Δ cells through all phases of the chronological aging process. 
Of note, the longevity-extending tor1Δ mutation did not cause a significant change in the 
pattern of methionine metabolism in cells cultured under non-CR conditions and recovered on day 
1 of culturing; this conclusion is based on the observation that the PCs of methionine metabolism 
intermediates in WT and tor1Δ cells cultured under non-CR conditions were not separated from 
each other (Figure 3.34). However, on days 7 and 10 of culturing, the PCs of methionine 
metabolism intermediates in WT and tor1Δ cells cultured under non-CR conditions were well 
separated from each other (Figures 3.35 and 3.36). Thus, the ability of the tor1Δ mutation to extend 
longevity under non-CR conditions coincides (and may cause) the ability of this mutation to 
remodel the pattern of methionine metabolism under these conditions. 
Furthermore, the PCs of methionine metabolism intermediates in WT and tor1Δ cells 




y and Day10 of culturing (Figures 3.34-3.36). Thus, through the entire process of chronological 
aging, CR establishes the same pattern of methionine metabolism in both WT and tor1Δ cells. 
 
Figure 3.34. Scores plots from 
the principal components analysis 
(PCA) of the concentrations of 
METHIONINE METABOLISM 
intermediates in extracts of wild-type 
and tor1Δ cells (the metabolites were 
normalized to an internal standard and 
auto-scaled). Cells grown under CR or 
non-CR conditions were recovered for 
metabolite extraction on Day 1 




Figure 3.35. Scores plots from 
the principal components analysis 
(PCA) of the concentrations of 
METHIONINE METABOLISM 
intermediates in extracts of wild-type 
and tor1Δ cells (the metabolites were 
normalized to an internal standard and 
auto-scaled). Cells grown under CR or 
non-CR conditions were recovered for 
metabolite extraction on Day 7 (the end 
of post-diauxic/beginning of stationary 




Figure 3.36. Scores plots from 
the principal components analysis 
(PCA) of the concentrations of 
METHIONINE METABOLISM 
intermediates in extracts of wild-type 
and tor1Δ cells (the metabolites were 
normalized to an internal standard and 
auto-scaled). Cells grown under CR or 
non-CR conditions were recovered for 
metabolite extraction on Day 10 
(stationary phase of culturing). 
 
3.3.6 Through the entire process of chronological aging, both CR and the tor1 mutation 




Our LC-MS/MS analysis has revealed that CR alters concentrations of methionine 




Figure 3.37. In WT cells, the CR diet alters concentrations of METHIONINE METABOLISM 




Figure 3.38. In WT cells, the CR diet alters concentrations of METHIONINE METABOLISM 
intermediates. Cells grown under CR or non-CR conditions were recovered for metabolite extraction on Day 2 (the 






Figure 3.39. In WT cells, the CR diet alters concentrations of METHIONINE METABOLISM 





Figure 3.40. In WT cells, the CR diet alters concentrations of METHIONINE METABOLISM 
intermediates. Cells grown under CR or non-CR conditions were recovered for metabolite extraction on Day 7 (the 






Figure 3.41. In WT cells, the CR diet alters concentrations of METHIONINE METABOLISM 




These metabolites include ATP, 2-ketobutyric acid, 5’-methylthioadenosine, 
cystathionine, glutamate, aspartate, cysteine, methionine, O-acetyl-L-homoserine, S-adenosyl- 
homocysteine, S-adenosyl-methionine, serine, spermidine and threonine (Figures 3.37-3.41). As it 
has been mentioned above, these methionine metabolism intermediates comprise a network which 
integrates the following pathways of intermediary metabolism: 1) the biosynthesis of methionine 
from aspartate; 2) the biosynthesis of threonine from aspartate; 3) the biosynthesis of both cysteine 
and glutathione from homocysteine, an intermediate in the biosynthetic pathway for methionine; 
and 4) the biosynthesis of spermidine and other polyamines from S-adenosylmethionine, an 
intermediate in the biosynthetic pathway for methionine (Figure 3.9). 
Our LC-MS/MS analysis also demonstrated that the tor1 mutation alters concentrations 
of methionine metabolism intermediates in chronologically aging yeast cells cultured under non- 
CR conditions and recovered on days 2, 7 and 10 of culturing (Table 3.2). Of note, the pattern of 
methionine-related metabolome that was established by the tor1Δ mutation was like that 




Table 3.2. Cellular concentrations of METHIONINE METABOLISM intermediates are significantly 
increased or decreased by the tor1Δ mutation in yeast cultured under non-CR conditions. Cells grown under 
non-CR conditions were recovered for metabolite extraction on Day 2 (diauxic phase), Day 7 (the end of post-diauxic 






Recent studies have demonstrated that a characteristic age-related remodeling of cellular 
metabolism may play essential roles in regulating cellular aging, influencing age-related 
pathologies and defining organismal longevity in evolutionarily distant eukaryotes [149, 213-227]. 
However, mechanisms underlying such remodeling and mechanisms by which longevity- 
extending dietary and genetic interventions regulate such remodeling remain unknown. This study 
provided the first evidence that both the longevity-extending diet CR and the-longevity extending 
mutation tor1 establish a similar pattern of relative concentrations of methionine metabolism 
intermediates through the entire process of chronological aging in S. cerevisiae (Figure 3.42). The 
methionine metabolism intermediates whose concentrations are increased by both these longevity- 
extending interventions include ATP, aspartate, O-acetyl-L-homoserine, glutamate and cysteine, 
whereas among methionine metabolism intermediates whose concentrations are decreased by both 
these longevity-extending interventions are threonine, methionine, serine, glutathione, spermidine, 
S-adenosyl-homocysteine and S-adenosyl-methionine (Figure 3.42). All these methionine 
metabolism intermediates are integrated into a network which integrates the following pathways 
of intermediary metabolism: 1) the biosynthesis of methionine from aspartate; 2) the biosynthesis 
of threonine from aspartate; 3) the biosynthesis of both cysteine and glutathione from 




of  spermidine  and  other  polyamines  from  S-adenosylmethionine,  an  intermediate  in  the 




Figure 3.42. The CR diet and the tor1Δ mutation establish a similar pattern of methionine-related 
metabolome in chronologically aging yeast. 
 
Based on these findings, we hypothesize that the observed redirection of metabolite flow 
within the network from the biosynthesis of methionine and spermidine to the biosynthesis of 
cysteine and glutathione may represent an anti-aging pattern characteristic of the ʺmetabolic 
signatureʺ of longevity extension in chronologically aging yeast cells placed on the CR diet or 
having the TOR pro-aging signaling pathway inhibited (Figure 3.42). 
Future studies in the Titorenko laboratory need to address the following 2 important 
questions. 
First, it remains unclear if the observed remodeling of methionine-related metabolome 
indeed represents an anti-aging ʺmetabolic signatureʺ of longevity extension in chronologically 
aging yeast. To address this question, it will be interesting to examine how mutations eliminating 
individual enzymes involved in various pathways within the network of methionine-related 
intermediary metabolism influence yeast longevity. The chronological lifespans of the following 




hom6Δ, each lacking a non-essential enzyme involved in the biosynthesis of threonine from 
aspartate; 2) met2Δ, met6Δ, met7Δ, met17Δ, sam1Δ and sam2Δ, each lacking a non-essential 
enzyme involved in the biosynthesis of methionine from homoserine; 3) spe2Δ and spe3Δ, each 
lacking a non-essential enzyme involved in the biosynthesis of spermidine and other polyamines 
from S-adenosylmethionine; 4) cys3Δ and cys4Δ, each lacking a non-essential enzyme involved in 
the biosynthesis of cysteine from homocysteine and serine; 5) str2Δ and str3Δ, each lacking a non- 
essential enzyme involved in the conversion of cysteine to homocysteine; and 6) gsh1Δ and gsh2Δ, 
each lacking a non-essential enzyme involved in the biosynthesis of glutathione from cysteine 
[212]. LC-MS/MS will then be used to determine the concentrations of various intermediates 
within the network of methionine-related intermediary metabolism in cells of each of these mutants 
recovered at different stages of the aging process under CR and non-CR conditions. If mutations 
that reverse the proposed anti-aging ʺmetabolic signatureʺ decrease the extent of longevity 
extension by CR, whereas mutations that enhance the proposed anti-aging ʺmetabolic signatureʺ 
increase the extent of longevity extension by CR, our hypothesis on the existence of the ʺmetabolic 
signatureʺ of longevity extension in chronologically aging yeast will be confirmed. 
 
Figure 3.43. Methionine restriction extends 
longevity of chronologically aging yeast by attenuating the 
pro-aging TOR pathway, thereby stimulating autophagy- 















Second, it remains unclear how the observed remodeling of methionine-related 
metabolome may delay yeast chronological aging and extend yeast longevity. A recent study has 
revealed that methionine restriction extends longevity of chronologically aging yeast by 
attenuating the pro-aging TOR pathway, thereby stimulating autophagy-dependent acidification of 




features of the observed remodeling of methionine-related metabolome (Figure 3.42). Therefore, 
it will be interesting to investigate how mutations eliminating individual enzymes involved in 
various pathways within the network of methionine-related intermediary metabolism (see above) 
influence the following: 1) functional states of protein components of the TOR pathway and their 





4 LCA-dependent changes in mitochondrial lipidome alter mitochondrial proteome 
and increase the geroprotective efficiency of LCA in chronologically aging yeast 
 
4.1 Introduction 
As described in the Introduction section, studies in the Titorenko laboratory have 
revealed that in chronologically aging yeast under CR conditions exogenously added LCA delays 
yeast chronological aging, enters the yeast cell, is sorted to mitochondria, resides in both 
mitochondrial membranes, changes the relative concentrations of different membrane 
phospholipids, triggers changes in the concentrations of many mitochondrial proteins, and alters 
some key aspects of mitochondrial functionality. Based on the above findings, we hypothesized 
that the LCA-driven changes in mitochondrial lipidome may have a causal role in the age-related 
remodeling of proteome, thus eliciting changes in mitochondrial functionality and delaying yeast 
chronological aging. The objectives of studies described in this chapter was to test this hypothesis 
by investigating how certain mutations that eliminate enzymes involved in mitochondrial 
phospholipid metabolism influence the mitochondrial proteome and how they affect the 
geroprotective efficiency of LCA in chronologically aging yeast. 
 
4.2 Materials and methods 
4.2.1 Yeast strains, media and growth conditions 
The wild-type (WT) strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 
lys20 ura30) and the ups1 and ups2 single-gene-deletion mutant strains in the BY4742 
genetic background from Open Biosystems/Dharmacon (a part of GE Healthcare) were grown in 
YP medium (1% yeast extract, 2% peptone; both from Fisher Scientific; #BP1422-2 and #BP1420- 
2, respectively) initially containing 0.2% (w/v) glucose (#D16-10; Fisher Scientific) with 50 µM 
LCA or without it. Cells were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer 
flasks at a ʺflask volume/medium volumeʺ ratio of 5:1. 
 
4.2.2 Purification of mitochondria 
Yeast cells were harvested at 3,000 × g for 5 min at room temperature, washed with water 
and resuspended in DTT buffer (100 mM Tris-H2SO4, pH 9.4, 10 mM dithiothreitol [DTT]). The 




washed with Zymolyase buffer (1.2 M sorbitol, 20 mM potassium phosphate, pH 7.4) and 
centrifuged at 3,000 × g for 5 min at room temperature. The cells were then incubated with 3 mg/g 
(wet weight) of Zymolyase-100T in 7 ml/g (wet weight) Zymolyase buffer for 45 min at 30°C. 
Following an 8-min centrifugation at 2,200 × g at 4°C, the isolated spheroplasts were washed in 
ice-cold homogenization buffer (5 ml/g) (0.6 M sorbitol, 10 mM Tris-HCl, pH7.4, 1 mM EDTA, 
0.2% (w/v) BSA) and centrifuged at 2,200 × g for 8 min at 4°C. The spheroplasts were 
homogenized in ice-cold homogenization buffer using 15 strokes. Cell debris was removed by 
centrifuging the resulting homogenates at 3,000 × g for 10 min at 4°C. The resulting supernatant 
was then centrifuged at 12,000 × g for 15 min at 4°C to pellet mitochondria. The remnant cell 
debris was removed by centrifuging the mitochondrial fraction at 3,000 × g for 5 min at 4°C. The 
resulting supernatant was centrifuged at 12,000 × g for 15 min at 4°C to obtain the crude 
mitochondrial pellet, which was then resuspended in 3 ml of SEM Buffer (250 mM sucrose, 1 mM 
EDTA, 10 mM MOPS, pH 7.2) and used for further purification of mitochondria. A sucrose 
gradient was made by overlaying 1.5 ml of 60% sucrose with 4 ml of 32% sucrose, 1.5 ml of 23% 
sucrose, and then 1.5 ml of 15% sucrose (all in EM buffer; 1 mM EDTA, 10 mM MOPS, pH 7.2). 
Finally, a 3-ml aliquot of the crude mitochondrial fraction in SEM buffer was applied to the 
gradient and centrifuged at 134,000 × g (33,000 rpm) for three hours at 4°C in vacuum (Rotor 
SW40Ti, Beckman). The purified mitochondria found at the 60%/32% sucrose interface were 
carefully removed and stored at - 80°C until mass spectrometric identification of phosphorylated 
mitochondrial proteins. 
 
4.2.3 Identification and quantification of proteins by mass spectrometry (MS) 
Protein bands stained with QC Colloidal Coomassie Blue was cut out from an SDS-PAGE 
gel with a razor blade. The gel pieces were placed in individual 0.5-ml siliconized Eppendorf tubes. 
The bands were destained by washing twice with distilled water for 1 h. The bands were then 
incubated in 50 l of acetonitrile (ACN) for 5 min at 37°C, after which ACN was removed and the 
bands were dried at 37°C. Next, the destained bands were incubated in 50 l of 10 mM 
dithiothreitol for 30 min at 37°C to reduce thiol groups in peptides. DTT was discarded and the 
bands were incubated in 50 l of 55 mM iodoacetamide (IAA) for 20 min at 37°C in the dark to 
remove the residual DTT. IAA was removed, and the bands were incubated in 50 l of a 1:1 




and the bands were incubated twice in 50 l of ACN under the same conditions and dried at 37°C. 
The trypsin and trypsin buffer were prepared as follows: (1) 1.6 ml of a 1:1 mixture of 100 mM 
ABC and 10mM CaCl2 were used to resuspend 20 g of trypsin; and (2) for protein digest, 50 l 
of trypsin solution (1 mg/ml) was added to the bands, which were then incubated overnight at 
37°C. 
The following day, the samples were spun down and the supernatants containing peptides 
were transferred to new 0.5-ml siliconized Eppendorf tubes. To extract more peptides, the gel 
pieces were subjected to several washes and treatments at room temperature; the supernatants were 
conserved and combined with the first set to extracted peptides. For the first extraction, the bands 
were initially incubated in 50 l of 25 mM ABC for 10 min and then in 50 l of ACN for 10 min. 
The samples were spun down, and the supernatant were added to the first set of extracted peptides. 
For the second extraction, the bands were incubated in 50 l of 5% formic acid for 10 min and 
then in 50 l of ACN for 10 min. The samples were spun down, and the supernatant were combined 
with the first set of extracted peptides. The gel pieces were no longer used and discarded. To 
prevent possible oxidation during storage, 12.5 l of 100 mM DTT was added to each set of 
peptides. The peptides were completely dried in a Speed-Vac at medium temperature settings 
(37°C) for 2 h and stored at -20°C until MS analysis. 
Dried peptides were resuspended in 20 l of 5% ACN. For each recovered protein band, 
an aliquot of 10 l of dried peptides in 5% ACN was diluted 2-fold in Nano pure water for MS 
analysis. Samples can be stored at -20°C until being subjected to MS analysis. Individual proteins 
composing each band were then identified by reverse phase high performance liquid 
chromatography coupled to mass spectrometry (RP-HPLC/MS) using an LTQ Orbitrap. 3-l 
aliquots of peptides were separated in ACN gradient using a 100-M capillary column packed 
with C18 mobile phase. 
Once acquiring time was completed using the LTQ Orbitrap, the raw mass spectrometry 
data file obtained by Xcalibur were analyzed using the Thermo Scientific Xcalibur Proteome 
Discoverer application (version 1.3) hereafter referred to as the Proteome Discoverer. The 
Proteome Discoverer was used to identify individual proteins by comparing the raw data of mass 
spectra of digested fragments to the mass spectra of peptides within the Uniprot FASTA database. 




the peak-finding search engine SEQUEST. The SEQUEST engine processes MS data using a 
peak-finding algorithm to search the raw data for generating a peak probability list with relative 
protein abundances. 
The following settings of the SEQUEST search wizard within the Proteome Discoverer 
application were used: 
Raw file and Scan Range Selection Parameters: The raw file was selected, and the Base 
peak ion chromatogram appeared to reveal: 1) the “Intensity (counts)” corresponding to the 
intensity of the largest peak in the spectrum; and 2) the “Time (min)” showing the retention time 
(RT). The following algorithm and settings were used: 
Lower RT Limit (min): The beginning of the RT of the scan range of interest: 10 min. 
Upper RT Limit (min): The end of the retention time of the scan range of interest: 18 min. 
Scan Extraction Parameters 
First mass: The mass of the first precursor ion in the range of ion fragments to search for 
in the database: 350 Daltons (Da). 
Last mass: The mass of the last precursor ion in the range of ion fragments to search for in 
the database: 5000 Daltons (Da). 
Activation type: The fragmentation method to use for activating the scan: Collision 
Induced Dissociation (CID). 
Unrecognized charge replacement: Specifies the charge number of the precursor ions: 
Automatic (Default), assigns a charge number of +2 and +3 to the spectrum. 
Intensity threshold: Specifies the intensity threshold below which ions are filtered out. The 
default value of 0.0 was used. 
Minimum ion count: The minimum ion count corresponds to the minimum number of ions 
that must be present in an MS/MS spectrum for it to be included in a search. The default value of 
1 was used. 
S/N threshold: The signal-to-noise threshold is the intensity of the signal to the intensity 
of the background noise. The use of this threshold filters out low-intensity ions that function as a 
noise. The value of 1.5 was used. 





Missed Cleavages: The maximum number of internal cleavage sites per peptide fragment 
that is acceptable for an enzyme to miss during proteolytic digest. The default value of 2 was used. 
Precursor mass tolerance: The precursor mass tolerance value used for finding peptide 
candidates. The possible range of values is 0.01 to 5000 ppm. The default value of 10 ppm was 
used. 
Fragment mass tolerance: The default mass tolerance value of 0.8 Da was used for 
matching fragment peaks. The possible range of values was 0.0001 to 2.0 Da. 
Ions series calculated: Specifies the ion factors for a, b, c, x, y, and z ions for the 
experiment type. The possible range is 0 through 1.0 for all ion factors. The ion factors used are b 
ions: 1 and y ions :1. 
Search against decoy database: Specifies if the application uses a decoy database in the 
search; the “yes” was used. 
Target FDR (strict): Specifies a strict target false discovery rate (FDR) for peptide matches 
with high confidence. The possible value range of 0.0 to 1.0 was used. The default value of 0.01 
(1% FDR) was used. 
Target FDR (relaxed): Specifies a relaxed target false discovery rate (FDR) for peptide 
matches with moderate confidence. The possible value ranges from 0.0 to 1.0 was used. The 
default value of 0.05 (5% FDR) was used. 
The Thermo Proteome Search Results Report for the identification of proteins was created. 
The protein page displays all the proteins and their corresponding peptides found in the sample 
during the database search. For each protein, the report shows the following results: 
Accession: The unique identifier was assigned to the protein by the Uniprot FASTA 
database. 
Description: The name and description of the protein of the identifier appeared in the 
corresponding Accession column. 
Score: The SEQUEST protein score is the sum of all peptide XCorr values above the 
specified score threshold. The score threshold was calculated as 0.8 + peptide charge * peptide 
relevance factor, where peptide relevance factor has a default value of 0.4. For each spectrum, 
only the highest-scoring match was used. For each spectrum and sequence, the Proteome 




Coverage: Represents the percentage of the protein sequence covered by the identified 
peptides. 
# Proteins: Represents the number of identified proteins in the protein group of a master 
protein. When the Protein Grouping setting is disabled, the #Proteins is always equal to 1. 
# Unique Peptides: Represents the number of peptide sequences unique to a protein. 
# Peptides: Represents the number of different peptide sequences identified in the protein. 
# PSMs: The peptide spectrum matches (PSMs) value corresponds to the total number of 
identified peptide sequences for the protein, including those that have been identified redundantly. 
# AAs: Represents the number of amino acid in the sequence length of the protein. 
MW kDa: Represents the calculated molecular weight of the protein. 
Calc. pI: Represents the theoretically calculated isoelectric point, i.e. the pH value at which 
a molecule carries no net electrical charge. 




Protein Descriptions: Identifies a protein associated with the peptides. This description is 
taken from the Uniprot FASTA file. 
# Proteins: Represents the total number of proteins in which this peptide can be found. 
Probability: Represents the probability score for the peptide. 
SpScore (search-dependent): Represents the raw value of the preliminary score of the 
SEQUEST algorithm. 
XCorr (search-dependent): Scores the number of fragment ions that are common to two 
different peptides with the same precursor mass; calculates the cross-correlation score for all 
candidate peptides queried from the database. 
Δ Score: A measure of the difference between the top two scores for the peptides identified 
by that spectrum; the Proteome Discoverer application calculates this score as follows: ΔScore = 
Score (Rank N Peptide) – Score (Rank 1 Peptide)/Score (Rank 1 Peptide). 
ΔCn: Represents the normalized score difference between the currently selected PSM and 
the highest-scoring PSM for that spectrum. 
# Missed Cleavages: Represents the number of cleavage sites in a peptide sequence that 
trypsin did not cleave, excluding the cases where the presence of proline prevents trypsin from 




Peptides Matched: Represents the number of peptides included in the precursor mass 
tolerance window set for the search. 
Charge: Represents the charge state of the peptide. 
Intensity: Represents the intensity of the precursor ion. 
MH+ Da: Represents the protonated monoisotopic mass of the peptide, in Daltons. 
ΔM ppm: Represents the difference between the theoretical mass of the peptide and the 
experimental mass of the precursor ion. 
RT min: Represents the retention time when the peptide was observed, in minutes. 
Xcalibur is a registered trademark of Thermo Fisher Scientific Inc. in the United States. 
SEQUEST is a registered trademark of the University of Washington in the United States. 
The ″Proteome Discoverer″ software was used to calculate the exponentially modified 
protein abundance index (emPAI), a measure of the relative abundance of mitochondrial proteins 
in a pair of analyzed datasets. 
 
4.2.4 A plating assay for the analysis of chronological lifespan 
Cells were grown in YEPD (0.2% glucose) medium at 30oC with rotational shaking at 200 
rpm in Erlenmeyer flasks at a flask volume/medium volume ratio of 5:1. A sample of cells was 
removed from each culture at various time points. A fraction of the cell sample was diluted to 
determine the total number of cells per ml of culture using a hemacytometer. 10 l of serial 
dilutions (1:10 to 1:103) of cells were applied to the hemacytometer, where each large square is 
calibrated to hold 0.1 l. The number of cells in 4 large squares was then counted and an average 
was taken to ensure greater accuracy. The concentration of cells was calculated as follows: number 
of cells per large square x dilution factor x 10 x 1,000 = total number of cells per ml of culture. A 
second fraction of the cell sample was diluted and serial dilutions (1:102 to 1:105) of cells were 
plated onto YEPD (2% glucose) plates in triplicate to count the number of viable cells per ml of 
each culture. 100 l of diluted culture was plated onto each plate. After a 48-h incubation at 30oC, 
the number of colonies per plate was counted. The number of colony forming units (CFU) equals 
to the number of viable cells in a sample. Therefore, the number of viable cells was calculated as 
follows: number of colonies x dilution factor x 10 = number of viable cells per ml. For each culture 
assayed, % viability of the cells was calculated as follows: number of viable cells per ml / total 




viability for that culture. The life span curves for wild-type and some of the mutant strains were 
also validated using a LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's 
instructions for stationary-phase cultures. 
 
4.2.5 Statistical analysis 
Statistical analysis was performed using Microsoft Excel's (2010) Analysis ToolPak - 
VBA. All data on cell survival are presented as mean ± SEM. The p values for comparing the 
means of two groups using an unpaired two-tailed t test were calculated with the help of the 
GraphPad Prism 7 statistics software. The logrank test for comparing each pair of survival curves 
was performed with GraphPad Prism 7. Two survival curves were considered statistically different 





4.3.1 The concentrations of membrane phospholipids in yeast mitochondria depends on 
several processes of phospholipid synthesis and transfer 
A spatiotemporal dynamic of processes that define the relative concentrations of different 
classes of membrane phospholipids in yeast mitochondria is well-understood [152, 229-235]. 
These processes are catalyzed by enzymes that reside in both mitochondria and the endoplasmic 
reticulum (ER). These processes include the following steps of phospholipid synthesis and 
transfer: 1) the synthesis of phosphatidic acid (PA), cytidine diphosphate-diacylglycerol (CDP- 
DAG), diacylglycerol (DAG), phosphatidylserine (PS), phosphatidylcholine (PC) and 
phosphatidylinositol (PI) in the ER; 2) the movement of PA from the ER to the OMM through 
mitochondria-ER contact sites at zones of a juxtaposition between the OMM and the mitochondria- 
associated membrane (MAM) domain of the ER; 3) the transfer of PA from the OMM across the 
intermembrane space (IMS) to the IMM, which is catalyzed by the Ups1/Mdm35 protein complex 
and inhibited by CL; 4) the conversion of ER-derived PA into CDP-DAG, phosphatidylglycerol- 
phosphate (PGP), phosphatidylglycerol (PG), cardiolipin (CL) and monolysocardiolipin (MLCL) 
in a series of reactions that are catalyzed by Tam41, Pgs1, Gep4, Crd1, Cld1 and Taz1 
(respectively) in the IMM; 5) the transfer of PS from the ER to the OMM via mitochondria-ER 






Figure 4.1. The relative concentrations of different classes of membrane phospholipids in yeast 
mitochondria depend on several processes of phospholipid synthesis and transfer. These processes are catalyzed 
by enzymes that reside in the inner mitochondrial membrane (IMM), intermembrane space (IMS), outer mitochondrial 
membrane (OMM) and endoplasmic reticulum (ER). Only enzymes catalyzing these processes in the IMM, IMS and 
OMM are shown. A T bar denotes a cardiolipin (CL)-dependent inhibition of phosphatidic acid (PA) transfer from 
the OMM across the IMS to the IMM. In this study we investigated various effects of single-gene-deletion mutations 
that eliminate enzymes displayed in red color. See text for more details. Abbreviations: CDP-DAG, cytidine 
diphosphate-diacylglycerol; DAG, diacylglycerol; MAM, the mitochondria-associated membrane domain of the ER; 
MICOS, the mitochondrial contact site protein complex; MLCL, monolysocardiolipin; PC, phosphatidylcholine; PG, 
phosphatidylglycerol; PGP, phosphatidylglycerol-phosphate; PI, phosphatidylinositol; PS, phosphatidylserine. This 
figure was prepared by Anna Leonov and me. It has been published in Leonov A, Arlia-Ciommo A, Bourque SD, 
Koupaki O, Kyryakov P, Dakik P, McAuley M, Medkour Y, Mohammad K, Di Maulo T, Titorenko VI. Specific 
changes in mitochondrial lipidome alter mitochondrial proteome and increase the geroprotective efficiency of 
lithocholic acid in chronologically aging yeast. Oncotarget. 2017; 8(19):30672-91. 
 
 
the OMM via the IMS to the IMM, where PS is converted into phosphatidylethanolamine 
(PE) in a reaction catalyzed by Psd1; 7) the synthesis of PE from PS in the OMM, which is 
catalyzed by Psd1, requires a close apposition between the two mitochondrial membranes and is 
assisted by the mitochondrial contact site (MICOS) protein complex; 8) the transfer of PC and PI 
from the ER to the OMM via mitochondria-ER contact sites, which is followed by the movement 
of PC and PI from the OMM to the IMM; mechanisms of both these processes remain obscure; 
and 9) the movement of DAG and CDP-DAG from the ER to the OMM across mitochondria-ER 
contact sites, and the subsequent transfer of these two phospholipids to the IMM by currently 
unknown mechanisms (Figure 4.1) [152, 229-235]. 
 
4.3.2 The ups1 and ups2 mutations differently alter mitochondrial membrane lipidome 
and have different effects on the geroprotective efficiency of LCA 
Studies by Anna Leonov, a former Doctoral student in the Titorenko laboratory, have 




component of the Ups1/Mdm35 protein complex involved in the transfer of PA from the OMM 
across the IMS to the IMM; Figure 4.1) exhibits the following effects on mitochondrial membrane 
lipidome: 1) it increases the PA/PS, PA/PC and PA/PI ratios for non-bilayer forming PA vs. bilayer 
forming PS, PC and PI; 2) it does not alter the PE/PS, PE/PC and PE/PI ratios for non-bilayer 
forming PE vs. PS, PC and PI; 3) it decreases the CL/PS, CL/PC and CL/PI ratios for non-bilayer 
forming CL vs. PS, PC and PI; 4) it does not change the PS/PI, PS/PC and PI/PC ratios for all 
these bilayer forming phospholipid classes; and 5) it increases the PA/PE, PA/CL and PE/CL ratios 
for all these non-bilayer forming phospholipid classes [236]. Thus, while the ups1Δ mutation alters 
the relative to each other concentrations for all non-bilayer forming phospholipids, it has no effect 
on the relative to each other concentrations for phospholipids that exhibit the bilayer forming 
shape. Of note, PA, PE and CL are phospholipid classes that have the non-bilayer forming shape 
of a cone; they increase the extent of membrane curving for the IMM, thereby raising the 
abundance of mitochondrial cristae (formed by the IMM) and mitochondrial contact cites (formed 
between the IMM and OMM) [64, 234, 235, 237-242]. In contrast, PS, PC and PI are phospholipid 
classes that exhibit the bilayer forming shape of a cylinder; they decrease the extent of membrane 
curving for the IMM, thus 1) increasing the abundance of the IMM domains having ″flat″ bilayer 
conformation; 2) decreasing the abundance of the IMM domains exhibiting negative curvature 
typical of mitochondrial contact sites; and 3) decreasing the abundance of the IMM domains 
displaying positive curvature characteristic of mitochondrial cristae [64, 234, 235, 237-242]. 
Anna Leonov has also found that the ups1Δ mutation 1) significantly shortens yeast 
chronological lifespan (CLS) in the absence of LCA; and 2) substantially lowers the geroprotective 
efficiency of LCA by almost eliminating the ability of LCA to increase both the mean and the 
maximum CLS [236]. 
Anna Leonov’s studies also revealed that, in cells cultured in the presence or absence of 
LCA, the ups2Δ mutation (which eliminates a component of the Ups2/Mdm35 protein complex 
involved in the transfer of PS from the OMM across the IMS to the IMM; Figure 4.1) exhibits the 
following effects on mitochondrial membrane lipidome: 1) it raises the PA/PS, PA/PC and PA/PI 
ratios for non-bilayer forming PA vs. bilayer forming PS, PC and PI; 2) it lowers the PE/PS, PE/PC 
and PE/PI ratios for non-bilayer forming PE vs. PS, PC and PI; 3) it lessens the CL/PS, CL/PC and 
CL/PI ratios for non-bilayer forming CL vs. PS, PC and PI; 4) it does not alter the PS/PI, PS/PC 




PA/CL ratios for all these non-bilayer forming phospholipid classes; and 6) it does not alter the 
PE/CL ratio for these two non-bilayer forming phospholipids [236]. Thus, unlike the ups1Δ 
mutation, ups2Δ allows to maintain the equimolar concentrations of two non-bilayer forming 
phospholipids, PE and CL, by proportionally decreasing their concentrations. 
According to Anna Leonov’s data, the ups1Δ mutation 1) extends yeast CLS in the absence 
of LCA; and 2) significantly amplifies the geroprotective efficiency of LCA by enhancing the 
ability of this bile acid to increase both the mean and the maximum CLS [236]. 
Based on these findings, it was suggested (and then confirmed by other studies in the 
Titorenko laboratory) that the ups2Δ mutation may slow down yeast chronological aging and 
increase the geroprotective efficiency of LCA because it establishes a distinctive aging-delaying 
pattern of mitochondrial lipidome [236]. This ups2Δ-specific pattern may consist of the following 
distinct changes in the relative concentrations of different phospholipid classes: 1) an increase of 
the PA/PS, PA/PC and PA/PI ratios for non-bilayer forming PA vs. bilayer forming PS, PC and 
PI; 2) a decrease of the PE/PS, PE/PC and PE/PI ratios for non-bilayer forming PE vs. bilayer 
forming PS, PC and PI; 3) a decline of the CL/PS, CL/PC and CL/PI ratios for non-bilayer forming 
CL vs. bilayer forming PS, PC and PI; and 4) a rise of the PA/PE and PA/CL ratios for these non- 
bilayer forming classes of phospholipids [236]. 
 
4.3.3 The ups1Δ and ups2Δ mutations alter the concentrations of many mitochondrial 
proteins in yeast cultured with or without LCA 
Based on the above findings, we hypothesized that the LCA-dependent creation and 
preservation of a distinctive pro-longevity pattern of mitochondrial lipidome may cause a 
remodeling of mitochondrial proteome to establish a pro-longevity pattern of mitochondrial 
protein composition. To test this hypothesis, we used quantitative mass spectrometry to compare 
the identities and relative concentrations of proteins that were recovered in mitochondria purified 
from WT, ups1Δ and ups2Δ cells cultured with or without LCA. The ups1Δ mutation establishes 
and maintains a distinct pro-aging pattern of mitochondrial lipidome, shortens CLS, and lowers 
the geroprotective efficiency of LCA (see above; [236]). In contrast, the ups2Δ mutation institutes 
and preserves a specific pro-longevity pattern of mitochondrial lipidome, extends CLS, and 




We found that both mutations, ups1Δ and ups2Δ, alter the age-related chronology of 
changes in concentrations of numerous mitochondrial proteins in yeast cultured in the presence of 
LCA or in its absence; these proteins have been implicated in many essential mitochondrial 
functions (see Figure 4.2 and Suppl. Tables S1 - S9 for ups1Δ on  
http://www.oncotarget.com/index.php?journal=oncotarget&page=rt&op=suppFiles&path[]=167   
66&path[]=0, and Figure  4.3  and Suppl.  Tables S10 – S15  for ups2Δ on  





Figure 4.2. Scatter plots comparing the relative concentrations of proteins in mitochondria purified 
from WT or ups1Δ (short-lived) cells cultured with or without LCA. Mitochondria were purified from WT or 
ups1Δ cells recovered on day 2, 4 or 7 of cell culturing. Mass spectrometry-based identification and quantitation of 
proteins recovered in purified mitochondria were performed as described in Materials and methods. Scatter plots 
comparing the relative abundance of mitochondrial proteins between specified datasets were plotted on a log-log scale 
spanning six orders of magnitude. Data on the relative abundance of mitochondrial proteins are presented as means of 






Figure 4.3. Scatter plots comparing the relative concentrations of proteins in mitochondria purified 
from WT or ups2Δ (long-lived) cells cultured with or without LCA. Mitochondria were purified from WT or ups2Δ 
cells recovered on day 2, 4 or 7 of cell culturing. Mass spectrometry-based identification and quantitation of proteins 
recovered in purified mitochondria were performed as described in Materials and methods. Scatter plots comparing 
the relative abundance of mitochondrial proteins between specified datasets were plotted on a log-log scale spanning 




We then compared the datasets of relative concentrations of mitochondrial proteins that are 
statistically significantly downregulated or upregulated 1) by LCA in WT; 2) by the ups1Δ or 
ups2Δ mutation in the absence of LCA; and 3) by LCA in ups1Δ or ups2Δ cells. 
Our comparative analysis of these datasets for ups1Δ revealed the following: 1) many 
mitochondrial proteins that are downregulated or upregulated in ups1Δ cells cultured without LCA 
are unique to these datasets (i.e. these proteins are not present in the datasets of mitochondrial 
proteins that are downregulated or upregulated by LCA in WT or by LCA in ups1Δ cells) (Figures 
4.4A – 4.4F); and 2) the total number and identities of mitochondrial proteins that are 
downregulated or upregulated in ups1Δ cells cultured with or without LCA fluctuate significantly 
in cells recovered on day 2, 4 or 7 of cell culturing (i.e. at different stages of chronological aging) 






Figure 4.4. The ups1Δ mutation alters the concentrations of many mitochondrial proteins in yeast 
cultured with or without LCA. (A –  F) Venn diagrams  showing a comparison of the datasets of relative 
concentrations of mitochondrial proteins that are statistically significantly downregulated or upregulated by LCA in 
WT, by the ups1Δ mutation in the absence of LCA, and by LCA in ups1Δ cells; WT cells were recovered on day 2, 4 
or 7 of culturing. (G and J) Venn diagrams showing a comparison of the datasets of relative concentrations of 
mitochondrial proteins that are statistically significantly downregulated or upregulated by LCA in WT cells recovered 
on day 2, 4 or 7 of culturing. (H and K) Venn diagrams showing a comparison of the datasets of relative concentrations 
of mitochondrial proteins that are statistically significantly downregulated or upregulated by the ups1Δ mutation in 
the absence of LCA; ups1Δ cells were recovered on day 2, 4 or 7 of culturing. (I and L) Venn diagrams showing a 
comparison of the datasets of relative concentrations of mitochondrial proteins that are statistically significantly 
downregulated or upregulated by LCA in ups1Δ cells recovered on day 2, 4 or 7 of culturing. 
 
 
For ups2Δ, we found that: 1) a number of mitochondrial proteins that are downregulated 
or upregulated in ups2Δ cells cultured in the absence of LCA cannot be found in the datasets of 
mitochondrial proteins downregulated or upregulated by LCA in WT or by LCA in ups2Δ cells 
(Figures 4.5A – 4.5F); 2) the total number and identities of mitochondrial proteins that are 
downregulated or upregulated in ups2Δ cells cultured in the absence of LCA vary substantially 
with the chronological age of cells (Figures 4.5H and 4.5K); 3) numerous mitochondrial proteins 




cannot be found in the datasets of mitochondrial proteins downregulated or upregulated by LCA 
in WT or by the ups2Δ mutation in the absence of LCA (Figures 4.5A – 4.5F); and 4) the total 
number and identities of mitochondrial proteins that are downregulated or upregulated by LCA in 




Figure 4.5. The ups2Δ mutation alters the concentrations of many mitochondrial proteins in yeast 
cultured with or without LCA. (A –  F) Venn diagrams  showing a comparison of the datasets of relative 
concentrations of mitochondrial proteins that are statistically significantly downregulated or upregulated by LCA in 
WT, by the ups2Δ mutation in the absence of LCA, and by LCA in ups2Δ cells; WT cells were recovered on day 2, 4 
or 7 of culturing. (G and J) Venn diagrams showing a comparison of the datasets of relative concentrations of 
mitochondrial proteins that are statistically significantly downregulated or upregulated by LCA in WT cells recovered 
on day 2, 4 or 7 of culturing. (H and K) Venn diagrams showing a comparison of the datasets of relative concentrations 
of mitochondrial proteins that are statistically significantly downregulated or upregulated by the ups2Δ mutation in 
the absence of LCA; ups2Δ cells were recovered on day 2, 4 or 7 of culturing. (I and L) Venn diagrams showing a 
comparison of the datasets of relative concentrations of mitochondrial proteins that are statistically significantly 
downregulated or upregulated by LCA in ups2Δ cells recovered on day 2, 4 or 7 of culturing. 
 
 
Taken together, these findings indicate that in yeast cultured with or without LCA 1) the 




lived ups1Δ cells [236] correlate with the establishment and maintenance of a specific aging- 
accelerating pattern of mitochondrial proteome in these mutant cells (this study); and 2) the 
institution and preservation of a specific pro-longevity pattern of mitochondrial lipidome in long- 
lived ups2Δ cells [236] correlate with the institution and preservation of a distinctive aging- 
delaying pattern of mitochondrial proteome in these mutant cells (this study). 
 
4.3.4 The mitochondrial proteomes of ups1Δ and ups2Δ differ substantially 
Because our findings suggest that in yeast cultured with or without LCA the ups1Δ and 
ups2Δ mutations can establish and maintain either an aging-accelerating or an aging-delaying 
(respectively) pattern of mitochondrial proteome, we compared the datasets of relative 
concentrations of mitochondrial proteins that are statistically significantly downregulated or 
upregulated in ups1Δ or ups2Δ cells in the absence or presence of LCA. 
For ups1Δ and ups2Δ cells cultured without LCA, we found the following: 1) many 
mitochondrial proteins that are downregulated or upregulated in long-lived ups2Δ cells are not 
present in the datasets of mitochondrial proteins that are downregulated or upregulated in short- 
lived ups1Δ cells (Figures 4.6A – 4.69F; Suppl. Tables S16 and S17 on  
http://www.oncotarget.com/index.php?journal=oncotarget&page=rt&op=suppFiles&path[]=167   
66&path[]=0);  and  2)  the  total  number  and  identities  of  mitochondrial  proteins  that  are 
downregulated or upregulated only in long-lived ups2Δ cells fluctuate significantly in cells 
recovered at different stages of chronological aging (Figures 4.6A – 4.6F; Suppl. Tables S16 and 
S17            on 
http://www.oncotarget.com/index.php?journal=oncotarget&page=rt&op=suppFiles&path[]=167   
66&path[]=0). Functions of some mitochondrial proteins that are downregulated or upregulated 
only in long-lived ups2Δ cells remain to be established (Figures 4.6G – 4.6L; Suppl. Tables S16 
and S17 on  
http://www.oncotarget.com/index.php?journal=oncotarget&page=rt&op=suppFiles&path[]=167   
66&path[]=0). Many mitochondrial proteins that are downregulated or upregulated only in long- 
lived ups2Δ cells have been implicated in essential mitochondrial functions, including the electron 
transport chain (ETC), respiration, the tricarboxylic acid (TCA) cycle, ribosome assembly, amino 
acid metabolism, carbohydrate metabolism, protein import, proteostasis, metabolite synthesis, 




maintenance, redox homeostasis, mitochondrial DNA (mtDNA) maintenance, stress response, 
mRNA synthesis and processing, the maintenance of contact sites between mitochondria and 
vacuoles,  and  mitochondrial  fusion  (Figures  4.6G  –  4.6L;  Suppl.  Tables  S16  and  S17  on  




Figure 4.6. In cells cultured without LCA, many mitochondrial proteins that are downregulated or 
upregulated in long-lived ups2Δ cells are not downregulated or upregulated in short-lived ups1Δ cells. (A – F) 
Venn diagrams showing a comparison of the datasets of relative concentrations of mitochondrial proteins that are 
statistically significantly downregulated or upregulated in ups1Δ or ups2Δ cells cultured in the absence of LCA; cells 
were recovered on day 2, 4 or 7 of culturing. (G – L) Mitochondrial proteins that are downregulated or upregulated 
only in long-lived ups2Δ cells belong to various functional categories. The names of functional categories whose 
protein representatives were downregulated or upregulated in ups2Δ cells recovered on every of the three days are 
underlined. Functions of some mitochondrial proteins that are downregulated or upregulated only in ups2Δ cells are 
currently unknown. Abbreviations: ETC, electron transport chain; mtDNA, mitochondrial DNA; TCA, the 
tricarboxylic acid cycle. 
 
 
For ups1Δ and ups2Δ cells cultured with LCA, we found the following: 1) many 




cannot be found in the datasets of mitochondrial proteins that are downregulated or upregulated 
by LCA in WT or short-lived ups1Δ cells (Figures 4.7A – 4.7F; Suppl. Tables S18 and S19 on  
http://www.oncotarget.com/index.php?journal=oncotarget&page=rt&op=suppFiles&path[]=167   
66&path[]=0);  and  2)  the  total  number  and  identities  of  mitochondrial  proteins  that  are 
downregulated or upregulated by LCA only in long-lived ups2Δ cells vary notably in cells 
recovered at different stages of chronological aging (Figures 4.7A – 4.7F; Suppl. Tables S18 and 
S19 on 




Figure 4.7. In cells cultured with LCA, many mitochondrial proteins that are downregulated or 
upregulated by LCA in long-lived ups2Δ cells are not downregulated or upregulated by LCA in WT or short- 
lived ups1Δ cells. (A – F) Venn diagrams showing a comparison of the datasets of relative concentrations of 
mitochondrial proteins that are statistically significantly downregulated or upregulated by LCA in WT, ups1Δ or 
ups2Δ; cells were recovered on day 2, 4 or 7 of culturing. (G – L) Mitochondrial proteins that are downregulated or 
upregulated by LCA only in long-lived ups2Δ cells belong to many different functional categories. The names of 
functional categories whose protein representatives were downregulated or upregulated by LCA in ups2Δ cells 




or upregulated by LCA only in ups2Δ cells are currently unknown. Abbreviations: ETC, electron transport chain; 
mtDNA, mitochondrial DNA; TCA, the tricarboxylic acid cycle. 
 
 
Functions of some mitochondrial proteins that are downregulated or upregulated by LCA 
only in long-lived ups2Δ cells remain unknown (Figures 4.7G – 4.7L; Suppl. Tables S18 and S19 
on 
http://www.oncotarget.com/index.php?journal=oncotarget&page=rt&op=suppFiles&path[]=167   
66&path[]=0). Numerous mitochondrial proteins that are downregulated or upregulated by LCA 
only in long-lived ups2Δ cells are known for their essential roles in the same set of mitochondrial 
functions as the ones played by proteins that are downregulated or upregulated only in long-lived 
ups2Δ cells culture without LCA (compare Figures 4.6G – 4.6L and Suppl. Tables S16 and S17 
on 
http://www.oncotarget.com/index.php?journal=oncotarget&page=rt&op=suppFiles&path[]=167   
66&path[]=0 to Figures 4.7G – 4.7L and Suppl. Tables S18 and S19on  
http://www.oncotarget.com/index.php?journal=oncotarget&page=rt&op=suppFiles&path[]=167   
66&path[]=0). 
In sum, these findings suggest that in yeast cultured with or without LCA the ups2Δ 
mutation may establish and maintain an aging-delaying pattern of mitochondrial proteome. 
 
 
4.3.4 Many mitochondrial proteins that are downregulated or upregulated by LCA only in 
long-lived ups2Δ cells play essential roles in aging delay by LCA 
Because our findings suggest that in yeast cultured with LCA the ups2Δ mutation may 
establish and maintain a distinct pattern of mitochondrial proteome that is essential for the ability 
of LCA to delay aging, we investigated how single-gene-deletion mutations eliminating the key 
proteins constituting such pattern affect the geroprotective efficiency of LCA. 
We thought that some of the proteins downregulated by LCA in ups2Δ may function in 
attenuating the geroprotective efficiency of LCA, and thus the elimination of these proteins by 
mutations may increase such efficiency. We also thought that some of the proteins upregulated by 
LCA in ups2Δ may act as facilitators of aging delay by LCA, and therefore the elimination of these 
proteins by mutations may decrease the geroprotective efficiency of LCA. 
We found that mutants that lack 10 out of 12 proteins most highly downregulated by LCA 




slight increase of such efficiency seen in mutants that lack 2 other downregulated by LCA proteins 
was not statistically significant (Figures 4.8A – 4.8C). We also found that mutants that lack 11 out 
of 12 proteins vastly upregulated by LCA in ups2Δ display a statistically significantly decrease of 
the geroprotective efficiency of LCA; a minor decrease of such efficiency observed in a mutant 
lacking one of the downregulated by LCA proteins was not statistically significant (Figures 4.8D 
– 4.8F). Of note, none of these mutants exhibits such robust change of the aging-delaying 
efficiency of LCA as the changes seen in the ups1Δ, ups2Δ and psd1Δ mutants [236]. This finding 
suggests that Ups1, Ups2 and Psd1 may function as upstream regulators of various mitochondrial 
processes whose synergistic action defines the efficiency of aging delay by LCA. 
 
 
Figure 4.8. Many mutations eliminating proteins downregulated by LCA in ups2Δ increase the aging- 
delaying efficiency of LCA, while many mutations eliminating proteins upregulated by LCA in ups2Δ decrease 
such efficiency. WT and mutant cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with 50 µM LCA. (A - C) Survival curves of chronologically aging WT and mutant strains that lack proteins most 
highly downregulated by LCA in ups2Δ are shown. Data are presented as means ± SEM (n = 3). Also shown are p 
values for different pairs of survival curves of WT and mutant strains cultured with LCA. Survival curves shown in 
(A - C) were compared. Two survival curves were considered statistically different if the p value was less than 0.05. 
The p values for comparing pairs of survival curves using the logrank test were calculated as described in Materials 
and methods. (D - F) Survival curves of chronologically aging WT and mutant strains that lack proteins most 
substantially upregulated by LCA in ups2Δ are shown. Data are presented as means ± SEM (n = 3). Also shown are p 
values for different pairs of survival curves of WT and mutant strains cultured with LCA. Survival curves shown in 
(D - F) were compared. Two survival curves were considered statistically different if the p value was less than 0.05. 




and methods. These experiments were performed by Pavlo Kyryakov, Pamela Dakik, Melissa McAuley, Younes 
Medkour and Tamara Di Maulo. 
 
 
Taken together, these findings further support the notion that the ups2Δ mutation may allow 
to sustain a distinct aging-delaying pattern of mitochondrial proteome that is essential for the 
ability of LCA to delay aging. 
 
4.4 Discussion 
This study, along with studies described elsewhere [236], provide evidence that the 
mitochondrial lipidome defines not only the rate of yeast chronological aging but also the 
geroprotective efficiency of LCA in chronologically aging yeast. We demonstrated the existence 
of a distinct pro-longevity pattern of mitochondrial lipidome, which extends yeast CLS in the 
absence of LCA and amplifies the geroprotective efficiency of LCA [236]. This pattern consists 
in a proportional decrease of PE and CL concentrations, and in a concomitant increase of PA 
concentration. PE, CL and PA are non-bilayer forming, cone-shaped phospholipid classes that 
increase the extent of membrane curving for the IMM to rise the abundance of mitochondrial 
cristae (formed by the IMM) and mitochondrial contact cites (formed between the IMM and 
OMM) [236]. We also show that these LCA-driven specific changes in the composition of 
mitochondrial membrane lipids cause a distinct remodeling of mitochondrial proteome by 
decreasing and increasing concentration of many mitochondrial proteins (this study). These 
proteins have been implicated in such vital mitochondrial functions as the ETC and respiration, 
the TCA cycle, ribosome assembly, amino acid metabolism, carbohydrate metabolism, protein 
import, proteostasis, metabolite synthesis, protein synthesis, ATP synthesis, metabolite transport, 
lipid metabolism, contact sites and cristae maintenance, redox homeostasis, mtDNA maintenance, 
stress response, mRNA synthesis and processing, the maintenance of contact sites between 
mitochondria and vacuoles, and mitochondrial fusion (this study). We provided evidence that the 
LCA-dependent remodeling of mitochondrial lipidome and the resulting changes in mitochondrial 
proteome allow to change the age-related chronology of changes in such vital mitochondrial 
processes as respiration, electrochemical potential maintenance, ROS homeostasis preservation 
and ATP synthesis [236]. These changes facilitate the establishment and maintenance of an aging- 





The Titorenko laboratory has previously demonstrated that LCA causes major changes not 
only in mitochondrial membrane lipidome but also in the size, number and morphology of 
mitochondria [64]. One could envision that these LCA-driven changes in mitochondrial abundance 
and morphology may affect mitochondrial protein import, folding, assembly and other aspects of 
mitochondrial proteostasis, thereby altering mitochondrial proteome. The ongoing studies in the 




5 Mechanisms through which lithocholic acid delays yeast chronological aging under 
caloric restriction conditions 
 
5.1 Introduction 
As described in the Introduction section, our recent studies have indicated that under CR 
conditions lithocholic acid (LCA) influences not only the composition and functionality of 
mitochondria but also some cellular processes confined to other cellular compartments. Based on 
these recent studies, we hypothesized that LCA may delay chronological aging of yeast limited in 
calorie supply also because it affects these other cellular processes taking place in various cellular 
locations. The objectives of studies described in Chapter 5 was to test this hypothesis by 
investigating mechanisms through which LCA controls the spatiotemporal dynamics of these other 
cellular processes in different cellular locations under CR conditions. 
 
5.2 Materials and methods 
5.2.1 Yeast strains, media and growth conditions 
The WT strain BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) and single-gene-deletion mutant 
strains in the BY4742 genetic background (all from Open Biosystems/Dharmacon, a part of GE 
Healthcare) were grown in YP medium (1% yeast extract, 2% peptone; both from Fisher Scientific; 
#BP1422-2 and #BP1420-2, respectively) initially containing 0.2% glucose (#D16-10; Fisher 
Scientific) with 50 µM LCA (#L6250; Sigma) or without it. Cells were cultured at 30oC with 
rotational shaking at 200 rpm in Erlenmeyer flasks at a ʺflask volume/medium volumeʺ ratio of 
5:1. 
 
5.2.2 Chronological life span assay 
A sample of cells was taken from a culture at a certain time-point. A fraction of the sample 
was diluted to determine the total number of cells using a hemocytometer. Another fraction of the 
cell sample was diluted, and serial dilutions of cells were plated in duplicate onto YP plates 
containing 2% glucose as carbon source. After 2 d of incubation at 30oC, the number of colony 
forming units (CFU) per plate was counted. The number of CFU was defined as the number of 
viable cells in a sample. For each culture, the percentage of viable cells was calculated as follows: 




in  mid-logarithmic  phase  was  set  at  100%.  The  life  span  curves  were  validated  using  a 
LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's instructions. 
 
5.2.3 Mass spectrometric identification and quantitation of cellular lipids 
Extraction of cellular lipids and their mass spectrometric identification and quantitation 
were performed as previously described [227]. A sample of cells was taken from a culture on a 
certain day of culturing. A fraction of the sample was diluted to determine the total number of cells 
using a hemocytometer (# 3200; Hausser Scientific). 5 × 107 cells were harvested by centrifugation 
in a Centra CL2 clinical centrifuge for 5 min at 3,000 × g at room temperature. The cell pellet was 
washed once in ice-cold nanopure water and once in ice-cold 155 mM ammonium bicarbonate (pH 
8.0), and the cells were harvested by centrifugation at 16,000 × g for 1 min at 4oC. The cell pellet 
was stored at -80oC until lipid extraction. For lipid extraction, the pelleted cells kept at -80ᴼC were 
thawed on ice before being resuspended in 200 µl of ice-cold nanopure water. The re-suspended 
sample was transferred to a 15-ml high-strength glass screw top centrifuge tube with a Teflon lined 
cap (#0556912; Fisher Scientific). The volume of each sample was topped off to 1 ml with ice- 
cold nanopure water. To each tube the following was added: 20 µL of the internal standard mix 
prepared in Chromasolv HPLC (>99.9%) chloroform (Sigma-Aldrich) as described [215], 800 µl 
of 425-600 µM acid-washed glass beads to break open the cells (#G8772; Sigma-Aldrich) and 3 
ml of a Chromasolv HPLC (>99.9%) chloroform-methanol mixture (both from Sigma-Aldrich) at 
a 17:1 ratio. The samples were then vortexed vigorously for 2 h at 4oC and subjected to 
centrifugation in a Centra CL2 clinical centrifuge at 3,000 × g for 5 min at room temperature. The 
lower organic phase was then transferred to another 15-ml high-strength glass screw top centrifuge 
tube using a glass Pasteur pipette with careful attention not to disrupt the glass beads or upper 
aqueous phase. 1.5 ml of chloroform-methanol (2:1) solution was added to the remaining upper 
aqueous phase. The samples were again vortexed vigorously at 4oC for 2 h. The initial separated 
organic band was kept at 4oC for the duration of the second vortexing. At the end of 2-h vortexing, 
the samples were again centrifuged for 5 min at 3,000 × g at room temperature; the lower organic 
phase was then separated and added to the corresponding initial organic phase with a glass Pasteur 
pipette. With both lower organic phases combined, the solvent was evaporated off by nitrogen gas 
flow. Once all solvent was evaporated, the remaining lipid film was dissolved in 100 µl of 




tops to avoid evaporation until samples were analyzed by mass spectrometry. Samples were then 
stored at -80oC and ran on the LTQ Orbitrap Mass Spectrometer within one week of the extraction. 
Samples were diluted (1:1) with chloroform/methanol (1:2) mixture supplemented with 0.1% 
ammonium hydroxide. Lipids were resolved by direct injection using a Thermo Orbitrap Velos 
mass spectrometer equipped with a HESI-II ion source (Thermo Scientific, Waltham, MA, USA) 
at a flow rate of 5 μl/min. The optimized tune setting and instrument methods for mass 
spectrometric analysis of lipids were previously described [227]. Mass spectra were converted to 
open format mzXML using the ProteoWizard MSConvert software 
(http://proteowizard.sourceforge.net/), the file format used by the Lipid Identification Software 
LipidXplorer (https://wiki.mpi-cbg.de/lipidx/Main_Page) for the automated detection and 
quantitation of lipid species. Data were normalized by taking the ratio of signal intensity of 
precursor ions to that of their respective lipid class-specific internal standard (spiked standard), 
multiplied by the concentration of that standard to give a molar quantity. 
 
5.2.4 Fluorescence microscopy 
BODIPY 493/503 (#D3922, Thermo Fisher Scientific) staining for monitoring neutral 
lipids deposited in lipid droplets [23], propidium iodide (PI; #P4170, Sigma) staining for 
visualizing the extent of plasma membrane permeability for small molecules was performed as 
described previously [243], 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI; #D9542; 
Sigma) staining for visualizing nuclei [243] and Annexin V (#A13201; Thermo Fisher Scientific) 
staining for visualizing externalized phosphatidylserine [243] were performed according to 
established procedures. Live imaging was performed on a Leica DM6000B epifluorescence 
microscope equipped with a high-resolution Hamamatsu Orca ER CCD camera using oil 
immersion and a 100× objective. Images were acquired with 20-ms exposures using PerkinElmer 
Volocity software. Image files were exported as TIFFs then opened in ImageJ, where the 
percentage of BODIPY 493/503-, PI- and Annexin V-positive cells or cells with fragmented 
nucleus was calculated. 
 
5.2.5 Cell viability assay for monitoring the susceptibility of yeast to a mode of cell death 




A sample of cells was taken from a culture on a certain day of culturing. A fraction of the 
sample was diluted to determine the total number of cells using a hemocytometer. 8 × 107 cells 
were harvested by centrifugation for 1 min at 21,000 × g at room temperature and resuspended in 
8 ml of YP medium containing 0.2% glucose as carbon source. Each cell suspension was divided 
into 8 equal aliquots. Three pairs of aliquots were supplemented with POA (#P9417; Sigma) from 
a 50-mM stock solution (in 10% chloroform, 45% hexane and 45% ethanol; #650498, #248878 
and #34852, respectively; all from Sigma). The final concentration of POA was 0.05 mM, 0.1 mM 
or 0.15 mM for each pair of aliquots; in all these aliquots, the final concentrations of chloroform, 
hexane and ethanol were 0.03%, 0.135% and 0.135%, respectively. One pair of aliquots was 
supplemented only with chloroform, hexane and ethanol added to the final concentrations of 
0.03%, 0.135% and 0.135%, respectively. All aliquots were then incubated for 2 h at 30oC on a 
Labquake rotator (#400110; Thermolyne/Barnstead International) set for 360o rotation. Serial 
dilutions of cells were plated in duplicate onto plates containing YP medium with 2% glucose as 
carbon source. After 2 d of incubation at 30oC, the number of colony forming units (CFU) per 
plate was counted. The number of CFU was defined as the number of viable cells in a sample. For 
each aliquot of cells exposed to POA, the % of viable cells was calculated as follows: (number of 
viable cells per ml in the aliquot exposed to POA/number of viable cells per ml in the control 
aliquot that was not exposed to POA) × 100. 
 
5.2.6 Cell viability assay for monitoring the susceptibility of yeast to a mode of cell death 
induced by hydrogen peroxide 
A sample of cells was taken from a culture on a certain day of culturing. A fraction of the 
sample was diluted to determine the total number of cells using a hemocytometer. 8 × 107 cells 
were harvested by centrifugation for 1 min at 21,000 × g at room temperature and resuspended in 
8 ml of YP medium containing 0.2% glucose as carbon source. Each cell suspension was divided 
into 8 equal aliquots. Three pairs of aliquots were supplemented with hydrogen peroxide (#H325- 
500; Fisher Scientific) to the final concentration of 0.5 mM, 1.5 mM or 2.5 mM for each pair. One 
pair of aliquots remained untreated. All aliquots were then incubated for 2 h at 30oC on a Labquake 
rotator (#400110; Thermolyne/Barnstead International) set for 360o rotation. Serial dilutions of 
cells were plated in duplicate onto plates containing YP medium with 2% glucose as carbon source. 




was defined as the number of viable cells in a sample. For each aliquot of cells exposed to hydrogen 
peroxide, the % of viable cells was calculated as follows: (number of viable cells per ml in the 
aliquot exposed to hydrogen peroxide/number of viable cells per ml in the control aliquot that was 
not exposed to hydrogen peroxide) × 100. 
 
5.2.7 Statistical analysis 
Statistical analysis was performed using Microsoft Excel's (2010) Analysis ToolPak - 
VBA. All data on cell survival are presented as mean ± SEM. The p values for comparing the 
means of two groups using an unpaired two-tailed t test were calculated with the help of the 
GraphPad Prism 7 statistics software. The logrank test for comparing each pair of survival curves 
was performed with GraphPad Prism 7. Two survival curves were considered statistically different 
if the p value was less than 0.05. The Pearson correlation coefficient (r) and the R-squared values 
were computed using Microsoft Excel's (2010) Analysis ToolPak - VBA. The Pearson’s 
correlation coefficient (r) values ranging from 0.9 to 1.0 (-0.9 to -1.0) were considered a very high 
positive (negative) correlation between the two variables, whereas the Pearson’s correlation 
coefficient (r) values ranging from 0.7 to 0.9 (-0.7 to -0.9) were considered a high positive 





5.3.1 Our hypothesis on mechanisms through which LCA may delay yeast chronological 
aging under CR conditions 
Our recent studies have revealed that LCA not only alters mitochondrial lipidome and 
proteome, enlarges mitochondria, decreases mitochondrial number, modifies mitochondrial cristae 
structure, and changes vital aspects of mitochondrial functionality [14, 59, 64, 70, 107, 145, 221, 
236, 245-248], but also affects some other cellular processes in different cellular locations. 
Specifically, during post-diauxic (PD) and the non-proliferative stationary (ST) phases of culturing 
yeast under CR conditions on 0.2% glucose, LCA also affects the following cellular processes: 1) 
it increases the concentration of triacylglycerols (TAG), so-called ″neutral″ (uncharged) lipids 
initially synthesized in the endoplasmic reticulum (ER) and then deposited in lipid droplets (LD) 




Figure 5.1. The anabolic branch of TAG 
metabolism occurs in the  endoplasmic reticulum 
(ER), whereas the catabolic branch of TAG 
metabolism is confined to lipid droplets (LD) and 
peroxisomes. TAG are ″neutral″ (uncharged) lipids 
initially synthesized in the ER from free fatty acids 
(FFA). FFA can also be formed as the products of TAG 
lipolysis in LD. Moreover, FFA can undergo β- 
oxidation in peroxisomes. Proteins displayed in red 
color: proteins that are eliminated by the single-gene- 
deletion mutations whose effects on yeast 
chronological lifespan, lipid concentrations, percent of 
cells exhibiting propidium iodide positive staining 
characteristic of necrotic cell death and cell viability 
following a short-term treatment with palmitoleic acid 
were studied. See text for more details. Abbreviations: 
Acc1, acetyl-CoA carboxylase 1; Ale1, acyltransferase 
for lysophosphatidylethanolamine 1; App1, actin patch 
protein 1; Are1/2, acyl-coenzyme A: cholesterol acyl 
transferase-related enzymes 1 and 2; Dga1, 
diacylglycerol acyltransferase 1; Dgk1, diacylglycerol 
kinase 1; Dpp1, diacylglycerol pyrophosphate 
phosphatase 1; DHAP, dihydroxyacetone phosphate; 
Faa1/4, fatty acid activation 1 and 2; FA-CoA, fatty 
acyl-CoA ester; Fas1/2, fatty acid synthetases 1 and 2; Fat1, fatty acid transporter 1; Fox1/2/3, fatty acid oxidation 1, 
2 and 3; Gpd1/2, glycerol-3-phosphate dehydrogenases 1 and 2; Gpt2, glycerol-3-phosphate acyltransferase; Gro, 
glycerol; Gro-3-P, glycerol-3-phosphate; Loa1, lysophosphatidic acid: oleoyl-CoA acyltransferase 1; Lpp1, lipid 
phosphate phosphatase 1; LPA, lysophosphatidic acid; MAG, monoacylglycerol; PA, phosphatidic acid; Pah1, 
phosphatidic acid phosphohydrolase 1; Sct1, suppressor of choline-transport mutants 1; Slc1/4, sphingolipid 
compensation 1 and 4; Tgl1/3/4/5, triglyceride lipases 1, 3, 4 and 5. 
 
 
Figure 5.2. As the final product of the β- 
oxidation of free fatty acids (FFA) in peroxisomes, 
acetyl-CoA: 1) is transported to mitochondria via the 
carnitine shuttle; 2) is oxidized in mitochondria 
through the TCA cycle, thus providing reducing 
equivalents NADH and FADH2 for ATP synthesis via 
oxidative phosphorylation (OXPHOS); and 3) is 
transported to mitochondria in the forms of the 
glyoxylate cycle intermediates citrate and succinate 
to replenish the mitochondrial pool of TCA cycle 
intermediates. As the final product of glycolysis, 
pyruvate: 1) is transported to mitochondria via 
mitochondrial pyruvate carrier; and 2) is converted 
to acetyl-CoA, which is oxidized in mitochondria 
through the TCA cycle. Proteins displayed in red color: 
proteins that are eliminated by the single-gene-deletion 
mutations whose effects on yeast chronological lifespan 
were studied. See text for more details. Abbreviations: 
Cat2, carnitine acetyl-CoA transferase; Cit2, citrate 
synthase; Crc1, carnitine transporter; Ctp1, citrate 
transporter; Dic1, dicarboxylate carrier; Mpc1, Mpc2 
and Mpc3, mitochondrial pyruvate carrier1 1, 2 and 3; 








substrates for TAG synthesis in the ER and can also be formed as the products of TAG 
lipolysis in LD; FFA can then undergo β-oxidation in peroxisomes (Figure 5.1); 3) it increases the 
concentrations of the Gpd2, Gpt2, Slc1, Are1 and Dga1 proteins, all of which reside in the ER and 
are involved in the synthesis of TAG from FFA (Figure 5.1); 4) it decreases the concentrations of 
the Tgl1, Tgl3, Tgl4 and Tgl5 proteins, all of which exist in LD and catalyze TAG lipolysis that 
yields FFA (Figure 5.1); 5) it increases the concentrations of Cat2, Crc1, Yat1 and Yat2; these 
proteins are required for the carnitine-dependent transport of acetyl-CoA from peroxisomes (where 
acetyl-CoA is formed as the final product of the β-oxidation of FFA) to mitochondria (Figure 5.2); 
6) it decreases the concentrations of the Cit2, Ctp1 and Dic1 proteins (Cit2 catalyzes a peroxisomal 
anaplerotic reaction transforming acetyl-CoA into citrate; this reaction is followed by the 
conversion of citrate into succinate and then by the Ctp1- and Dic1-dependent delivery of citrate 
and succinate (respectively) to mitochondria) (Figure 5.2); 7) it increases the concentrations of 
Mpc1 and Mpc3, the two protein components of a mitochondrial pyruvate carrier involved in 
pyruvate transport to mitochondria during respiratory growth; it does not, however, alter the 
concentration of the Mpc2 protein component of the mitochondrial pyruvate carrier Mpc1/Mpc2 
that assembles and operates during fermentative growth (Figure 5.2); 8) it increases the percentage 
of cells exhibiting a tubular mitochondrial network and decreases the percentage of cells displaying 
fragmented mitochondria; 9) it lowers cell susceptibility to an apoptotic mode of regulated cell 
death (RCD) caused by an exposure to hydrogen peroxide or acetic acid; and 9) it decreases cell 
susceptibility to liponecrotic RCD triggered by a treatment with FFA [14, 54, 59, 145, 236, 246, 
248]. It remained unclear how LCA regulates the anabolic and catabolic branches of TAG 
metabolism in the ER, LD and peroxisomes (Figure 5.1), and how it regulates other cellular 
processes named in this section. It was also unknown if and how such LCA-dependent regulation 
of some (or all) of these cellular processes contributes to the ability of LCA to delay yeast 
chronological aging. We put forward the hypothesis that LCA may delay chronological aging of 
yeast under CR also because this bile acid affects these other cellular processes confined to 
different cellular locations. To test this hypothesis, we examined mechanisms underlying the 
ability of LCA to regulate the spatiotemporal dynamics of these other cellular processes confined 




there is a causal relationship between such LCA-driven regulation of these other cellular processes 
and the LCA-dependent delay of yeast chronological aging under CR conditions. 
 
5.3.2 LCA increases the abundance of LD in an age-related manner 
We have previously found that, during PD and ST phases of culturing yeast under CR on 
0.2% glucose, LCA rises the abundance of TAG and increases the concentrations of enzymes 
involved in the synthesis of this class of neutral lipids from FFA in the ER [14, 236, 246]. We have 
also noticed that, in these yeast cells, LCA decreases the abundance of FFA and decreases the 
concentrations of enzymes involved in the lipolytic conversion of TAG into FFA in LD [14, 236, 
246]. Based on the above observations, we hypothesized that LCA may have the following effects 
on TAG metabolism and transport in yeast limited in calorie supply: 1) it may accelerate TAG 
synthesis in the ER and, perhaps, the ensuing TAG deposition in LD; and 2) it may decelerate 
TAG lipolysis in LD. This hypothesis posits that LCA may increase the abundance of LD in 
chronologically aging yeast under CR conditions, perhaps during certain stages of the aging 
process (i.e. in an age-related manner). To test this hypothesis, we used live-cell fluorescence 
microscopy with BODIPY 493/503, a stain for neutral lipids, to assess the percentage of cells that 
contain LD in wild-type (WT) strain cultured under CR conditions with or without LCA; the cells 
were recovered on different days (i.e. in different phases) of culturing. We found that LCA has the 
following effects: 1) it increases the percentage of cells with LD in logarithmic (L) phase (Figures 
5.3A and 5.3B), when neutral lipids are known to be synthesized in the ER and deposited in LD 
[23]; and 2) it rises the percentage of cells with LD in PD and ST phases (Figures 5.3A and 5.3B), 
when neutral lipids are known to be lipolytically degraded in LD [23]. 
These findings support our hypothesis on the following effects of LCA in yeast cells of 
WT strain limited in calorie supply: 1) LCA accelerates TAG synthesis in the ER and the 
subsequent TAG deposition in LD; and 2) LCA decelerates TAG lipolysis in LD. The first effect 
of LCA prevails during L phase of culturing under CR conditions, whereas the second effect of 
LCA predominates during PD and ST phases of such culturing. 
 





As we found, LCA accelerates TAG synthesis from FFA during L phase and decelerates 
TAG lipolysis into FFA during PD and ST phases of culturing under CR conditions. We therefore 
hypothesized that LCA may decrease the concentration of FFA through several phases of culturing 
under CR conditions. To test this hypothesis, we used quantitative mass spectrometry to compare 
cellular lipidomes of WT yeast cultured under CR conditions with or without LCA. In support of 
our hypothesis, we found that LCA causes a significant decline in the concentration of FFA in L, 
diauxic (D), PD and the beginning of ST phases (Figure 5.4A). 
 
 
Figure 5.3. Under CR conditions, LCA causes an age-related increase in the percentage of wild-type (WT) cells 
that contain lipid droplets (LD). WT cells were cultured in the nutrient-rich YP medium initially containing 0.2% 
glucose with 50 µM LCA or without it. (A) Cells recovered on different days of culturing were visualized using the 
differential interference contrast (DIC) microscopy and stained with BODIPY 493/503, which was used to detect 
neutral lipids of LD as described in Materials and Methods. (B) Percentage of cells that contain LD. Images like the 
representative images shown in (A) were quantitated. Data are presented as means ± SEM (n = 3; *p < 0.05; **p < 
0.01). Abbreviations: L, D, PD and ST, logarithmic, diauxic, post-diauxic and stationary growth phases (respectively). 
 
 
Furthermore, almost mirroring the effects of LCA on the temporal dynamics of TAG- 




LCA increased TAG concentration in L phase; 2) LCA had no significant effect on TAG 




Figure 5.4. Under CR conditions, LCA exhibits age-related differential effects on the concentrations of several 
classes of cellular lipids in WT yeast. WT cells were cultured in the nutrient-rich YP medium initially containing 
0.2% glucose with 50 µM LCA or without it. Following extraction of lipids from cells recovered on different days of 
culturing, various lipid classes were identified and quantitated by mass spectrometry as described in Materials and 
Methods. Data are presented as means ± SEM (n = 3; *p < 0.05; **p < 0.01; ns, not significant). Abbreviations: CL, 
cardiolipin; FFA, free fatty acids; L, D, PD and ST, logarithmic, diauxic, post-diauxic and stationary growth phases 
(respectively); MLCL, monolysocardiolipin; PA, phosphatidic acid; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; TAG, 




Moreover, as we have described previously [64, 145, 236, 248], because within a yeast cell 
LCA amasses primarily in both mitochondrial membranes and specifically alters phospholipid 
metabolism and transport in these membranes, LCA exhibited the following effects on the cellular 
concentrations of the signature mitochondrial membrane lipids cardiolipin (CL), 
monolysocardiolipin (MLCL) and phosphatidylglycerol (PG): 1) in D and PD phases, LCA 




PG (Figures 2H and 2I, respectively); and 2) in D and PD phases, LCA also increased the 
concentration of PG (Figure 5.4G). 
Unlike the ability of LCA to alter the cellular concentrations of FFA, TAG, CL, MLCL 
and PG, this bile acid had no significant effect on the concentrations of the following 
phospholipids: phosphatidic acid (PA), phosphatidylserine (PS), phosphatidylethanolamine (PE), 
phosphatidylcholine (PC) and phosphatidylinositol (PI) (Figures 5.4B, 5.4C, 5.4D, 5.4E and 5.4F, 
respectively). 
In sum, these findings further support our hypothesis on the mechanism through which 
LCA regulates the anabolic branch of TAG metabolism in the ER and the catabolic branch of TAG 
metabolism in LD. In this mechanism: 1) by accelerating TAG synthesis from FFA within the ER 
and the subsequent TAG deposition within LD during L and, likely, D phases of culturing under 
CR conditions, LCA decreases the concentration of FFA during these two phases; and 2) by 
decelerating TAG lipolysis into FFA within LD during PD and ST phases of culturing under CR 
conditions, LCA decreases the concentration of FFA during these two phases (Figure 5.5). 
Figure 5.5. Mechanism 
through which LCA regulates the 
anabolic branch of triacylglycerol 
(TAG) metabolism in the endoplasmic 
reticulum (ER) and the catabolic 
branch of TAG metabolism in lipid 
droplets (LD). (A) Relative rates of 
reactions and relative concentrations of 
metabolites in the anabolic branch of TAG 
metabolism in the ER and the catabolic 
branch of TAG metabolism in LD in yeast 
cells cultured under CR conditions 
without LCA. (B) During logarithmic (L) 
and diauxic (D) phases of culturing under 
CR conditions with LCA, this bile acid 
accelerates TAG synthesis from free fatty 
acids (FFA) within the ER and the 
subsequent TAG deposition within LD, 
thereby decreasing the concentration of 
FFA during these phases. (C) During 
post-diauxic (PD) and stationary (ST) 
phases of culturing under CR conditions 
with LCA, this bile acid decelerates TAG 
lipolysis into FFA within LD, thus 
decreasing the concentration of  FFA 
during PD and ST phases. The thickness 
of black arrows is proportional to the rates of the corresponding metabolic reactions. Arrows next to the names of lipid 
classes denote those of them whose concentrations are increased (red arrows) or decreased (blue arrows) in yeast 
cultured under CR conditions with LCA. Abbreviations: Are1/2, acyl-coenzyme A: cholesterol acyl transferase-related 
enzymes 1 and 2; Dga1, diacylglycerol acyltransferase 1; FA-CoA, fatty acyl-CoA ester; Gro, glycerol; MAG, 




5.3.4 The efficiency of longevity extension by LCA inversely correlates with the 
intracellular concentration of FFA 
Because LCA causes a significant decline in the concentration of FFA during several 
consecutive phases of culturing under CR conditions, we sought to determine if the extent of such 
decline correlates with the efficiency of longevity extension by LCA under these conditions. 
We first assessed how a single-gene-deletion mutation eliminating the Dga1, Are1 or Are2 
protein, each catalyzing the synthesis of TAG from FFA in the ER (Figure 5.5), influences the 
efficiency of yeast chronological lifespan (CLS) extension by LCA and how it affects the cellular 
concentration of FFA under CR conditions. We found that the dga1, are1 and are2 mutations 
exhibit the following effects: 1) each of them significantly decreases the extent to which LCA can 
extend both the mean and maximum CLS (Figures 5.6A-5.6D for dga1, Figures 5.6F-5.6I for 
are1 and Figures 5.6K-5.6N for are2); and 2) each of them significantly increases the cellular 
concentration of FFA (Figures 5.6E, 5.6J and 5.6O for dga1, are1 and are2 [respectively]). 
Figure  5.6. 
Under CR 
conditions in the 
presence of LCA, 
lack of any of the 
three enzymes 
involved in the 
synthesis of TAG 
from FFA increases 
the concentration of 
FFA and decreases 
the extent to which 
LCA can extend 
yeast chronological 
lifespan (CLS). WT 
cells and mutant cells 
carrying    a    single- 
gene-deletion 
mutation eliminating 
either the Dga1, Are1 
or Are2 protein were 
cultured      in      the 
nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it. (A, F, K) Survival curves 
of the chronologically aging WT and dga1 (A), WT and are1 (F) or WT and are2 (K) strains are shown. Data are 
presented as means ± SEM (n = 3). Data for the WT strain cultured with or without LCA are replicated in graphs A, 
F, K of this Figure. (B, G, L) p Values for different pairs of survival curves of the WT and dga1 (B), WT and are1 
(G) or WT and are2 (L) strains cultured with or without LCA. Survival curves shown in (A, F or K, respectively) 
were compared. Two survival curves were considered statistically different if the p value was less than 0.05. The p 
values for comparing pairs of survival curves using the logrank test were calculated as described in Materials and 
Methods. The p values displayed on a yellow color background indicate that LCA extends the CLS of the WT, dga1 
(B), are1 (G) and are2 (L) strains. The p values displayed on a blue color background indicate that LCA extends 




M, N) Survival curves shown in (A, F, K) were used to calculate the fold of increase of the mean (C, H, M) and 
maximum (D, I, N) CLS by LCA for the WT and dga1 (C, D), WT and are1 (H, I) or WT and are2 (M, N) 
strains. Data are presented as means ± SEM (n = 3; *p < 0.05). (E, J, O) The maximum concentration of FFA, which 
was observed in WT and dga1 (E), WT and are1 (J) or WT and are2 (O) cells recovered on day 2 of culturing 
with LCA, is shown. Data are presented as means ± SEM (n = 3; *p < 0.05; **p < 0.01). Abbreviations: FFA, free 
fatty acids; L, D, PD and ST, logarithmic, diauxic, post-diauxic and stationary growth phases (respectively). These 
experiments were performed by Alexander Goldberg, Pavlo Kyryakov, Alejandra Gomez-Perez and Olivia Koupaki. 
 
 
Using these data, we compared the fold increase of mean or maximum CLS and the 
maximum intracellular concentration of FFA (which was observed in WT, dga1, are1 and 
are2 cells recovered on day 2 of culturing with LCA under CR conditions). We found that the 
Pearson’s correlation coefficient (r) values for the correlation between these two compared 
variables are less than -0.8 for both possible pairwise combinations of the mean or maximum CLS 
and the maximum intracellular concentration of FFA (Figure 5.7). Because the Pearson’s r value 
ranging from -0.7 to -0.9 is considered a high negative correlation between the two variables [244], 
we concluded that the fold increase of mean or maximum CLS has a high negative correlation with 
the intracellular concentration of FFA. Thus, the efficiency of longevity extension by LCA 
inversely correlates with the intracellular concentration of FFA. 
Figure 5.7. Under CR conditions  in the 
presence of LCA, lack of any of the three enzymes 
involved in the synthesis of TAG from FFA 
decreases the extent to which LCA can extend yeast 
CLS proportionally to the cellular concentration of 
FFA. WT cells and mutant cells carrying a single- 
gene-deletion mutation eliminating either Dga1, Are1 
or Are2 were cultured in the nutrient-rich YP medium 
initially containing 0.2% glucose with 50 µM LCA. 
Survival curves shown in Figures 3A, 3F and 3K were 
used to calculate the folds of increase of the mean and 
maximum CLS by LCA for the WT and dga1, are1 
or are2 strains. (A, B) Plots comparing the folds 
increase of mean (A) or maximum (B) CLS and the 
maximum intracellular concentration of FFA (which 
was observed in WT and mutant cells recovered on day 
2 of culturing with LCA). Different points show the 
data for WT, dga1, are1 or are2 cells. Linear trendlines and the R-squared values are displayed; these values 
demonstrate a good fit of the line to the data. The Pearson’s correlation coefficient (r) values are also shown; because 
the r value ranging from -0.7 to -0.9 is considered a high negative correlation between the two variables, the fold 
increase of the mean (A) or maximum (B) CLS has a high negative correlation with the intracellular concentration of 
FFA. (C) The experimental data used to create plots shown in (A and B). Genetic backgrounds of strains, the folds of 
increase of the mean and maximum CLS by LCA, and the maximum concentration of FFA (which was observed in 
WT and mutant cells recovered on day 2 of culturing with LCA) are shown. Data are presented as means ± SEM (n = 
3). Abbreviation: FFA, free fatty acids. These experiments were performed by Simon Bourque, Vincent Richard, 




We then investigated how a single-gene-deletion mutation eliminating the Tgl1, Tgl3, Tgl4 
or Tgl5 protein, each catalyzing TAG lipolysis that yields FFA in LD (Figure 5.5), affects the 
efficiency of yeast CLS extension by LCA and how it influences the cellular concentration of FFA 
under CR conditions. We found that the tgl1, tgl3, tgl4 and tgl5 mutations have the following 
effects: 1) each of them significantly increases the extent to which LCA can prolong both the mean 
and maximum CLS (Figures 5.8A-5.8D for tgl1, Figures 5.8F-5.8I for tgl3, Figures 5.9A-5.9D 
for tgl4 and Figures 5.9F-5.9I for tgl5); and 2) each of them significantly decreases the cellular 
concentration of FFA (Figures 5.8E, 5.8J, 5.9E and 5.9J for tgl1, tgl3, tgl4 and tgl5 
[respectively]). We used these data to compare the fold increase of mean or maximum CLS and 
the maximum intracellular concentration of FFA (which was observed in WT, tgl1, tgl3, tgl4 
and tgl5 cells recovered on day 2 of culturing with LCA under CR conditions). The Pearson’s r 
values for the correlation between these two variables were less than -0.9 for both possible pairwise 
combinations (Figure 5.10). Hence, the fold increase of mean or maximum CLS has a very high 
negative correlation with the intracellular concentration of FFA. These results confirm our 
assumption that the efficiency of longevity extension by LCA inversely correlates with the 
intracellular concentration of FFA. 
Figure 5.8. Under CR conditions in the 
presence of LCA, lack of the Tgl1 or Tgl3 enzymes 
involved in the TAG lipolysis that yields FFA decreases 
the concentration of FFA and increases the extent to 
which LCA can extend yeast CLS. WT cells and mutant 
cells carrying a single-gene-deletion mutation eliminating 
either the Tgl1 or Tgl3 protein were cultured in the nutrient- 
rich YP medium initially containing 0.2% glucose with 50 
µM LCA or without it. (A, F) Survival curves of the 
chronologically aging WT and tgl1 (A) or WT and tgl3 
(F) strains are shown. Data are presented as means ± SEM 
(n = 3). Data for the WT strain cultured with or without 
LCA are replicated in graphs A, F of this Figure and in 
graphs A, F of Figure 5. (B, G) p Values for different pairs 
of survival curves of the WT and tgl1 (B) or WT and tgl3 
(G) strains cultured with or without LCA. Survival curves 
shown in A or F (respectively) were compared. Two 
survival curves were considered statistically different if the 
p value was less than 0.05. The p values for comparing pairs 
of survival curves using the logrank test were calculated as 
described in Materials and Methods. The p values displayed on a yellow color background indicate that LCA extends 
the CLS of the WT (B and G), tgl1 (B) and tgl3 (G) strains. The p values displayed on a blue color background 
indicate that LCA extends the CLS of the tgl1 (B) and tgl3 (G) strains to a higher extent that that of the WT strain. 
(C, D, H, I) Survival curves shown in (A, F) were used to calculate the fold of increase of the mean (C, H) and 
maximum (D, I) CLS by LCA for the WT and tgl1 (C, D) or WT and tgl3 (H, I) strains. Data are presented as 




and tgl1 (E) or WT and tgl3 (J) cells recovered on day 2 of culturing with LCA, is shown. Data are presented as 
means ± SEM (n = 3; *p < 0.05). Abbreviations: FFA, free fatty acids; L, D, PD and ST, logarithmic, diauxic, post- 
diauxic and stationary growth phases (respectively). These experiments were performed by Alexander Goldberg, 
Pavlo Kyryakov, Alejandra Gomez-Perez and Olivia Koupaki. 
 
Figure 5.9. Under CR conditions in the 
presence of LCA, lack of the Tgl4 or Tgl5 enzymes 
involved in the TAG lipolysis that yields FFA decreases 
the concentration of FFA and increases the extent to 
which LCA can extend yeast CLS. WT cells and mutant 
cells carrying a single-gene-deletion mutation eliminating 
either the Tgl4 or Tgl5 protein were cultured in the nutrient- 
rich YP medium initially containing 0.2% glucose with 50 
µM LCA or without it. (A, F) Survival curves of the 
chronologically aging WT and tgl4 (A) or WT and tgl5 
(F) strains are shown. Data are presented as means ± SEM 
(n = 3). Data for the WT strain cultured with or without 
LCA are replicated in graphs A, F of this Figure and in 
graphs A, F of Figure 4. (B, G) p Values for different pairs 
of survival curves of the WT and tgl4 (B) or WT and tgl5 
(G) strains cultured with or without LCA. Survival curves 
shown in A or F (respectively) were compared. Two 
survival curves were considered statistically different if the 
p value was less than 0.05. The p values for comparing pairs 
of survival curves using the logrank test were calculated as 
described in Materials and Methods. The p values displayed on a yellow color background indicate that LCA extends 
the CLS of the WT (B and G), tgl4 (B) and tgl5 (G) strains. The p values displayed on a blue color background 
indicate that LCA extends the CLS of tgl4 (B) and tgl5 (G) strains to a higher extent that that of the WT strain. (C, 
D, H, I) Survival curves shown in (A, F) were used to calculate the fold of increase of the mean (C, H) and maximum 
(D, I) CLS by LCA for the WT and tgl4 (C, D) or WT and tgl5 (H, I) strains. Data are presented as means ± SEM 
(n = 3; *p < 0.05; **p < 0.01). (E, J) The maximum concentration of FFA, which was observed in WT and tgl4 (E) 
or WT and tgl5 (J) cells recovered on day 2 of culturing with LCA, is shown. Data are presented as means ± SEM 
(n = 3; *p < 0.05; **p <0.01). Abbreviations: FFA, free fatty acids; L, D, PD and ST, logarithmic, diauxic, post- 
diauxic and stationary growth phases (respectively). These experiments were performed by Alexander Goldberg, 
Pavlo Kyryakov, Alejandra Gomez-Perez and Olivia Koupaki. 
 
Figure 5.10 Under CR conditions in the presence 
of LCA, lack of any of the four enzymes involved in the 
TAG lipolysis that yields FFA increases the extent to 
which LCA can extend yeast CLS proportionally to the 
cellular concentration of FFA. WT cells and mutant cells 
carrying a single-gene-deletion mutation eliminating either 
Tgl1, Tgl3, Tgl4 or Tgl5 were cultured in the nutrient-rich 
YP medium initially containing 0.2% glucose with 50 µM 
LCA. Survival curves shown in Figures 4A, 4F, 5A and 5F 
were used to calculate the folds of increase of the mean and 
maximum CLS by LCA for the WT, tgl1, tgl3, tgl4 and 
tgl5 strains. (A, B) Plots comparing the folds increase of 
mean (A) or maximum (B) CLS and the maximum 
intracellular concentration of FFA (which was observed in 
WT and mutant cells recovered on day 2 of culturing with 
LCA). Different points show the data for WT, tgl1, tgl3, 
tgl4 or tgl5 cells. Linear trendlines and the R-squared 
values are displayed; these values demonstrate a good fit of the line to the data. The Pearson’s correlation coefficient 




between the two variables, the fold increase of the mean (A) or maximum (B) CLS has a high negative correlation 
with the intracellular concentration of FFA. (C) The experimental data used to create plots shown in (A and B). Genetic 
backgrounds of strains, the folds of increase of the mean and maximum CLS by LCA, and the maximum concentration 
of FFA (which was observed in WT and mutant cells recovered on day 2 of culturing with LCA) are shown. Data are 
presented as means ± SEM (n = 3). Abbreviation: FFA, free fatty acids. These experiments were performed by Simon 
Bourque, Vincent Richard, Karamat Mohammad and me. 
 
 
In sum, the above findings indicate that LCA delays yeast chronological aging in part 
because it decreases the intracellular concentration of FFA. 
 
5.3.5 LCA delays the age-related onset and decelerates progression of liponecrosis and 
decreases cell susceptibility to this form of RCD in an age-dependent manner 
Our recent study has revealed that CR extends yeast CLS in part because this low-calorie 
diet allows cells to maintain a low concentration of FFA during PD and ST phases, thereby 
postponing the onset of the liponecrotic mode of RCD [249]. The present study indicates that in 
yeast cultured under CR conditions, LCA causes further decline in the concentration of FFA in L, 
D, PD and the beginning of ST phases (Figure 5.4A). We therefore sought to determine if LCA 
may further postpone the age-related onset of liponecrotic RCD in chronologically aging yeast 
under CR conditions. 
We first used live-cell fluorescence microscopy with propidium iodide (PI), a stain for 
visualizing the loss of plasma membrane (PM) integrity (a hallmark event of necrosis), to monitor 
how LCA influences age-related changes in the percentage of calorically restricted WT cells 
exhibiting PI positive staining; this staining is characteristic of necrotic cell death. We found that 
in WT cells LCA delays the onset of necrosis in the end of PD phase and slows down the 
progression of this cell death mode during ST phase of culturing under CR conditions (Figures 
5.11A and 5.11B). 
We then examined if LCA influences the susceptibility of calorically restricted WT cells 
to liponecrotic RCD; this mode of age-related RCD can be triggered by a short-term treatment of 
yeast with FFA [14, 103, 185, 186, 238]. We found that in WT yeast cultured under CR conditions, 
LCA significantly increases clonogenic survival of cells briefly (for 2 h) treated with palmitoleic 
acid (POA; a monounsaturated form of FFA) if these cells were recovered during PD or ST phase 
of culturing (Figure 5.11C). 
These findings indicate that in WT yeast limited in calorie supply, LCA postpones the age- 






Figure 5.11. Under CR conditions, LCA postpones the age-related onset of necrotic cell death and 
decreases cell susceptibility to a liponecrotic mode of regulated cell death (RCD). WT cells were cultured in the 
nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it. (A) Cells recovered on 
different days of culturing were visualized using the DIC microscopy and stained with propidium iodide (PI) for 
visualizing the loss of plasma membrane integrity (a hallmark event of necrosis) as described in Materials and 
Methods. (B) Percentage of cells exhibiting PI positive staining characteristic of necrotic cell death. Images like the 
representative images shown in (A) were quantitated. Data are presented as means ± SEM (n = 3; *p < 0.05; **p < 
0.01). Data for the WT strain cultured with LCA are replicated in graph A of Figure 7. (C) Clonogenic survival of 
cells recovered on different days of culturing and then treated for 2 h with 0.15 mM palmitoleic acid (POA, a 
monounsaturated form of FFA) to elicit a liponecrotic mode of RCD as described in Materials and Methods. Data are 
presented as means ± SEM (n = 3; *p < 0.05; **p < 0.01). Data for the WT strain cultured with LCA are replicated in 




to this mode of RCD in an age-dependent manner. It is conceivable that LCA may extend longevity 
of chronologically aging WT cells under CR conditions in part by decreasing the risk of 
liponecrotic RCD during PD and ST phases and actively increasing the chance of cell survival 
during these phases. 
 
5.3.6 The efficiency with which LCA decreases the risk of age-related liponecrotic RCD 




Since LCA elicits a substantial reduction in the concentration of FFA in yeast cultured 
under CR conditions, we assessed if the extent of such reduction correlates with the efficiencies of 
the following LCA-dependent processes: 1) the delay of the age-related onset of liponecrotic RCD; 
2) the deceleration of progression of liponecrotic RCD; and 3) the decrease in cell susceptibility 
to liponecrotic RCD. 
We initially tested how a single-gene-deletion mutation eliminating the Dga1, Are1 or Are2 
protein, each catalyzing the synthesis of TAG from FFA in the ER (Figure 5.5), influences age- 
related changes in the following traits of yeast cells limited in calorie supply: 1) the percentage of 
cells that display PI positive staining characteristic of necrotic cell death; 2) the susceptibility of 
cells to liponecrotic RCD caused by a brief (for 2 h) treatment of these cells with POA; and 3) the 
intracellular concentration of FFA. We found that the dga1, are1 and are2 mutations have the 
following effects: 1) since the middle of PD phase of cell culturing, each of them significantly 
increases the percentage of cells exhibiting PI positive staining typical of necrotic cell death 
(Figure 5.12A); 2) since the middle of PD phase of cell culturing, each of them significantly 
increases cell susceptibility to liponecrotic RCD caused by a 2-h treatment with POA (Figure 
5.12D); 3) each of them significantly increases the cellular concentration of FFA (Figures 5.6E, 
5.6J and 5.6O for dga1, are1 and are2 [respectively]). We used these data to compare the 
maximum intracellular concentration of FFA (which was observed in WT, dga1, are1 and 
are2 cells recovered on day 2 of culturing with LCA under CR conditions) as one variable and 
each of the following two variables: 1) the maximum percentages of cells exhibiting PI positive 
staining (which were observed in WT and mutant cells recovered on day 21, the last day of 
culturing with LCA); or 2) the minimum percentages of clonogenic survival of POA-treated cells 
(which were observed in WT and mutant cells recovered on day 10, the last day of cell recovery 
from the culture for the treatment with POA). The Pearson’s r value for the correlation between 
the maximum intracellular concentration of FFA and the maximum percentage of cells exhibiting 
PI positive staining was more than 0.8 (Figure 5.12B). Thus, the maximum percentage of cells 
exhibiting PI positive staining has a high positive correlation with the intracellular concentration 
of FFA. The Pearson’s r value for the correlation between the maximum intracellular concentration 
of FFA and the minimum percentage of clonogenic survival of POA-treated cells was less than - 
0.8 (Figure 5.12E). Hence, the minimum percentage of clonogenic survival of POA-treated cells 




concluded that there is an inverse relationship between the extent of the LCA-dependent decline 
in the concentration of FFA and the efficiencies of the following LCA-dependent processes: 1) the 
delay of the age-related onset of liponecrotic RCD; 2) the deceleration of progression of 
liponecrotic RCD; and 3) the decrease in cell susceptibility to liponecrotic RCD. 
 
 
Figure 5.12. Under CR conditions in the presence of LCA, lack of any of the three enzymes involved 
in the synthesis of TAG from FFA accelerates the age-related onset of necrotic cell death and increases cell 
susceptibility to liponecrotic RCD proportionally to the cellular concentration of FFA. WT cells and mutant cells 
carrying a single-gene-deletion mutation eliminating either the Dga1, Are1 or Are2 protein were cultured in the 
nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA. (A) Cells recovered on different days 
of culturing were visualized using the DIC microscopy and stained with PI for visualizing the loss of plasma membrane 
integrity (a hallmark event of necrosis) as described in Materials and Methods. Percentage of cells exhibiting PI 
positive staining characteristic of necrotic cell death is shown. Data are presented as means ± SEM (n = 3; *p < 0.05; 
**p < 0.01). Data for the WT strain cultured with LCA are replicated in graph B of Figure 6. (B) Plot comparing the 
maximum percentage of cells exhibiting PI positive staining (which was observed in WT and mutant cells recovered 
on day 21, the last day of culturing with LCA) and the maximum concentration of FFA (which was observed in WT 
and mutant cells recovered on day 2 of culturing with LCA). Different points show the data for WT, dga1, are1 or 
are2 cells. Linear trendline and the R-squared value are displayed; the R-squared value demonstrates a good fit of 
the line to the data. The Pearson’s correlation coefficient (r) value is also shown; because the r value ranging from 0.7 
to 0.9 is considered a high positive correlation between the two variables, the percentage of cells exhibiting PI positive 




create the plot shown in (B). Genetic backgrounds of strains, the percentage of cells exhibiting PI positive staining on 
day 21 (the last day) of culturing with LCA and the maximum concentration of FFA, which was observed in WT and 
mutant cells recovered on day 2 of culturing with LCA, are shown. Data are presented as means ± SEM (n = 3). (D) 
Clonogenic survival of cells recovered on different days of culturing and then treated for 2 h with 0.15 mM POA (a 
monounsaturated form of FFA) to elicit a liponecrotic mode of RCD as described in Materials and Methods. Data are 
presented as means ± SEM (n = 3; *p < 0.05; **p < 0.01). Data for the WT strain cultured with LCA are replicated in 
graph C of Figure 6. (E) Plot comparing the minimum percentage of clonogenic survival of POA-treated cells (which 
was observed in WT and mutant cells recovered on day 10, the last day of cell recovery from the culture for the 
treatment with POA) and the maximum concentration of FFA (which was observed in WT and mutant cells recovered 
on day 2 of culturing with LCA). Different points show the data for WT, dga1, are1 or are2 cells. Linear trendline 
and the R-squared value are displayed; the R-squared value demonstrates a good fit of the line to the data. The 
Pearson’s correlation coefficient (r) value is also shown; because the r value ranging from -0.7 to -0.9 is considered a 
high negative correlation between the two variables, the percentage of clonogenic survival of POA-treated cells has a 
high negative correlation with the intracellular concentration of FFA. (F) The experimental data used to create the plot 
shown in (E). Genetic backgrounds of strains, the percentage of clonogenic survival of POA-treated cells on day 10 
(the last day of cell recovery from the culture for the treatment with POA) and the maximum concentration of FFA, 
which was observed in WT and mutant cells recovered on day 2 of culturing with LCA, are shown. Data are presented 
as means ± SEM (n = 3). Abbreviations: FFA, free fatty acids; L, D, PD and ST, logarithmic, diauxic, post-diauxic 
and stationary growth phases (respectively); PI, propidium iodide. 
 
 
We then investigated how a single-gene-deletion mutation eliminating the Tgl1, Tgl3, Tgl4 
or Tgl5 protein, each catalyzing TAG lipolysis that yields FFA in LD (Figure 5.5), affects age- 
related changes in the above traits of liponecrotic RCD and how it influences the cellular 
concentration of FFA under CR conditions. We found that the tgl1, tgl3, tgl4 and tgl5 
mutations exhibit the following effects: 1) since the beginning of ST phase of cell culturing, each 
of them significantly decreases the the percentage of cells exhibiting PI positive staining 
characteristic of necrotic cell death (Figure 5.13A); 2) since the end of PD phase of cell culturing, 
each of them significantly decreases cell susceptibility to liponecrotic RCD elicited in response to 
a 2-h treatment with POA (Figure 5.13D); 3) each of them significantly decreases the cellular 
concentration of FFA (Figures 5.8E, 5.8J, 5.9E and 5.9J for tgl1, tgl3, tgl4 and tgl5 
[respectively]). Using these data, we compared the maximum intracellular concentration of FFA 
(which was observed in WT, tgl1, tgl3, tgl4 and tgl5 cells recovered on day 2 of culturing 
with LCA under CR conditions) as one variable and each of the above traits of liponecrotic RCD 
as another variable. The Pearson’s r value for the correlation between the maximum intracellular 
concentration of FFA and the maximum percentage of cells exhibiting PI positive staining was 
more than 0.9 (Figure 5.13B). Hence, the maximum percentage of cells exhibiting PI positive 
staining has a very high positive correlation with the intracellular concentration of FFA. The 
Pearson’s r value for the correlation between the maximum intracellular concentration of FFA and 




5.13E). Thus, the minimum percentage of clonogenic survival of POA-treated cells has a very high 
negative correlation with the intracellular concentration of FFA. These results confirm our 
assumption that the extent of the LCA-dependent decline in the concentration of FFA is in an 
inverse relationship with the LCA-dependent postponement of the age-related onset of liponecrotic 
RCD, the LCA-dependent slowing of progression of liponecrotic RCD and the LCA-dependent 
decline in cell susceptibility to liponecrotic RCD. 
 
Figure 5.13. Under CR conditions in the presence of LCA, lack of any of the four enzymes involved in 
the TAG lipolysis that yields FFA decelerates the age-related onset of necrotic cell death and decreases cell 
susceptibility to liponecrotic RCD proportionally to the cellular concentration of FFA. WT cells and mutant cells 
carrying a single-gene-deletion mutation eliminating either the Tgl1, Tgl3, Tgl4 or Tgl5 protein were cultured in the 
nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA. (A) Cells recovered on different days 
of culturing were visualized using the DIC microscopy and stained with PI for visualizing the loss of plasma membrane 
integrity (a hallmark event of necrosis) as described in Materials and Methods. Percent of cells exhibiting PI positive 
staining characteristic of necrotic cell death is shown. Data are presented as means ± SEM (n = 3; *p < 0.05; **p < 
0.01). (B) Plot comparing the maximum percentage of cells exhibiting PI positive staining (which was observed in 
WT and mutant cells recovered on day 40, the last day of culturing with LCA) and the maximum concentration of 




the data for WT, tgl1, tgl3, tgl4 or tgl5 cells. Linear trendline and the R-squared value are displayed; the R- 
squared value demonstrates a good fit of the line to the data. The Pearson’s correlation coefficient (r) value is also 
shown; because the r value ranging from 0.9 to 1.0 is considered a very high positive correlation between the two 
variables, the percentage of cells exhibiting PI positive staining has a very high positive correlation with the 
intracellular concentration of FFA. (C) The experimental data used to create the plot shown in (B). Genetic 
backgrounds of strains, the percentage of cells exhibiting PI positive staining on day 40 (the last day) of culturing with 
LCA and the maximum concentration of FFA, which was observed in WT and mutant cells recovered on day 2 of 
culturing with LCA, are shown. Data are presented as means ± SEM (n = 3). (D) Clonogenic survival of cells recovered 
on different days of culturing and then treated for 2 h with 0.15 mM POA (a monounsaturated form of FFA) to elicit 
a liponecrotic mode of RCD as described in Materials and Methods. Data are presented as means ± SEM (n = 3; *p < 
0.05; **p < 0.01). (E) Plot comparing the minimum percentage of clonogenic survival of POA-treated cells (which 
was observed in WT and mutant cells recovered on day 14, the last day of POA treatment) and the maximum 
concentration of FFA (which were observed in WT and mutant cells recovered on day 2 of culturing with LCA). 
Different points show the data for WT, tgl1, tgl3, tgl4 or tgl5 cells. Linear trendline and the R-squared value are 
displayed; the R-squared value demonstrates a good fit of the line to the data. The Pearson’s correlation coefficient 
(r) value is also shown; because the r value ranging from -0.9 to -1.0 is considered a very high negative correlation 
between the two variables, the percentage of clonogenic survival of POA-treated cells has a very high negative 
correlation with the intracellular concentration of FFA. (F) The experimental data used to create the plot shown in 
(E). Genetic backgrounds of strains, the percentage of clonogenic survival of POA-treated cells on day 14 (the last 
day of POA treatment) and the maximum concentration of FFA, which was observed in WT and mutant cells recovered 
on day 2 of culturing with LCA, are shown. Data are presented as means ± SEM (n = 3). Abbreviations: FFA, free 




It needs to be noted that the age-related onset of liponecrotic RCD and the rate of its 
progression in the above experiments were monitored in the absence of endogenous POA (a 
monounsaturated form of FFA), whereas cell susceptibility to liponecrotic RCD in these 
experiments was measured in yeast exposed to exogenous POA. Our previous studies have 
revealed that the buildup of POA-containing phospholipids in the PM and the excessive 
accumulation of POA-containing phospholipids in both mitochondrial membranes are direct pro- 
death processes in yeast treated with POA, whereas the assimilation of POA into TAG in the ER 
and the ensuing buildup of POA-containing TAG in LD are direct pro-survival processes in this 
yeast [103, 197, 198, 250]. We have also previously demonstrated that the dga1 and are2 
mutations, both of which decelerate the synthesis of TAG from FFA in the ER (Figure 5.5) and 
decrease the incorporation of POA into TAG, increase cell susceptibility to liponecrotic RCD [103, 
197]. These previous findings indicate the following: 1) an increase in the intracellular 
concentration of POA (a 16-carbon monounsaturated form of FFA) and the subsequent 
incorporation of POA into phospholipids increase the risk of liponecrotic RCD; and 2) a decrease 
in the intracellular concentration of POA caused by the assimilation of this form of FFA into TAG 




Altogether, the above findings and our previously published data [103, 197, 198, 250] 
indicate that the efficiency of decreasing the risk of age-related liponecrotic RCD by LCA 
inversely correlates with the intracellular concentration of FFA. Thus, in support of our hypothesis 
proposed at the end of the previous section, LCA delays yeast chronological aging under CR 
conditions in part by decreasing the risk of liponecrotic RCD during PD and ST phases and actively 
increasing the chance of cell survival during these phases. 
 
5.3.7 The peroxisome-to-mitochondrion transport of acetyl-CoA via the carnitine shuttle is 
essential for the delay of yeast chronological aging by LCA 
We have previously noticed that, during PD and ST phases of culturing yeast under CR on 
0.2% glucose, LCA increases the concentrations of Cat2, Crc1, Yat1 and Yat2 [14, 236, 246]. All 
these proteins are known to be required for the carnitine-dependent transport of acetyl-CoA from 
peroxisomes (where acetyl-CoA is made as the final product of the β-oxidation of FFA) to 
mitochondria [251, 252] (Figure 5.2). We hypothesized that such peroxisome-to-mitochondrion 
transport of acetyl-CoA via the carnitine shuttle may contribute to the ability of LCA to postpone 
chronological aging of yeast limited in calorie supply. To test this hypothesis, we investigated how 
a single-gene-deletion mutation eliminating the Cat2, Crc1, Yat1 or Yat2 protein influences the 
efficiency of yeast CLS extension by LCA under CR conditions. We found that each of these 
mutations significantly decreases the extent to which LCA can prolong both the mean and 
maximum CLS (Figures 5.14A, 5.14E, 5.14I and 5.14J for cat2; Figures 5.14B, 5.14F, 5.14I and 
5.14J for crc1; Figures 5.14C, 5.14G, 5.14I and 5.14J for yat1; and Figures 5.14D, 5.14H, 5.14I 
and 5.14J for yat2). We therefore concluded that the carnitine-dependent transport of acetyl-CoA 
from peroxisomes to mitochondria makes an essential contribution to the LCA-dependent delay of 
yeast chronological aging under CR conditions. 
 
5.3.8 The peroxisome-to-mitochondrion transport of acetyl-CoA in the forms of the 
glyoxylate cycle intermediates citrate and succinate is dispensable for the delay of yeast 
chronological aging by LCA 
Our previous studies have revealed that, during PD and ST phases of culturing yeast under 
CR on 0.2% glucose, LCA decreases the concentrations of the Cit2, Ctp1 and Dic1 proteins [14, 




conversion of acetyl-CoA into citrate [253] (Figure 5.2). Ctp1 has been implicated in the delivery 
of this peroxisomally produced citrate to mitochondria, whereas Dic1 has been shown to be a 
mitochondrial transporter for another intermediate of the glyoxylate cycle, succinate [254]; both 




Figure 5.14. Under CR conditions in the presence of LCA, lack of any of the four proteins required for 
the transport of acetyl-CoA from peroxisomes to mitochondria via the carnitine shuttle decreases the efficiency 
of yeast CLS extension by LCA. WT cells and mutant cells carrying a single-gene-deletion mutation eliminating 
either the Cat2, Crc1, Yat1 or Yat2 protein were cultured in the nutrient-rich YP medium initially containing 0.2% 
glucose with 50 µM LCA or without it. (A, B, C, D) Survival curves of the chronologically aging WT and cat2 (A), 
WT and crc1 (B), WT and yat1 (C) or WT and yat2 (D) strains are shown. Data are presented as means ± SEM 
(n = 3). Data for the WT strain cultured with or without LCA are replicated in graphs A, B, C, D of this Figure. (E, F, 
G, H) p Values for different pairs of survival curves of the WT and cat2 (E), WT and crc1 (F), WT and yat1 (G) 
or WT and yat2 (H) strains cultured with or without LCA. Survival curves shown in (A, B, C or D, respectively) 
were compared. Two survival curves were considered statistically different if the p value was less than 0.05. The p 
values for comparing pairs of survival curves using the logrank test were calculated as described in Materials and 
Methods. The p values displayed on a yellow color background indicate that LCA extends the CLS of the WT, cat2 
(E), crc1 (F), yat1 (G) and yat2 (H) strains. The p values displayed on a blue color background indicate that LCA 
extends the CLS of the cat2 (E), crc1 (F), yat1 (G) and yat2 (H) strains to a lower extent than that of the WT 
strain. (I, J) Survival curves shown in (A, B, C, D) were used to calculate the fold of increase of the mean (I) and 
maximum (J) CLS by LCA for the WT, cat2, crc1, yat1 and yat2 strains. Data are presented as means ± SEM 




growth phases (respectively). These experiments were performed by Alexander Goldberg, Pavlo Kyryakov, Alejandra 
Gomez-Perez and Olivia Koupaki. 
 
 
We sought to determine whether the transport of acetyl-CoA from peroxisomes to 
mitochondria in the forms of citrate and succinate plays a role in the LCA-dependent delay of yeast 
chronological aging under CR conditions. We therefore assessed how a single-gene-deletion 
mutation eliminating the Cit2, Ctp1 or Dic1 protein affects the extent to which LCA can increase 
yeast CLS under CR conditions. We found that none of these mutations has a significant effect on 
the efficiency with which LCA can extend CLS under CR conditions (Figures 5.15A, 5.15D, 5.15G 
and 5.15H for cit2; Figures 5.15B, 5.15E, 5.15G and 5.15H for ctp1; and Figures 5.15C, 5.15F, 
5.15G and 5.15H for dic1). Hence, in  yeast limited in calorie supply, the peroxisome-to- 
mitochondrion transport of acetyl-CoA in the forms of the glyoxylate cycle intermediates citrate 
and succinate does not make an essential contribution to the delay of yeast chronological aging by 
LCA. 
 
Figure 5.15. Under CR conditions in the presence of LCA, lack of any of the three proteins required 
for the peroxisome-to-mitochondrion transport of acetyl-CoA in the forms of the glyoxylate cycle intermediates 
citrate and succinate does not alter the efficiency of yeast CLS extension by LCA. WT cells and mutant cells 
carrying a single-gene-deletion mutation eliminating either the Cit2, Ctp1 or Dic1 protein were cultured in the nutrient- 
rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it. (A, B, C) Survival curves of the 




presented as means ± SEM (n = 3). Data for the WT strain cultured with or without LCA are replicated in graphs A, 
B, C of this Figure and in graphs A, B, C of Supplemental figure S7. (D, E, F) p Values for different pairs of survival 
curves of the WT and cit2 (D), WT and ctp1 (E) or WT and dic1 (F) strains cultured with or without LCA. 
Survival curves shown in (A, B, or C, respectively) were compared. Two survival curves were considered statistically 
different if the p value was less than 0.05. The p values for comparing pairs of survival curves using the logrank test 
were calculated as described in Materials and Methods. The p values displayed on a yellow color background indicate 
that LCA extends the CLS of the WT, cit2 (D), ctp1 (E) and dic1 (F) strains. The p values displayed on a blue 
color background indicate that LCA extends the CLS of the cit2 (D), ctp1 (E) and dic1 (F) strains as efficiently 
as it extends the CLS of the WT strain. (G, H) Survival curves shown in (A, B, C) were used to calculate the fold of 
increase of the mean (G) and maximum (H) CLS by LCA for the WT, cit2, ctp1 and dic1 strains. Data are 
presented as means ± SEM (n = 3; ns, not significant). Abbreviations: L, D, PD and ST, logarithmic, diauxic, post- 
diauxic and stationary growth phases (respectively). These experiments were performed by Alexander Goldberg, 
Pavlo Kyryakov, Alejandra Gomez-Perez and Olivia Koupaki. 
 
 
5.3.9 The Mpc1/Mpc3 mitochondrial pyruvate carrier is necessary for the delay of yeast 
chronological aging by LCA 
As we have previously found, during PD and ST phases of culturing yeast under CR on 
0.2% glucose, LCA exhibits the following effects [14, 236, 246]: 1) it rises the concentrations of 
Mpc1 and Mpc3, the two protein components of a mitochondrial pyruvate carrier involved in 
pyruvate transport to mitochondria during respiratory growth [255, 256]; and 2) it does not change 
the concentration of the Mpc2 protein component of the mitochondrial pyruvate carrier 
Mpc1/Mpc2 formed during fermentative growth [255, 256] (Figure 5.2). Based on these findings, 
we hypothesized that the Mpc1/Mpc2 and/or Mpc1/Mpc3 mitochondrial pyruvate carriers may 
contribute to the LCA-dependent delay of yeast chronological aging under CR conditions. To test 
this hypothesis, we examined the effect of a single-gene-deletion mutation eliminating the Mpc1, 
Mpc2 or Mpc3 protein on the efficiency with which LCA can increase yeast CLS under CR 
conditions. We found the following: 1) the mpc1 and mpc3 mutations decrease the efficiency 
of yeast CLS extension by LCA (Figures 5.16A, 5.16D, 5.16G and 5.16H for mpc1; and Figures 
5.16C, 5.16F, 5.16G and 5.16H for mpc3); and 2) the mpc2 mutation does not affect such 
efficiency (Figures 5.16B, 5.16E, 5.16G and 5.16H). These findings indicate that the Mpc1/Mpc3 
mitochondrial pyruvate carrier (which is formed during respiratory growth) plays an essential role 
in the LCA-dependent delay of chronological aging in yeast limited in calorie supply. In contrast, 
the Mpc1/Mpc2 mitochondrial pyruvate carrier (which is formed during fermentative growth) is 






Figure 5.16. Under CR conditions in the presence of LCA, lack of the Mpc1 or Mpc3 protein 
component of the Mpc1/Mpc3 mitochondrial pyruvate carrier decreases the efficiency of yeast CLS extension 
by LCA, whereas lack of the Mpc2 protein component of the Mpc1/Mpc2 mitochondrial pyruvate carrier does 
not affect such efficiency. WT cells and mutant cells carrying a single-gene-deletion mutation eliminating either the 
Mpc1, Mpc2 or Mpc3 protein were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 
µM LCA or without it. (A, B, C) Survival curves of the chronologically aging WT and mpc1 (A), WT and mpc2 
(B) or WT and mpc3 (C) strains are shown. Data are presented as means ± SEM (n = 3). Data for the WT strain 
cultured with or without LCA are replicated in graphs A, B, C of this Figure and in graphs A, B, C of Supplemental 
figure S6. (D, E, F) p Values for different pairs of survival curves of the WT and mpc1 (D), WT and mpc2 (E) or 
WT and mpc3 (F) strains cultured with or without LCA. Survival curves shown in (A, B or C, respectively) were 
compared. Two survival curves were considered statistically different if the p value was less than 0.05. The p values 
for comparing pairs of survival curves using the logrank test were calculated as described in Materials and Methods. 
The p values displayed on a yellow color background indicate that LCA extends the CLS of the WT, mpc1 (D), 
mpc2 (E) and mpc3 (F) strains. The p values displayed on a blue color background in D and F indicate that LCA 
extends the CLS of the mpc1 (D) and mpc3 (F) strains to a lower extent than that of the WT strain. The p value 
displayed on a blue color background in E indicates that LCA extends the CLS of the mpc2 strain as efficiently as it 
extends the CLS of the WT strain. (G, H) Survival curves shown in (A, B, C) were used to calculate the fold of 
increase of the mean (G) and maximum (H) CLS by LCA for the WT, mpc1, mpc2 and mpc3 strains. Data are 
presented as means ± SEM (n = 3; *p < 0.05; ns, not significant). Abbreviations: L, D, PD and ST, logarithmic, 
diauxic, post-diauxic and stationary growth phases (respectively). These experiments were performed by Alexander 
Goldberg, Pavlo Kyryakov, Alejandra Gomez-Perez and Olivia Koupaki. 
 
 
5.3.10 The ability of LCA to shift a balance between the processes of mitochondrial fusion 
and fission toward fusion is essential for the delay of yeast chronological aging by LCA 
We have previously noticed that, during PD and ST phases of culturing yeast under CR on 




mitochondria: 1) it increases the percentage of cells exhibiting a tubular mitochondrial network 
[14]; 2) it decreases the percentage of cells displaying fragmented mitochondria [14]; 3) it causes 
a major enlargement of mitochondria [64]; 4) it significantly decreases mitochondrial number [64]; 
5) it decreases the concentrations of the Caf4 and Mdv1 protein components of the mitochondrial 
fission machine [246]; and 6) it increases the concentrations of the Fzo1 and Ugo1 protein 
components of the mitochondrial fusion machine [236]. Because mitochondrial morphology is 
known to be defined by a balance between the processes of mitochondrial fusion and fission [257, 
258], it is feasible that all these effects of LCA are due to its ability to shift this balance toward 
mitochondrial fusion. In support of this assumption, the mitochondrial membranes of LCA-treated 
yeast are enriched in PA [64, 236], a phospholipid known to increase mitochondrial size and to 
decrease mitochondrial number by causing the following two effects: 1) PA activates 
mitochondrial fusion [259-263]; in yeast treated with LCA, this effect of PA is due to its ability to 
stimulate the biogenesis of the Ugo1 protein component of the mitochondrial fusion machine 
[264]; and 2) PA inhibits mitochondrial fission because it decreases the efficiency with which the 
oligomerized dynamin-related protein component of the mitochondrial fission machine (Drp1 in 
mammals and Dnm1 in yeast) can constrict mitochondria [263, 265, 266]. We sought to determine 
whether the ability of LCA to shift a balance between the processes of mitochondrial fusion and 
fission toward fusion may play a role in the LCA-dependent delay of yeast chronological aging 
under CR conditions. We therefore examined how the extent to which LCA prolongs the CLS of 
yeast limited in calorie supply is influenced by the single-gene-deletion mutations eliminating 
protein components of the mitochondrial fusion or fission machine. We found the following: 1) 
the fzo1, mgm1 and ugo1 mutations, each eliminating a protein component of the 
mitochondrial fusion machine, decrease the efficiency of yeast CLS extension by LCA (Figures 
5.17A, 5.17D, 5.17G and 5.17H for fzo1; Figures 5.17B, 5.17E, 5.17G and 5.17H for mgm1; 
and Figures 5.17C, 5.17F, 5.17G and 5.17H for ugo1); and 2) the caf4, dnm1 and mdv1 
mutations, each eliminating a protein component of the mitochondrial fission machine, increase 
the efficiency of yeast CLS extension by LCA (Figures 5.18A, 5.18D, 5.18G and 5.18H for caf4; 
Figures 5.18B, 5.18E, 5.18G and 5.18H for dnm1; and Figures 5.18C, 5.18F, 5.18G and 5.18H 
for mdv1). We therefore concluded that the ability of LCA to shift a balance between the 
processes of mitochondrial fusion and fission toward fusion makes an essential contribution to the 




Figure 5.17. Under CR 
conditions in the  presence  of 
LCA, lack of the Fzo1, Mgm1 
or Ugo1 protein component of 
the mitochondrial fusion 
machine decreases the 
efficiency of yeast CLS 
extension by LCA. WT cells and 
mutant cells carrying a  single- 
gene-deletion mutation 
eliminating either the Fzo1, 
Mgm1 or Ugo1 protein were 
cultured in the nutrient-rich YP 
medium initially containing 
0.2% glucose with 50 µM LCA 
or without it. (A, B, C) Survival 
curves of the chronologically 
aging WT and fzo1 (A), WT 
and  mgm1  (B)  or  WT  and 
ugo1 (C) strains are shown. Data are presented as means ± SEM (n = 3). Data for the WT strain cultured with or 
without LCA are replicated in graphs A, B, C of this Figure. (D, E, F) p Values for different pairs of survival curves 
of the WT and fzo1 (D), WT and mgm1 (E) or WT and ugo1 (F) strains cultured with or without LCA. Survival 
curves shown in (A, B or C, respectively) were compared. Two survival curves were considered statistically different 
if the p value was less than 0.05. The p values for comparing pairs of survival curves using the logrank test were 
calculated as described in Materials and Methods. The p values displayed on a yellow color background indicate that 
LCA extends the CLS of the WT, fzo1 (D), mgm1 (E) and ugo1 (F) strains. The p values displayed on a blue 
color background in D, E and F indicate that LCA extends the CLS of the fzo1 (D), mgm1 (E) and ugo1 (F) 
strains to a lower extent than that of the WT strain. (G, H) Survival curves shown in (A, B, C) were used to calculate 
the fold of increase of the mean (G) and maximum (H) CLS by LCA for the WT, fzo1, mgm1 and ugo1 strains. 
Data are presented as means ± SEM (n = 3; *p < 0.05). Abbreviations: L, D, PD and ST, logarithmic, diauxic, post- 
diauxic and stationary growth phases (respectively). These experiments were performed by Alexander Goldberg, 
Pavlo Kyryakov, Alejandra Gomez-Perez and Olivia Koupaki. 
 
 
Figure 5.18. Under CR 
conditions in the  presence of 
LCA, lack of the Caf4, Dnm1 
or Mdv1 protein component of 
the mitochondrial fission 
machine increases the 
efficiency of yeast CLS 
extension by LCA. WT cells and 
mutant cells carrying a  single- 
gene-deletion mutation 
eliminating either the Caf4, 
Dnm1 or Mdv1 protein were 
cultured in the nutrient-rich YP 
medium initially containing 
0.2% glucose with 50 µM LCA 
or without it. (A, B, C) Survival 
curves of the chronologically 
aging WT and caf4 (A), WT 
and  dnm1  (B)  or  WT  and 
mdv1 (C) strains are shown. Data are presented as means ± SEM (n = 3). Data for the WT strain cultured with or 




of the WT and caf4 (D), WT and dnm1 (E) or WT and mdv1 (F) strains cultured with or without LCA. Survival 
curves shown in (A, B or C, respectively) were compared. Two survival curves were considered statistically different 
if the p value was less than 0.05. The p values for comparing pairs of survival curves using the logrank test were 
calculated as described in Materials and Methods. The p values displayed on a yellow color background indicate that 
LCA extends the CLS of the WT, caf4 (D), dnm1 (E) and mdv1 (F) strains. The p values displayed on a blue 
color background in D, E and F indicate that LCA extends the CLS of the caf4 (D), dnm1 (E) and mdv1 (F) 
strains to a higher extent than that of the WT strain. (G, H) Survival curves shown in (A, B, C) were used to calculate 
the fold of increase of the mean (G) and maximum (H) CLS by LCA for the WT, caf4, dnm1 and mdv1 strains. 
Data are presented as means ± SEM (n = 3; *p < 0.05). Abbreviations: L, D, PD and ST, logarithmic, diauxic, post- 
diauxic and stationary growth phases (respectively). These experiments were performed by Alexander Goldberg, 
Pavlo Kyryakov, Alejandra Gomez-Perez and Olivia Koupaki. 
 
 
5.3.11 LCA delays the age-related onset and slows progression of mitochondria-controlled 
apoptosis and decreases cell susceptibility to this form of RCD in an age-dependent manner 
Mitochondrial network fragmentation is known as one of the hallmarks of a mitochondria- 
controlled form of age-related apoptotic RCD [23, 249, 267-277]. We have demonstrated that, 
during  PD  and  ST  phases  of  culturing  yeast  under  CR  on  0.2%  glucose,  LCA  attenuates 
mitochondrial network fragmentation  [14,  64,  236,  246]  by shifting  a  balance between the 
processes of mitochondrial fusion and fission toward fusion (this study), and that this effect of 
LCA is essential for its ability to delay yeast chronological aging under CR conditions (this study). 
We therefore sought to determine whether in yeast limited in calorie supply LCA may affect age- 
related changes in some other hallmark events of this mitochondria-controlled form of apoptotic 
RCD. We found that the ability of LCA to delay mitochondrial network fragmentation during PD 
and  ST  phases  coincides  with  its  ability  to  postpone  the  age-related  onset  and  decelerate 
progression  of  such  characteristic  event  in  apoptotic  RCD  as  cytochrome  c  efflux  from 
mitochondria during ST phase (Figure 5.19A); cytochrome c is known as a pro-apoptotic protein 
whose release from fragmented mitochondria into the cytosol of yeast cells is a late event in 
mitochondria-controlled apoptotic RCD [23, 249, 267-277]. We also found that LCA delays the 
age-related onset and slows progression of nuclear fragmentation during ST phase (Figures 5.19B 
and 5.19C); nuclear fragmentation in yeast is known as another characteristic late event of age- 
related apoptotic RCD [23, 249, 267-277]. Moreover, we noticed that LCA postpones the age- 
related onset and slows progression of phosphatidylserine (PS) translocation from the inner to the 
outer leaflet of the plasma membrane during PD and ST phases (Figures 5.20A and 5.20B); this 







Figure 5.19. Under CR conditions, LCA postpones the age-related onset and decelerates progression 
of such late events in apoptotic RCD as cytochrome c efflux from mitochondria and nuclear fragmentation. WT 
cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or without it. 
(A) Western blot analysis of cytochrome c in purified mitochondria (M) and in the cytosolic fraction (C) recovered 
from cells that were taken on different days of culturing. Equal portions of mitochondrial and cytosolic fractions were 
analyzed by immunoblotting to cytochrome c. (B) Percentage of cells exhibiting fragmented nucleus, a characteristic 
trait of apoptotic RCD. Images like the representative images shown in (C) were quantitated as described in Materials 
and Methods. Data are presented as means ± SEM (n = 3; *p < 0.05; **p < 0.01). (C) Cells recovered on different 
days of  culturing were visualized using  the DIC microscopy and stained with  4′,6-diamidino-2-phenylindole 
dihydrochloride (DAPI) to detect nuclei as described in Materials and Methods. Abbreviations: L, D, PD and ST, 
logarithmic, diauxic, post-diauxic and stationary growth phases (respectively). 
 
 
Figure 5.20. Under CR conditions, LCA postpones the age-related onset and slows progression of such 
early event in apoptotic RCD as phosphatidylserine (PS) translocation from the inner to the outer leaflet of the 




50 µM LCA or without it. (A) Cells recovered on different days of culturing were visualized using the DIC microscopy 
and stained with Annexin V to detect the presence of PS in the outer leaflet of the plasma membrane as described in 
Materials and Methods. (B) Percentage of cells exhibiting externalized PS, a characteristic trait of apoptotic RCD 
consisting in the translocation of PS from the inner to the outer leaflet of the plasma membrane. Images like the 
representative images shown in (A) were quantitated as described in Materials and Methods. Data are presented as 
means ± SEM (n = 3; *p < 0.05; **p < 0.01). Abbreviations: L, D, PD and ST, logarithmic, diauxic, post-diauxic and 
stationary growth phases (respectively). 
 
 
Mitochondrial network fragmentation and the efflux of several pro-apoptotic proteins 
(including cytochrome c) from the intermediate space of fragmented mitochondria are known to 
be characteristic traits of mitochondria-controlled apoptotic RCD induced by a short-term 
exposure of yeast cells to exogenous hydrogen peroxide [23, 249, 267-277]. Our assessment of 
how LCA influences cell susceptibility to this mode of apoptotic RCD under CR conditions has 
revealed the following: 1) LCA significantly increases clonogenic survival of cells briefly (for 2 
h) treated with hydrogen peroxide if these cells were recovered during PD or ST phase of culturing 
(Figure 5.21); and 2) LCA does not alter clonogenic survival of cells subjected to such treatment 
if these cells were recovered during L or D phase of culturing (Figure 5.21). 
Figure 5.21. Under CR conditions, LCA decreases cell 
susceptibility to mitochondria-controlled apoptotic RCD in an age- 
dependent manner. WT cells were cultured in the nutrient-rich YP medium 
initially containing 0.2% glucose with 50 µM LCA or without it. An assay for 
measuring clonogenic survival of cells recovered on different days of 
culturing and then treated for 2 h with 2.5 mM hydrogen peroxide to elicit a 
mitochondria-controlled mode of apoptotic RCD was performed as described 
in Materials and Methods. Data are presented as means ± SEM (n = 3; *p < 
0.05). Abbreviations: L, D, PD and ST, logarithmic, diauxic, post-diauxic and 






In sum, the above findings indicate that LCA delays yeast chronological aging in part 
because it attenuates mitochondrial network fragmentation, thereby delaying the onset of an age- 
related mode of mitochondria-controlled apoptotic RCD during PD and ST phases of culturing 
under CR conditions. 
 
5.4      Discussion 
This study and our previously published data [14, 64, 236, 246] suggest a hypothetical 
model for the mechanisms through which LCA delays chronological aging of yeast limited in 




1) if LCA is added to culture medium at the time of cell inoculation, it elicits an aging-delaying 
cellular pattern and preserves such pattern throughout the entire chronological lifespan of the yeast 
culture, before an arrest of cell growth and division (i.e. during L, D and PD phases of culturing) 
and after such arrest (i.e. during ST phase of culturing); 2) LCA causes the stepwise development 
and maintenance of the aging-delaying cellular pattern in part because it alters various 
intercompartmental communications; these communications involve movements of certain 
intermediates of lipid and carbohydrate metabolism between the ER and LD, LD and peroxisomes, 
peroxisomes and mitochondria, the ER and mitochondria, and the cytosol and mitochondria; 3) 
LCA attenuates mitochondrial network fragmentation by shifting a balance between the processes 
of mitochondrial fusion and fission toward fusion; 
 
Figure 5.22. Mechanisms through which LCA delays chronological aging of yeast limited in calorie 
supply. In yeast cultured under CR conditions, LCA elicits an aging-delaying cellular pattern and preserves such 
pattern throughout the entire chronological lifespan, before an arrest of cell growth and division (i.e. during L, D and 
PD phases of culturing) and after such arrest (i.e. during ST phase of culturing). Under these conditions, LCA causes 
the stepwise development and maintenance of the aging-delaying cellular pattern because it alters the spatiotemporal 
dynamics of a cellular network integrating certain pathways of lipid and carbohydrate metabolism, some 
intercompartmental communications, specific aspects of mitochondrial morphology and functionality, and 
liponecrotic and apoptotic modes of RCD. Because LCA decreases the risk of aging-associated cell death to increase 




arrows is proportional to the rates of processes. Arrows next to the names of affected processes denote those of them 
that are intensified (red arrows) or weakened (blue arrows). Arrows next to the names of affected metabolites signify 
those of them whose concentrations are increased (red arrows) or decreased (blue arrows). Please see text for 
additional details. Abbreviations: Ac-CoA, acetyl-CoA; ER, endoplasmic reticulum; ETC, electron transport chain; 
FFA, free fatty acids; L, D, PD and ST, logarithmic, diauxic, post-diauxic and stationary growth phases (respectively); 
LD, lipid droplets; RCD, regulated cell death; ROS, reactive oxygen species; TAG, triacylglycerols; TCA, 
tricarboxylic acid cycle; m, mitochondrial electrochemical membrane potential. 
 
 
4) the LCA-dependent changes in the communications between different cellular 
compartments and the LCA-driven weakening of mitochondrial network fragmentation decrease 
the risk of the cell commitment to liponecrotic and apoptotic RCD modes during PD and ST 
phases, thereby increasing the chance of cell survival during these phases of culturing; and 5) 
because LCA decreases the risk of aging-associated cell death to increase the chance of elderly 
cells to survive, it prolongs longevity of chronologically aging yeast (Figure 5.22). 
Our findings indicate that LCA decreases the cellular concentration of FFA through the 
entire chronological lifespan of yeast limited in calorie supply. In our model, two mechanisms 
underlie this effect of LCA. One mechanism consists in the ability of LCA to regulate the anabolic 
branch of TAG metabolism by accelerating TAG synthesis from FFA within the ER and the 
ensuing TAG deposition within LD during L and D phases of culturing (Figure 5.22). The other 
mechanism involves an LCA-dependent regulation of the catabolic branch of TAG metabolism 
through the deceleration of TAG lipolysis into FFA within LD during PD and ST phases of 
culturing (Figure 5.22). By decreasing the cellular concentration of FFA through the entire 
chronological lifespan, LCA delays the age-related onset and decelerates the progression of FFA- 
induced liponecrotic RCD during PD and ST phases of culturing under CR conditions (Figure 
5.22). This LCA-dependent decrease of the risk of aging-associated cell death increases the chance 
of elderly cells to survive and makes an essential contribution to the ability of LCA to extend 
longevity of chronologically aging yeast. 
Our model further posits that the LCA-dependent stimulation of the peroxisome-to- 
mitochondrion transport of acetyl-CoA via the carnitine shuttle during PD and ST phases [236, 
246] is indispensable for the delay of yeast chronological aging by LCA under CR conditions 
(Figure 5.22). Another essential contributor to this aging-delaying effect of LCA is the 
Mpc1/Mpc3 mitochondrial pyruvate carrier involved in the cytosol-to-mitochondrion transport of 
pyruvate during respiratory growth (Figure 5.22); akin to the carnitine-dependent transport of 




during PD and ST phases of culturing yeast under CR conditions [236, 246]. It is conceivable that 
these stimulating, aging-delaying effects of LCA on the peroxisome-to-mitochondrion transport 
of acetyl-CoA and the cytosol-to-mitochondrion transport of pyruvate may be involved in the 
following cause-effect relationship with other mitochondrial processes known to be elicited by 
LCA: 1) these effects may be caused by the accumulation of LCA in both mitochondrial 
membranes and by the subsequent remodeling of mitochondrial membrane lipidome during PD 
and ST phases of culturing under CR conditions [64, 107, 145, 221, 248]; and 2) these effects may 
cause the LCA-dependent changes in some vital aspects of mitochondrial functionality; these 
changes include a rise in mitochondrial respiration/electron transport chain, electrochemical 
membrane potential, reactive oxygen species concentration and ATP synthesis during PD and ST 
phases of culturing under CR conditions [64, 107, 145, 221, 248]. 
LCA is known to inhibit mitochondrial network fragmentation during PD and ST phases 
of culturing yeast under CR conditions [14, 64, 236, 246]. This study provides evidence that, 
during these phases of culturing, such effect of LCA on mitochondrial morphology is in the 
following cause-effect relationship with other cellular processes affected by LCA: 1) it is caused 
by the ability of LCA to shift a balance between the processes of mitochondrial fusion and fission 
toward fusion; 2) it causes a delay in the onset and a deceleration in the progression of an age- 
related mode of mitochondria-controlled apoptotic RCD (Figure 5.22). Like for the FFA-induced 
liponecrotic mode of RCD, the LCA-dependent decrease of the risk of aging-associated apoptotic 
mode of RCD increases the chance of elderly cells to survive and, thus, is an important contributing 
factor to longevity extension by LCA in chronologically aging yeast limited in calorie supply 
(Figure 5.22). 
In sum, this study provides important new insights into the mechanisms by which LCA 
delays yeast chronological aging under CR conditions by altering the spatiotemporal dynamics of 
a cellular network that integrates certain pathways of lipid and carbohydrate metabolism, some 
intercompartmental communications, specific aspects of mitochondrial morphology and 
functionality, and liponecrotic and apoptotic modes of RCD. In the future, it would be interesting 
to investigate how LCA influences a novel mechanism of longevity extension by CR in 
chronologically aging yeast. This recently discovered mechanism has been shown to link cellular 
aging to cell cycle regulation, maintenance of a quiescent state, entry into a non-quiescent state 




6 LCA elicits the establishment of a distinct phosphoprotein profile of mitochondria, 
which significantly differs from the phosphoprotein profile of mitochondria in yeast 
cells cultured without LCA 
 
6.1 Introduction 
As described in the Introduction section, because LCA triggers major changes in 
the age-related chronology of several vital processes taking place in mitochondria, we 
hypothesized that LCA may cause these changes by eliciting a reversible phosphorylation of some 
mitochondrial proteins. The objectives of studies described in Chapter 6 was to test this hypothesis 
by investigating if an exposure of chronologically aging yeast to exogenous LCA can trigger such 
phosphorylation of some mitochondrial proteins. 
 
6.2 Materials and methods 
6.2.1 Yeast strains, media and growth conditions 
The WT strain BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) was grown in YP medium (1% 
yeast extract, 2% peptone; both from Fisher Scientific; #BP1422-2 and #BP1420-2, respectively) 
initially containing 0.2% glucose (#D16-10; Fisher Scientific) with 50 µM LCA (#L6250; Sigma) 
or without it. Cells were cultured at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks 
at a ʺflask volume/medium volumeʺ ratio of 5:1. 
 
6.2.2 Purification of mitochondria 
Yeast cells were harvested at 3,000 × g for 5 min at room temperature, washed with water 
and resuspended in DTT buffer (100 mM Tris-H2SO4, pH 9.4, 10 mM dithiothreitol [DTT]). Cells 
were incubated in DTT buffer for 20 min at 30°C to weaken the cell wall. The cells were washed 
with Zymolyase buffer (1.2 M sorbitol, 20 mM potassium phosphate, pH 7.4) and centrifuged at 
3,000 × g for 5 min at room temperature. The cells were then incubated with 3 mg/g (wet weight) 
of Zymolyase-100T in 7 ml/g (wet weight) Zymolyase buffer for 45 min at 30°C. Following an 8- 
min centrifugation at 2,200 × g at 4°C, the isolated spheroplasts were washed in ice-cold 
homogenization buffer (5 ml/g) (0.6 M sorbitol, 10 mM Tris-HCl, pH7.4, 1 mM EDTA, 0.2% 
(w/v) BSA) and centrifuged at 2,200 × g for 8 min at 4°C. The spheroplasts were homogenized in 




resulting homogenates at 3,000 × g for 10 min at 4°C. The resulting supernatant was then 
centrifuged at 12,000 × g for 15 min at 4°C to pellet mitochondria. The remnant cell debris were 
removed by centrifuging the mitochondrial fraction at 3,000 × g for 5 min at 4°C. The resulting 
supernatant was then centrifuged at 12,000 × g for 15 min at 4°C to obtain the crude mitochondrial 
pellet, which were then resuspended in 3 ml of SEM Buffer (250 mM sucrose, 1 mM EDTA, 10 
mM MOPS, pH 7.2) and used for further purification of mitochondria. A sucrose gradient was 
made by overlaying 1.5 ml of 60% sucrose with 4 ml of 32% sucrose, 1.5 ml of 23% sucrose, and 
then 1.5 ml of 15% sucrose (all in EM buffer; 1 mM EDTA, 10 mM MOPS, pH 7.2). Finally, a 3- 
ml aliquot of the crude mitochondrial fraction in SEM buffer was applied to the gradient and 
centrifuged at 134,000 × g (33,000 rpm) for three hours at 4°C in vacuum (Rotor SW40Ti, 
Beckman). The purified mitochondria found at the 60%/32% sucrose interface were carefully 
removed and stored at -80°C until mass spectrometric identification of phosphorylated 
mitochondrial proteins. 
 
6.2.3 Mass spectrometric identification of phosphorylated mitochondrial proteins 
Purified mitochondria were resuspended in TCL buffer (25 mM Tris/HCl pH 8.5, 150 mM 
NaCl, 1 mM EDTA, 0.1 mM DTT, 4% CHAPS, 1 mM PMSF, protease inhibitor cocktail) and 
subjected to vortexing with glass beads for 10 min at 4oC. The sample was subjected to 
centrifugation for 5 min at 16,000 × g at 4oC. Immediately after centrifugation, the supernatant 
was placed into a pre-chilled Eppendorf tube. The extracted mitochondrial proteins were 
precipitated with 10% TCA, washed with 80% acetone, dried, resuspended in the sample buffer 
for SDS-PAGE and then subjected to SDS-PAGE at 200 V until the sample reaches the running 
gel. After staining the running gel with QC Colloidal Coomassie Blue and destaining, protein 
bands were cut out from the SDS-PAGE gel with a razor blade. The gel pieces were placed in 
individual 0.5-ml siliconized Eppendorf tubes and incubated with 50 l of acetonitrile (ACN) for 
5 min at 37°C. ACN was removed and the gel pieces will be dried at 37°C. The gel pieces were 
incubated in 50 l of 10 mM dithiothreitol (DTT) for 30 min at 37°C to reduce thiol groups in 
peptides. DTT was discarded and the gel pieces were incubated in 50 l of 55 mM iodoacetamide 
(IAA) for 20 min at 37°C in the dark to remove the residual DTT. IAA was removed, and the gel 
pieces was incubated in 50 l of a 1:1 mixture of 100 mM ABC and 50% acetonitrile for 10 min 




under the same conditions and dried at 37°C. The trypsin and trypsin buffer were prepared as 
follows: 1) 1.6 ml of a 1:1 mixture of 100 mM ABC and 10mM CaCl2 was used to resuspend 20 
g of trypsin; and 2) for protein digest, 50 l of trypsin solution (1 mg/ml) was added to the gel 
piece, which was then incubated overnight at 37°C. The following day, the gel pieces were spun 
down and the supernatants containing peptides were transferred to new 0.5-ml siliconized 
Eppendorf tubes. To extract more peptides, the gel pieces were subjected to several washes and 
treatments at room temperature; the gel pieces were conserved and combined with the first set to 
extracted peptides. For the first extraction, the gel pieces were initially incubated in 50 l of 25 
mM ABC for 10 min and then in 50 l of ACN for 10 min. The samples were spun down, and the 
supernatant was added to the first set of extracted peptides. For the second extraction, the gel 
pieces were incubated in 50 l of 5% formic acid for 10 min and then in 50 l of ACN for 10 min. 
The samples were spun down, and the supernatant was combined with the first set of extracted 
peptides. For phosphopeptide enrichment using TiO2, the peptides obtained from the digestion step 
were dried down, re-dissolved in 100 µl of binding buffer (1 M glycolic acid, 80% acetonitrile, 
and 5% trifluoroacetic acid [TFA]) and mixed with 50 µl of TiO2 magnetic beads (Roche) pre- 
equilibrated with 500 µl of binding buffer. The beads were incubated for 30 min in a mixer, washed 
once with 500 µl of binding buffer, and then washed twice with 500 µl of wash buffer (80% 
acetonitrile, 1% TFA). The bound peptides were eluted twice with 50 µl of elution buffer (5% 
ammonium hydroxide, pH 12), dried and re-dissolved in 15 µl of 2% acetonitrile and 1% formic 
acid before LC-MS/MS analysis. Phosphorylated peptides were identified by reverse phase high 
performance liquid chromatography coupled to mass spectrometry (RP-HPLC/MS) using an LTQ 
Orbitrap. 3-µl aliquots of peptides were separated in ACN gradient using a 100-µM capillary 





6.3.1 Several proteins are differently phosphorylated in mitochondria of cells cultured in 
the presence or absence of LCA 
We have used centrifugation to equilibrium in a sucrose density gradient to purify 
mitochondria from yeast cells cultured in the nutrient-rich YP medium containing 0.2% glucose 




the purification of mitochondria devoid of contamination by other organelles, such as the nucleus, 





plasma membrane [PM]) and Pho8p (a protein marker of the vacuole). 
 
Figure 6.1. Purification of 
mitochondria from yeast cells using 
centrifugation to equilibrium in a 
sucrose density gradient. Equal 
volumes of gradient fractions were 
analyzed by immunoblotting with 
antibodies to Por1p (a protein marker of 
mitochondria), Nsp1p (a protein marker 
of the nucleus), Dpm1p (a protein 
marker of the endoplasmic reticulum 
[ER]), Vps10p (a protein marker of the 
Golgi), Pma1p (a protein marker of the 
 
We then used a quantitative, label-free mass spectrometry approach to compare 
phosphoproteomes of mitochondria from yeast cells that were cultured with or without LCA and 
recovered for mitochondria purification at day 2 (i.e. at diauxic phase of culturing), day 4 (i.e. at 
post-diauxic phase of culturing) or day 7 (i.e. at stationary phase of culturing). Cells for 
mitochondria purification were recovered at different days of culturing because we sought to assess 
how chronological age of these cells influences the mitochondrial proteome in yeast exposed to 
LCA or remained untreated. Cells for mitochondria purification were recovered at days 2, 4 and 7 
because our previous study has revealed that the first 7 days of culturing (but not the time after 
this critical period) are indispensable for the delay of yeast chronological aging by LCA [59]. 
We have detected and identified numerous phosphopeptides and phosphoproteins in 
mitochondria of yeast cells cultured with or without LCA and recovered for mitochondria 
purification at days 2, 4 and 7 of culturing, as outlined in Table 6.1. 
 
Table 6.1. Numbers of phosphopeptides and phosphoproteins that were detected and identified in 
mitochondria of yeast cells cultured with or without LCA and recovered for mitochondria purification at 
different days of culturing. 
 




- LCA 2 173 295 
 4 211 375 
 7 248 433 
+ LCA 2 178 302 
 4 220 390 




We have then analyzed the mitochondrial phosphoproteome data using principal 
component analysis (PCA). PCA of was performed for mitochondrial phosphoproteins and 
phosphopeptides that were found in cells cultured with or without LCA and recovered for 
mitochondria purification at days 2, 4 and 7 of culturing. 
PCA for mitochondrial phosphoproteins revealed that LCA elicits a distinct 
phosphoprotein profile that significantly differs from that of mitochondria in yeast cells cultured 
without LCA (Figure 6.2). This distinct LCA-driven phosphoprotein profile was observed in 
mitochondria of cells recovered at any of the three days of culturing. The sample with LCA and 
the reference without LCA were separated farthest from each other in case of mitochondrial 
phosphoproteins from chronologically old cells recovered at day 7 (Figure 6.2). Although the 
sample with LCA and the reference without LCA were also separated from each other in case of 
mitochondrial phosphoproteins from chronologically young cells recovered at day 2, they were 
clustered much closer to each other than those from chronologically old cells recovered at day 7 
(Figure 6.2). We therefore concluded that the ability of LCA to alter the mitochondrial 
phosphoproteome is gradually enhanced with the chronological age of yeast cells. 
PCA for mitochondrial phosphopeptides has supported my conclusions that 1) LCA 
prompts the establishment of a distinct phosphoprotein profile of mitochondria, which 
significantly differs from the phosphoprotein profile of mitochondria in yeast cells cultured 
without LCA; and 2) the efficiency with which LCA changes the mitochondrial phosphoproteome 
is progressively increased with the chronological age of yeast cells (Figure 6.3). 
Figure 6.2. Principal 
component   analysis 
for mitochondrial 
phosphoproteins 
found in cells 
cultured with  or 
without LCA  and 
recovered   for 
mitochondria 
purification at days 2, 
4 and 7 of culturing. 





Figure 6.3. Principal 
component  analysis 
for  mitochondrial 
phosphopeptides 
found  in  cells 
cultured  with  or 
without   LCA   and 
recovered   for 
mitochondria 
purification  at  days 
2, 4  and 7 of 











Our further analysis of the mitochondrial phosphoproteome data allowed to identify several 
proteins that are phosphorylated only in mitochondria of cells cultured with or without LCA (Table 
6.2). We found that the number of such proteins differently phosphorylated in mitochondria of 
cells cultured in the presence or absence of LCA is gradually enhanced with the chronological age 
of yeast cells (Table 6.2). 
Table 6.2. The number of phosphorylated proteins present only in mitochondria of cells cultured 
with or without LCA. See text for discussion. 
 
Day Number of mitochondrial 
phosphoproteins present only in 
yeast cultured without LCA 
Number of mitochondrial 
phosphoproteins present only in 
yeast cultured with LCA 
2 3 8 
4 3 12 
7 7 20 
 
The identities of proteins that are phosphorylated only in mitochondria of cells cultured 
with or without LCA and recovered at day 2, 4 or 7 of culturing are presented in Tables 6.3, 6.4 
and 6.5. Some of these proteins have been previously found only in mitochondria where they 
participate in carbohydrate metabolism and co-translational mitochondrial import (Tables 6.3, 6.4 
and 6.5). Many of these mitochondrial phosphoproteins 1) have also been found in other cellular 
locations; and 2) have been shown to participate in essential cellular processes most of which are 
not directly linked to mitochondria (Tables 6.3, 6.4 and 6.5). More than 30% of the proteins that 




with mitochondria only in phosphorylated forms and only in yeast cells cultured in media with 
alternative carbon sources or exposed to various mild stresses; the names of the proteins in Tables 
6.3, 6.4 and 6.5are shown in red color. The proteins that are phosphorylated only in mitochondria 
of cells cultured with or without LCA and recovered at day 2, 4 or 7 of culturing have been 
implicated in regulating PKA, protein phosphorylation, lipid metabolism, ion transport, 
endocytosis, TOR2-dependent regulation of lipid metabolism, G protein coupled receptor 
signaling, HOG signaling, cytoskeleton organization, stress response, nitrogen starvation response, 
cell wall maintenance, glucose-deprivation induced stress response, tubular ER morphology 
maintenance and proteostasis (Tables 6.3, 6.4 and 6.5). 
 
Table 6.3. The names, functions, phosphorylation sites and cellular locations of proteins that are 
phosphorylated only in mitochondria of cells cultured with or without LCA and recovered at day 2. See text for 
discussion. The names of proteins that have been found in other cellular locations and shown (by others) to be 
associated with mitochondria only in phosphorylated forms are shown in red color. 
+ or - 
LCA 
Protein name (SGD), function (SGD), phosphorylation site (my data) and cellular location (SGD) 
+ LCA BCY1 (YIL033C): Regulatory subunit of the cyclic AMP-dependent protein kinase (PKA); PKA is a 
component of a signaling pathway that controls a variety of cellular processes, including metabolism, 
cell cycle, stress response, stationary phase, and sporulation; Position in a master protein: [143-167; 
1xPhospho [T/S]; Location: Cytoplasm, Nucleus 
 YCK1 (YHR135C): Palmitoylated plasma membrane-bound casein kinase I (CK1) isoform; Is 
involved in glucose sensing; Causes glucose repression of respiratory metabolism; Is involved in the 
phosphorylation and regulation of glucose sensor Rgt2p; Also found on the outer surface of 
mitochondria; Position in a master protein: [43-59; 1xPhospho [S/T]; Location: Plasma membrane 
 YCK2 (YNL154C): Palmitoylated plasma membrane-bound casein kinase I (CK1) isoform; Is 
involved in glucose sensing; Causes glucose repression of respiratory metabolism; Is involved in the 
phosphorylation and regulation of glucose sensor Rgt2p; Also found on the outer surface of 
mitochondria; Position in a master protein: [448-481; 1xPhospho [S/Y]; Location: Plasma membrane 
 SPO14 (YKR031C): Phospholipase D; Catalyzes the hydrolysis of phosphatidylcholine, producing 
choline and phosphatidic acid; Position in a master protein: [1234-1252; 1xPhospho [S1244]; Location: 
Nucleus, Endosome 
 CTR1 (YPR124W): High-affinity copper transporter of plasma membrane; Mediates copper uptake 
under low copper conditions; Protein increases in abundance and relocates from nucleus to plasma 
membrane upon DNA replication stress; Position in a master protein: [191-204; 1xPhospho [S]; 
Location: Nucleus, Plasma membrane 
 PKH1 (YDR490C): Serine/threonine protein kinase; involved in sphingolipid-mediated signaling 
pathway that controls endocytosis and activates the signaling cascade required for maintenance of cell 
wall integrity; Position in a master protein: [491-503; 1xPhospho [S493]; Location: Cytoplasm 
 LSP1 (YPL004C): Sphingolipid long chain base-responsive protein LSP1; A core component of 
eisosomes, large immobile patch structures at the cell cortex associated with endocytosis; 
Phosphorylated on Thr233 upon Pkc1p hyperactivation in a Slt2p MAPK-dependent fashion; 
Represses Pkc1p/Ypk1p stress resistance pathways Position in a master protein: [134-143; 1xPhospho 
[S138]; Location: Cytoplasm 
 GPR1 (YDL035C): Plasma membrane G protein coupled receptor (GPCR); Interacts with the 
heterotrimeric G protein alpha subunit, Gpa2p, and with Plc1p; Sensor that integrates nutritional 
signals with the modulation of cell fate via PKA and cAMP synthesis; Position in a master protein: 





- LCA OM14 (YBR230C): Mitochondrial outer membrane receptor for cytosolic ribosomes; Integral protein 
of the outer membrane that interacts with the nascent chain-associated complex (NAC) bound to 
ribosomes, contributing to co-translational mitochondrial import; Interacts with porin (Por1p) and 
Om45p; Position in a master protein: [7-26; 2xPhospho [S15; S]; Location: Mitochondrion 
 PTK2 (YJR059W): Serine/threonine protein kinase; Involved in regulation of ion transport across 
plasma membrane; Is essential for glucose-dependent Pma1p activation via phosphorylation of Pma1p- 
Ser899; Enhances spermine uptake; Position in a master protein: [584-613; 1xPhospho [S592]; 
Location: Nucleus 
 HSP42 (YDR171W): Small heat shock protein with chaperone activity; Suppresses unfolded protein 
aggregation; Involved in cytoskeleton reorganization after heat shock; Protein abundance increases and 
forms cytoplasmic foci in response to DNA replication stress; Position in a master protein: [213-237; 
2xPhospho [S215; S223]; Location: Cytoskeleton 
 
 
Table 6.4. The names, functions, phosphorylation sites and cellular locations of proteins that are 
phosphorylated only in mitochondria of cells cultured with or without LCA and recovered at day 4. See text for 
discussion. The names of proteins that have been found in other cellular locations and shown (by others) to be 
associated with mitochondria only in phosphorylated forms are shown in red color. 
+ or - 
LCA 
Protein name (SGD), function (SGD), phosphorylation site (my data) and cellular location (SGD) 
+ LCA PIL1 (YGR086C): Sphingolipid long chain base-responsive protein PIL1; Eisosome core component; 
Eisosomes are large immobile cell cortex structures associated with endocytosis; detected in 
phosphorylated state in mitochondria; phosphorylated on Thr233 upon Pkc1p hyperactivation in a 
Slt2p MAPK-dependent fashion; represses Pkc1p/Ypk1p stress resistance pathways; Relocates from 
plasma membrane to cytoplasm upon DNA replication stress; Position in a master protein: [45-56; 
1xPhospho [S45]; Location: Plasms membrane, Mitochondrion, Lipid droplet 
 RAS2 (YNL098C): Ras-like protein 2; Regulates nitrogen starvation response, sporulation, and 
filamentous growth; Farnesylation and palmitoylation required for activity and localization to plasma 
membrane; Position in a master protein: [233-251; 1xPhospho [S/T]; Location: Plasma membrane 
 VIP1 (YLR410W): Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase; Is 
involved in such diverse processes as vacuolar biogenesis, the stress response, cell wall synthesis, actin 
cytoskeleton function, and phosphate signaling and homeostasis; Position in a master protein: [891- 
907; 1xPhospho [S895]; Location: Cytoskeleton 
 YDL218W: Uncharacterized membrane protein; Is induced by starvation and aerobic conditions, as 
well as in response to treatment with the mycotoxin patulin; Position in a master protein: [293-311; 
1xPhospho [S]; Location: A Membrane 
 FMP45 (YDL222C): SUR7 family integral membrane protein that is localized to mitochondria and 
plasma membrane; required for cell wall maintenance, sporulation and sphingolipid content 
maintenance; Position in a master protein: [242-277; 1xPhospho [T/S/Y]; Location: Mitochondria, 
Plasma membrane 
 ZEO1 (YOL109W): Peripheral membrane protein of the plasma membrane; Regulates the cell integrity 
pathway mediated by Pkc1p and Slt2p; Is detected in a phosphorylated state in highly purified 
mitochondria; Position in a master protein: [30-45; 1xPhospho [S40]; Location: Plasma membrane, 
Mitochondria 
 PKH2 (YOL100W): Serine/threonine protein kinase; Is involved in sphingolipid-mediated signaling 
pathway that controls endocytosis; activates the signaling cascade required for maintenance of cell wall 
integrity; Position in a master protein: [1007-1018; 1xPhospho [S1009]; Location: Cytoplasm, Nucleus 
 OM14 (YBR230C): Mitochondrial outer membrane receptor for cytosolic ribosomes; Integral protein 
of the outer membrane that interacts with the nascent chain-associated complex (NAC) bound to 
ribosomes, contributing to co-translational mitochondrial import; Interacts with porin (Por1p) and 
Om45p; Position in a master protein: [7-26; 2xPhospho [S15; S]; Location: Mitochondrion 
 MSS4 (YDR208W): Phosphatidylinositol-4-phosphate 5-kinase; involved in actin cytoskeleton 
organization and cell morphogenesis; Position in a master protein: [266-284; 1xPhospho [S/T]; 





 MYO3 (YKL129C): One of two type I myosins; localizes to actin cortical patches; Position in a master 
protein: [774-782; 1xPhospho [S777]; Location: Cytoplasm, Cytoskeleton 
 PBP1 (YGR178C): PAB1-binding protein 1; Component of glucose-deprivation induced stress 
granules; Involved in P-body-dependent granule assembly; Represses mRNA polyadenylation; 
Position in a master protein: [345-369; 1xPhospho [T353]; Location: Cytoplasm, Mitochondrion, 
Nucleus 
 CCC1 (YLR220W); Vacuolar Fe2+/Mn2+ transporter; Prevents mitochondrial iron accumulation; 
Position in a master protein: [60-77; 1xPhospho [S68]; Location: Cytoplasm, Vacuole, Golgi 
- LCA RTN2 (YDL204W): Reticulon-like protein involved in the maintenance of tubular ER morphology; 
promotes membrane curvature; regulates the ER asymmetry-induced inheritance block during ER 
stress; Is involved in ER-derived peroxisomal biogenesis; Position in a master protein: [240-259; 
1xPhospho [S]; Location: Endoplasmic reticulum 
 ENT4 (YLL038C): Putative clathrin binding protein, that is localized to cortical actin patches; it has a 
predicted role in actin filament organization and actin patch assembly, and endocytosis; Position in a 
master protein: [163-170; 1xPhospho [T/S]; Location: Cytoskeleton 
 SEG2 (YKL105C): Eisosome component involved in the assembly of eisosomes, large immobile patch 
structures at the cell cortex associated with endocytosis; Position in a master protein: [920-925; 
1xPhospho [S922]; Location: Plasma membrane 
 
Table 6.5. The names, functions, phosphorylation sites and cellular locations of proteins that are 
phosphorylated only in mitochondria of cells cultured with or without LCA and recovered at day 7. See text for 
discussion. The names of proteins that have been found in other cellular locations and shown (by others) to be 
associated with mitochondria only in phosphorylated forms are shown in red color. 
+ or - 
LCA 
Protein name (SGD), function (SGD), phosphorylation site (my data) and cellular location (SGD) 
+ LCA SUR7 (YML052W): Plasma membrane protein; Component of eisosomes; Is involved in sporulation 
and plasma membrane sphingolipid content; Position in a master protein: [239-283; 1xPhospho [S]; 
Location: Plasma membrane 
 YDL218W: Uncharacterized membrane protein; Is induced by starvation and aerobic conditions, as 
well as in response to treatment with the mycotoxin patulin; Position in a master protein: [257-292; 
257-287; 263-292; 263-287; 293-311; 1xPhospho [S/Y]; 1xPhospho [S/Y/T]; 1xPhospho [S/Y/T]; 
1xPhospho [S]; 1xPhospho [S305]; Location: A Membrane 
 RAS2 (YNL098C): Ras-like protein 2; Regulates nitrogen starvation response, sporulation, and 
filamentous growth; Farnesylation and palmitoylation required for activity and localization to plasma 
membrane; Position in a master protein: [181-196; 233-251; 233-239; 197-211; [197-211; 2xPhospho 
[S188; S192]; 2xPhospho [S235; S238]; 2xPhospho [S235; S238]; 1xPhospho [S207]; 2xPhospho 
[S202; S207]; Location: Plasma membrane 
 UIP4 (YPL186C): a Ubl (ubiquitin-like protein)-specific protease; Detected in a phosphorylated state 
in the mitochondrial outer membrane; Position in a master protein: [197-214; 1xPhospho [S205]; 
Location: Mitochondrial outer membrane, Endoplasmic reticulum, Nucleus 
 EIS1 (YMR031C): Component of the eisosome required for proper eisosome assembly; Is detected in 
a phosphorylated state in highly purified mitochondria; Position in a master protein: [128-137; 
2xPhospho [S130; S133]; Location: Plasma membrane, Mitochondria 
 RTN1 (YDR233C): Reticulon protein; Is involved in the maintenance of tubular ER morphology; 
Regulates the ER asymmetry-induced inheritance block during ER stress; Is involved in ER-derived 
peroxisomal biogenesis; Is involved in phosphatidylserine transfer between the ER and 
mitochondria; Position in a master protein: [219-247; 1xPhospho [S/T]; Location: Endoplasmic 
reticulum 
 PKH1 (YDR490C): Serine/threonine protein kinase; involved in sphingolipid-mediated signaling 
pathway that controls endocytosis and activates the signaling cascade required for maintenance of cell 
wall integrity; Position in a master protein: [294-317; 1xPhospho [S/Y/T]; Location: Cytoplasm 
 ALD4 (YOR374W): Mitochondrial aldehyde dehydrogenase; required for growth on ethanol and 
conversion of acetaldehyde to acetate; phosphorylated; expression is glucose repressed; Position in a 





 YKL050C (YKL050C): Protein of unknown function; Position in a master protein: [450-463; 
1xPhospho [S460]; Location: Unknown 
 MCK1 (YNL307C): Protein serine/threonine/tyrosine kinase involved in protein phosphorylation and 
breakdown; cyclin-binding protein; Is involved in chromosome segregation, meiotic entry, genome 
stability, phosphorylation-dependent protein degradation, inhibition of protein kinase A, 
transcriptional regulation, inhibition of RNA pol III, and calcium stress; Position in a master protein: 
[14-31; 1xPhospho [S24]; Location: Unknown 
 FMP45 (YDL222C): SUR7 family integral membrane protein that is localized to mitochondria and 
plasma membrane; required for cell wall maintenance, sporulation and sphingolipid content 
maintenance; Position in a master protein: [215-241; 1xPhospho [T/S]; Location: Mitochondria, 
Plasma membrane 
 YCK2 (YNL154C): Palmitoylated plasma membrane-bound casein kinase I (CK1) isoform; Is 
involved in glucose sensing; Causes glucose repression of respiratory metabolism; Is involved in the 
phosphorylation and regulation of glucose sensor Rgt2p; Also found on the outer surface of 
mitochondria; Position in a master protein: [448-481; 1xPhospho [S/Y/T]; Location: Plasma 
membrane 
 HER1 (YOR227W): HMG2-induced ER-remodeling protein 1; Is required for proliferation or 
remodeling of the ER that is caused by overexpression of Hmg2p; Position in a master protein: [1010- 
1035; 1xPhospho [S1013]; Location: Cytoplasm, Mitochondria 
 IST2 (YBR086C): Cortical ER protein involved in ER-plasma membrane tethering; one of 6 proteins 
that connect ER to the plasma membrane (PM) and regulate PM phosphatidylinositol-4-phosphate 
(PI4P) levels by controlling access of Sac1p phosphatase to its substrate PI4P in the PM; Position in a 
master protein: [828-855; 1xPhospho [S847]; Location: Plasma membrane, Endoplasmic reticulum 
(cortical) 
 TCB3 (YML072C): Cortical ER protein involved in ER-plasma membrane tethering; one of 6 proteins 
that connect ER to the plasma membrane (PM) and regulate PM phosphatidylinositol-4-phosphate 
(PI4P) levels by controlling access of Sac1p phosphatase to its substrate PI4P in the PM; Is detected in 
a phosphorylated state in mitochondria; Position in a master protein: [101-124; 1xPhospho [S112]; 
Location: Plasma membrane, Endoplasmic reticulum (cortical) 
 TCB1 (YOR086C): Lipid-binding ER protein involved in ER-plasma membrane tethering; one of 6 
proteins that connect ER to plasma membrane (PM) and regulate PI4P levels by controlling access of 
Sac1p phosphatase to its substrate PI4P in PM; Is also localizes to mitochondria; Position in a master 
protein: [33-47; 3xPhospho [S40; S42; S44]; Location: Plasma membrane, Endoplasmic reticulum 
(cortical), Mitochondria 
 GPD1 (YDL022W): NAD-dependent glycerol-3-phosphate dehydrogenase; key enzyme of glycerol 
synthesis, essential for growth under osmotic stress; expression regulated by high-osmolarity glycerol 
response pathway; protein abundance increases in response to DNA replication stress; constitutively 
inactivated via phosphorylation by the protein kinases Ypk1p and Ypk2p, dephosphorylation 
increases catalytic activity; Position in a master protein: [22-36; 2xPhospho [S25; S]; Location: 
Cytoplasm, Peroxisome 
 ORM2 (YLR350W): Protein that mediates sphingolipid homeostasis; Is required for resistance to 
agents that induce unfolded protein response; Orm1p and Orm2p together control membrane 
biogenesis by coordinating lipid homeostasis with protein quality control; Position in a master protein: 
[7-33; 1xPhospho [S]; Location: Endoplasmic reticulum 
 MYO5 (YMR109W): One of two type I myosin motors; Position in a master protein: [1134-1158; 
1xPhospho [T1153]; Location: Cytoplasm, Actin Cytoskeleton 
 SEG1 (YMR086W): Component of eisosome required for proper eisosome assembly; Controls 
eisosome length and shape; Forms heterogeneous patches at plasma membrane in small, medium and 
large buds; Expression is repressed by cAMP; Position in a master protein: [215-225; 296-329; 654- 
667; 442-460; 2xPhospho [S217; S220]; 1xPhospho [S]; 2xPhospho [S656; S]; 1xPhospho [T/S]; 
Location: Plasma membrane 
- LCA VTC2 (YFL004W): Regulatory subunit of the vacuolar transporter chaperone (VTC) complex; Is 
involved in membrane trafficking, vacuolar polyphosphate accumulation, microautophagy and non- 






 SUR7 (YML052W): Plasma membrane protein; Component of eisosomes; Is involved in sporulation 
and plasma membrane sphingolipid content; Position in a master protein: [216-226; 1xPhospho 
[S221]; Location: Plasma membrane 
HSP42 (YDR171W): Small heat shock protein with chaperone activity; Suppresses unfolded protein 
aggregation; Involved in cytoskeleton reorganization after heat shock; Protein abundance increases and 
forms cytoplasmic foci in response to DNA replication stress; Position in a master protein: [213-237; 
1xPhospho [S]; Location: Cytoskeleton 
TY1B-DR6 (YDR365W-B): Transposon Ty1-DR6 Gag-Pol polyprotein; Position in a master protein: 
[363-381; 1xPhospho [S/Y]; Location: Cytoplasm, Nucleus 
SYP1 (YCR030C); Negative regulator of WASP-Arp23 complex; Is involved in endocytic site 
formation; Inhibits actin assembly in vitro; Regulate assembly and disassembly of the septin ring; 
Potential role in actin cytoskeletal organization; Position in a master protein: [257-285; 1xPhospho [S]; 
Location: The mother-bud neck 
EDE1 (YBL047C): Scaffold protein involved in the formation of early endocytic sites; Putative 
regulator of cytokinesis; Is required for localization to and organization of endocytic sites; Interacts 
with other endocytic proteins; Functions upstream of CMK2 in regulating non-apoptotic cell death; 
Position in a master protein: [524-531; 1xPhospho [S]; Location: Cytoplasm, Cytoskeleton 
RTN1 (YDR233C): Reticulon protein; Is involved in the maintenance of tubular ER morphology; 
Regulates the ER asymmetry-induced inheritance block during ER stress; Is involved in ER-derived 
peroxisomal biogenesis; Is involved in phosphatidylserine transfer between the ER and 




Based on the above data on the LCA-driven remodeling of the mitochondrial 
phosphoproteome, we propose the following hypothesis. LCA is known to be a mildly toxic 
molecule with detergent-like properties that elicits a hormetic stress response, which is in part 
responsible for the delay of yeast chronological aging [14, 250]. Exogenous LCA has been shown 
to enter calorically restricted yeast cells, be sorted to mitochondria, amass in the IMM and OMM, 
and alter the concentrations of certain mitochondrial membrane phospholipids [248]. We 
hypothesize that the created by LCA mild stress and/or changes in mitochondrial membrane 
lipidome may convert the mitochondrion into a signaling platform stimulating activities of a 
distinct set of protein kinases and protein phosphatases confined to mitochondria as well as to 
some other cellular compartments. After being activated, these protein kinases and protein 
phosphatases that phosphorylate or dephosphorylate (respectively) certain target proteins; some of 
these target proteins reside in mitochondria, whereas other are in other cellular compartments. 
Following their phosphorylation or dephosphorylation, the phosphorylated or dephosphorylated 
forms of proteins in these other cellular compartments are sorted to mitochondria; they are likely 
not imported into these organelles but attached to their outer surface. The phosphorylated and 
dephosphorylated forms of proteins associated with mitochondria in response to LCA treatment 




these mitochondria-associated phosphorylated or dephosphorylated proteins alter mitochondrial 
functionality and/or allow mitochondria to operate as a signaling platform orchestrating certain 
aging-delaying processes in other cellular locations; and 2) the re-location of phosphorylated or 
dephosphorylated form of some other proteins from their initial cellular sites to mitochondria may 
allow to alter the rates of efficiencies of cellular processes in these initial sites in a way that causes 
a delay of yeast chronological aging. 
To test the above hypothesis, the Titorenko laboratory will attempt to identify protein 
kinases and protein phosphatases responsible for the phosphorylation or dephosphorylation of 
proteins whose phosphorylated or dephosphorylated forms associate with mitochondria in 
response to LCA treatment. The names of protein kinases and protein phosphatases that will be 
interesting to test for their possible involvement in the phosphorylation or dephosphorylation of 
proteins associated with mitochondria in LCA-treated cells are shown in Table 6.6; this table also 
specifies the reason why such involvement needs to be tested. WT and mutant strains carrying 
single-gene-deletion mutations eliminating each of these protein kinases or protein phosphatases 
will be cultured in the nutrient-rich YP (1% yeast extract, 2% peptone) medium containing 0.2% 
glucose with 50 µM LCA (the concentration of LCA that elicits the highest aging-delaying effect) 
or without LCA. Yeast cells will be recovered at days 2, 4 and 7 of culturing to analyze the 
mitochondrial proteome in cells of different chronological ages. A quantitative, label-free mass 
spectrometry approach will be then used to compare phosphoproteomes of mitochondria purified 
from WT and mutant cells that were cultured with or without LCA and recovered for mitochondria 
purification at different days of culturing. 
It will then be tested if single-gene-deletion mutations eliminating each of the protein 
kinases and protein phosphatases of interest influence the extent of yeast longevity extension by 
LCA. Our hypothesis predicts that 1) mutations eliminating protein kinases and protein 
phosphatases that phosphorylate or dephosphorylate proteins associated with mitochondria in 
response to LCA treatment are expected to weaken the extent of yeast longevity extension by LCA; 
and 2) mutations eliminating protein kinases and protein phosphatases that do not phosphorylate 
or dephosphorylate proteins associated with mitochondria in response to LCA treatment are 




Table 6.6. The names of protein kinases and phosphatases need to be tested (and the reason why they need to 
be tested) for the possible involvement in the phosphorylation or dephosphorylation of proteins associated with 
mitochondria in LCA-treated cells. 
 
Name Reason 
Tpk1 A catalytic subunit of PKA, which phosphorylates core protein components of mitochondrial protein 
import machinery 
Yck1 An isoform of CK1, which phosphorylates core protein components of mitochondrial protein import 
machinery 
Yck2 An isoform of CK1, which phosphorylates core protein components of mitochondrial protein import 
machinery 
Cka1 A catalytic subunit of CK2, which phosphorylates core protein components of mitochondrial protein 
import machinery and mitophagy 
Cka2 A catalytic subunit of CK2, which phosphorylates core protein components of mitochondrial protein 
import machinery and mitophagy 
Hog1 The MAPK which in response to cell-surfaces stresses stimulates the Cka2-dependent phosphorylation 
of Atg32, a mitochondrial receptor for mitophagy 
Tor1 A protein kinase subunit of the target of rapamycin complex 1 (TORC1), the key nutrient sensor 
Tap42 A downstream effector of TORC1, which regulates PP2a and PP2A-like protein phosphatases 
Sch9 A downstream effector of TORC1 and a nutrient-sensing protein kinase, which regulates oxidative 
phosphorylation and protein synthesis in mitochondria 
Pkp1 A mitochondrial protein kinase, which inhibits mitochondrial pyruvate dehydrogenase by 
phosphorylating its E1  subunit; found only in mitochondria 
Pkp2 A mitochondrial protein kinase, which inhibits mitochondrial pyruvate dehydrogenase by 
phosphorylating its E1  subunit; found only in mitochondria 
Ptc5 A mitochondrial protein phosphatase, which activates mitochondrial pyruvate dehydrogenase by 
dephosphorylating the phosphorylated form of its E1  subunit; found only in mitochondria 
Ptc6 A mitochondrial protein phosphatase, which activates mitochondrial pyruvate dehydrogenase by 
dephosphorylating the phosphorylated form of its E1  subunit; found only in mitochondria 
Fmp48 A mitochondrial protein kinase of unknown function; found only in mitochondria 
Ptc7 A mitochondrial protein phosphatase of unknown function; found only in mitochondria 
 
The above analysis is expected to identify protein kinases and protein phosphatases 
responsible for the phosphorylation or dephosphorylation of proteins whose phosphorylated or 
dephosphorylated forms associate with mitochondria in response to LCA treatment. The Titorenko 
laboratory will use this knowledge to formulate and to test further hypotheses on how the regulated 
protein phosphorylation and dephosphorylation of certain mitochondrial proteins by a distinct set 
of protein kinases and protein phosphatases may underlie the delay of yeast chronological aging 
by LCA. 
Although some of the single-gene-deletion mutations eliminating each of the protein 
kinases or protein phosphatases of interest may weaken or enhance the extent of yeast longevity 
extension by LCA, these effects may be non-specific (i.e. may not be due to changes in the 
phosphorylation state of specific mitochondrial proteins). Indeed, some of the protein kinases and 
protein phosphatases are known for their abilities to phosphorylate and dephosphorylate 




may therefore require testing how phosphomimetic and non-phosphorylatable mutations at the 
critical phosphorylation sites of each of the mitochondrial proteins of interest influence the extent 
of yeast longevity extension by LCA; mitochondrial proteins of interest are the ones whose 
phosphorylated or dephosphorylated forms associate with mitochondria in response to LCA 
treatment. Phosphomimetic mutations at the phosphorylation sites are known to result in amino 
acid substitutions that mimic a phosphorylated protein; such substitutions include serine for 
aspartate as well as serine or threonine for glutamate. Non-phosphorylatable mutations at the 
phosphorylation sites yield amino acid substitutions that prevent protein phosphorylation at a 
serine, tyrosine or threonine site; such substitutions include serine or threonine for alanine as well 




7 General conclusions 
 
 
Studies described in this thesis have revealed that some of the molecular and cellular 
mechanisms through which CR and LCA delay yeast chronological aging are common to these 
two longevity-extending interventions. Among the mechanisms of aging delay that CR and LCA 
have in common are the following ones: 1) both CR and LCA shift a balance between the processes 
of mitochondrial fusion and fission toward fusion, thus postponing the age-related onset and 
slowing the progression of the mitochondria-controlled apoptotic mode of regulated cell death; 
and 2) both CR and LCA stimulate the peroxisome-to-mitochondrion transport of acetyl-CoA via 
the carnitine shuttle, thereby delaying the age-related onset of the decline in mitochondrial 
functionality. 
We found that some mechanisms of yeast chronological aging delay are specific only to 
CR or LCA. Indeed, only CR (but not LCA) decelerates the chronological aging process in part 
because it causes a significant rise in the concentration of trehalose, thus postponing the age-related 
onset of the deterioration in cellular proteostasis. Moreover, only LCA (but not CR) slows down 
the chronological aging process in part because it stimulates the Mpc1/Mpc3 mitochondrial 
pyruvate carrier involved in the cytosol-to-mitochondrion transport of pyruvate, thereby 
postponing the age-related onset of the decline in mitochondrial functionality. 
Finally, although both CR and LCA delay the age-related onset and decelerate the 
progression of the FFA-driven liponecrotic form of regulated cell death, these two longevity- 
extending interventions decrease the concentration of FFA via different mechanisms. CR lowers 
the concentration of FFA by stimulating both TAG lipolysis in LD and the subsequent peroxisomal 
β-oxidation of FFA (the product of such lipolysis). In contrast, LCA lessens the concentration of 
FFA by promoting TAG synthesis from FFA in LD. 
In sum, studies described in this thesis have demonstrated that intercompartmental 
communications between the ER, LD, peroxisomes, mitochondria and the cytosol play essential 
roles in regulating the pace of chronological aging in S. cerevisiae. Furthermore, CR and LCA 
control some of these intercompartmental communications through similar mechanisms. However, 
other intercompartmental communications are controlled by CR and LCA via mechanisms that are 
specific for each of these two longevity-extending interventions. Based on these findings, we 




extension represent the core mechanisms that are controlled by many aging-delaying and 
longevity-extending interventions, whereas other such mechanisms have evolved as an adaptation 
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